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ABSTRACT
Despite a century of research and practice, the clinical accuracy of the electrocardiogram 
(ECG) to detect and localize myocardial ischemia remains less than satisfactory. Myocardial 
ischemia occurs when the heart does not receive adequate oxygen-rich blood to keep up 
with its metabolic requirements, and severe ischemia can lead to myocardial infarction and 
life-threatening arrhythmias. Early and accurate detection is an essential component of 
managing this condition.
Ischemia is known to be a dynamic condition tha t reflects a changing imbalance between 
blood supply and metabolic demand so tha t it is natural tha t examination under physical 
stress conditions or exercise testing (ET) is in widespread clinical use. However, ET 
is characterized by poor sensitivity (68%) and specificity (77%), limiting its diagnostic 
usefulness and providing the motivation to address some gaps in our understanding of 
myocardial ischemia and its ECG signature.
This dissertation is composed of three studies. The aim of the first study was to evaluate 
the conventionally held mechanisms for nontransmural ischemia using intramural electrodes 
to measure three-dimensional potential distributions in the ventricles of animals exposed 
to acute ischemia. We demonstrated tha t contrary to accepted dogma, the electrocar­
diographic response of acute myocardial ischemia originated throughout the ventricular 
wall, i.e., in the subendocardium, midmyocardium, or the subepicardium, under various 
conditions.
Our goal in the second study was to evaluate whether acute myocardial ischemia follows 
a similar pattern of spatial and temporal evolution as seen in myocardial infarction. Our 
findings show that the spatial and temporal evolution of acute ischemia is characterized 
by multiple distinct regions tha t expand in all three directions, with maximal expansion 
in the circumferential direction, especially in the early stages of ischemic development. 
Furthermore, with increased stress, these regions continue to expand and eventually merge 
into one another, and in the extreme become transmural. The progression of myocardial 
infarction, by contrast, was very quickly transmural in extent and formed a cohesive block 
of affected tissues.
The aim of the third study was to evaluate the sensitivity of epicardial electrical markers 
of acute ischemia relative to direct evidence of ischemia derived from intramural electro­
grams. The key finding from this study is tha t the epicardial T-wave is a more sensitive 
index of acute ischemia than epicardial ST segment changes, especially in the early stages 
of acute ischemia development.
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I dedicate this dissertation to my parents, Kirtikumar and Padma. I hope that this 
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CHAPTER 1
INTRODUCTION
Coronary artery disease (CAD) is one of the leading causes of mortality in the United 
States, affecting over 13 million people, with half suffering from myocardial (cardiac) 
ischemia [1]. Cardiac ischemia is a pathological condition tha t occurs when the heart does 
not receive enough oxygen-rich blood to keep up with its metabolic requirements. Severe 
ischemia leads to a heart attack, cell damage, and life-threatening arrhythmias so tha t early 
and accurate detection is an essential component of managing this condition.
The electrocardiogram (ECG) records the electrical activity of the heart and is used as a 
central tool to establish the diagnosis of myocardial ischemia. ECG evidence of myocardial 
ischemia includes shifts in the ST segment, the portion of the ECG between the end of the 
QRS complex and the beginning of the T-wave, all of which are described below in more 
detail. The use of ECG for ischemia diagnosis is most critical in two clinical settings and the 
consequences of errors in interpretation most costly. The first is the emergency room (ER), 
in which an ECG is often recorded in patients with symptoms of chest pain. Unfortunately, 
a relatively high percentage of the cases of myocardial ischemia occur without chest pain 
symptoms [1], a syndrome known as silent ischemia. Moreover, the ECG may also be 
normal or nonspecific in a patient with myocardial ischemia, leading to diagnostic errors of 
30-50% [1]. The second setting is exercise stress testing (ET), which is a noninvasive tool 
to evaluate cardiovascular response to exercise under controlled conditions. If the heart 
does not receive enough oxygenated blood during the test, it may produce abnormalities in 
the ECG suggestive of myocardial ischemia and underlying CAD. However, ET has poor 
sensitivity (68%) and specificity (77%) [1].
This poor performance of the ECG for detecting ischemia provides powerful motivation 
to address some gaps in our understanding of myocardial ischemia and its electrocar­
diographic signature. Additional motivation comes from the fact tha t the ECG remains 
the most widely available diagnostic tool that is painless, noninvasive, safe, and easy to 
perform. Accurate and robust characterization of the heart's electrocardiographic response
2to acute episodes of cardiac ischemia would provide the basis for improving the accuracy of 
myocardial ischemia detection and result in more effective treatments. The research in this 
dissertation focused on advancing this goal through a series of acute ischemia studies using 
high-resolution mapping of cardiac potentials.
We first investigated the spatial origins of acute myocardial ischemia through qualitative 
and quantitative analysis of different types and degrees of cardiac ischemia tha t we could 
induce in animal models. We began with an evaluation of the current dogma regarding the 
spatial organization and distribution of especially nontransmural ischemia and suggested an 
alternative formulation that better supports the available data. Next, we characterized the 
spatio-temporal progression of acute cardiac ischemia, again with the goal of establishing a 
robust description of the sequence of ischemia development over the acute time frame. The 
third and most clinically relevant component of the research was to extend these results 
to the cardiac surface with the goal of establishing realistic estimates of the degrees to 
which ischemic changes are detectable from the heart surface. The results from the third 
project provided valuable insights about information available on the cardiac surface relative 
to the location of nontransmural ischemia. The cumulative results from our studies have 
provided new understanding of the underlying bioelectric sources, their spatial organization 
and temporal progression, and the extent to which the cardiac surface ECG is sensitive to 
them.
1.1 Background and Significance
1.1 .1  M y o c a rd ia l  I s c h e m ia  P ro f ile
Each year in the Western world, there are about 5.8 million new cases of coronary artery 
disease (CAD), and about 40 million individuals with prevalent CAD are alive today [2]. 
In the United States, CAD is the single leading cause of death in adults, accounting for 
one in five deaths [2]. It is estimated that over 13 million Americans have CAD, about one 
half of whom experience episodes of myocardial ischemia [2]. The estimated annual health 
care burden in the US associated with CAD is about $142.5 billion USD [2]. Myocardial 
ischemia can be defined as an imbalance between the supply of oxygenated blood and the 
oxygen requirements of the heart [3]. Myocardial ischemia resulting predominantly from 
increased myocardial oxygen demand in the presence of critical narrowing of a coronary 
artery is termed demand ischemia. By contrast, myocardial ischemia caused predominantly 
by reduction of coronary blood flow is termed supply ischemia. Demand ischemia occurs 
in most episodes of stable angina (chest pain), whereas supply ischemia is associated with
3most episodes of unstable angina. Myocardial ischemia can also arise from a combination 
of both an increase in oxygen demand and a reduction in supply, i.e., supply an d  demand 
ischemia. According to its location, cardiac ischemia is also classified as transmural ischemia 
if it affects the full thickness of the ventricular wall or nontransmural ischemia if the injury 
does not span the entire thickness of the ventricular wall.
1 .1 .2  C o ro n a ry  P e r fu s io n  a n d  M y o c a rd ia l  I s c h e m ia
Since ischemia reflects an imbalance between blood supply and metabolic demand, it 
is important to understand the many parameters and regulatory mechanisms that control 
this central homeostatic system. On the side of metabolic demand, the main parameters 
dictating cardiac oxygen consumption are heart rate (chronotropy), cardiac contractility 
(inotropy), and left ventricular (LV) wall stress. At maximal levels, heart rate can increase 
threefold, contractility three- to fivefold [1]. The main mechanism to bring more oxygen 
to the myocardium upon increased demand is to increase coronary blood flow, which is 
regulated to continuously and dynamically match variation in metabolism. In fact, at 
maximal metabolic load (e.g., maximal exercise), coronary blood flow can reach values up 
to three to five times those at rest [1]. This difference between values at rest and maximal 
levels of coronary flow represents the coronary flow reserve. W hat is known as “coronary 
autoregulation” is the most powerful mechanism by which coronary flow reserve is recruited 
to maintain the desired perfusion level. Autoregulation is a local mechanism, i.e., it requires 
no control from the brain or nervous system, tha t has the ability to maintain a suitable blood 
flow despite changes in metabolic demand and local perfusion pressure. When the blood 
pressure falls, arterial resistance is reduced as the small arteries and arterioles dilate. The 
reduction in resistance causes blood flow to remain stable despite the presence of reduced 
perfusion pressure.
Myocardial ischemia represents a breakdown in this homeostasis and has a variety of 
consequences depending on the severity of the reduction in coronary blood flow, the length 
of the ischemic insult, the area of the myocardium served by the occluded artery, and the 
presence of collateral vessels from other adjacent beds within the heart. Under the most 
severe instances of complete occlusion of blood flow, myocardial ischemia can progress to 
myocardial infarction (heart attack) characterized by tissue death and, if left untreated, 
necrosis and scar.
41 .1 .3  P a th o p h y s io lo g y  o f  M y o c a rd ia l  Is c h e m ia
While the origins of ischemia are hemodynamic, there are rapid and profound elec- 
trophysiological consequences, changes that often represent the most lethal clinical im­
pacts of this condition. Carmeliet [4], in his exhaustive review of the electrophysiologi- 
cal changes during myocardial ischemia, described a series of metabolic, ultrastructural, 
mechanical, and electrical changes within myocardial cells and tissues tha t occurs during 
acutely compromised coronary blood flow. The myocardium becomes cyanotic because of 
the consumption of freely diffusible oxygen, causing decreased tissue oxygen tension. W ith 
increasing tissue hypoxia, intracellular respiration shifts from aerobic to anaerobic form. 
Adenosine triphosphate (A TP) stores are rapidly depleted, and characteristic metabolic 
changes occur in the ischemic tissue, including accumulation of tissue lactate, H+ ions, 
phosphate, and potassium. U ltrastructural changes consist of reduction in the size and 
number of glycogen granules, intracellular edema, swelling and distortion of mitochondria, 
and eventually margination of nuclear chromatin and relaxation of myofibrils. Diminished 
ATP stores and alteration of Ca++ lead to impairment of cardiac contractile function.
The most important consequences of ischemia from the perspective of the ECG and this 
research are those related to altered action potential shape and amplitude. The electrical 
changes in ischemic cells include a marked elevation in resting membrane potential due 
to increased extracellular K+ concentration, reduced action potential (AP) amplitude and 
a reduced rate of AP upstroke due to decreased inward Na+ current, and shortened AP 
duration due to reduced inward Ca++ current. These changes do not occur uniformly 
in space, and the resulting variations in action potential amplitude and morphology in 
different parts of the heart lead to what are known as “injury currents,” which ultimately 
cause important changes in the ECG tha t we describe in the next section.
1 .1 .4  E C G  M a rk e r s  fo r M y o c a rd ia l  I s c h e m ia
ECG records the electrical activity of the heart from the body surface and can detect 
noninvasively the occurrence of myocardial ischemia. The waves in the ECG reflect the 
sequence of electrical excitation and recovery as it moves through the atria and the ven­
tricles. Fig. 1.1(a) shows schematically the relationship between the activation sequence 
and the resulting phases/waves of the ECG. The P-wave represents the progression of 
atrial depolarization as it moves from the sino-atrial (SA) node across the right and then 
left atria. The QRS complex reflects the corresponding rapid depolarization of the right 
and left ventricles initiated when activation passes from the atria through the specialized 
conduction system of the atrio-ventricular (AV) node and the Bundle of His into the Purkinje
5Fig. 1.1. Clinical model of ischemia: (a) Electrocardiogram (ECG), (b) ventricular ac­
tion potentials (AP) under normal (blue) and ischemic (orange) conditions, (c) classical 
electrocardiography theory. ST segment elevation is diagnosed as ST segment elevation 
myocardial infarction (STEMI) or transmural ischemia, whereas ST segment depression is 
diagnosed as non-ST segment elevation myocardial infarction (NSTEMI) or unstable angina 
or nontransmural ischemia.
fiber network. The T-wave represents the repolarization of the ventricles, i.e., the gradual 
return of ventricular action potentials to resting values. Of special importance in the setting 
of ischemia is the “ST segment,” which connects the QRS complex and the T-wave and 
represents the period when the ventricles are depolarized. Under normal conditions, the 
ST segment is isoelectric, i.e., the action potentials all reach approximately the same value 
and so there are no potential differences across the myocardium and hence no current.
During cardiac ischemia, regional changes in the AP morphology of ischemic cells bring 
about alterations in the ECG. Best documented and used for clinical diagnosis are changes 
in the ST segment (described in more detail below). However, there are also changes in the 
QRS complex tha t include changes in amplitude, inversion of complex polarity, loss of some
6constituent waves, and in the case of conduction slowing, widening of the QRS complex. 
Abnormal repolarization during ischemia may also change the amplitude and polarity of 
the T-wave.
The most important ECG diagnostic marker for ischemia detection remains the upward 
or downward shifts in the ST segment, which occur within 15-30 seconds after the onset of 
ischemia [5]. ST segment shifts are caused by localized electrical changes tha t occur in the 
action potentials of ischemic cells, especially shortening of duration, diminished amplitude, 
and elevation of resting membrane potential. Fig. 1.1(b) shows these changes schematically, 
with the blue line indicating a normal action potential and the orange line a typical 
ischemic action potential. Regional differences in membrane action potentials generate 
injury currents and produce deflections from the isoelectric potentials of a healthy heart. 
Fig. 1.1(c) shows the resulting changes in ST segments, the orientation of which depends on a 
set of geometric factors, both of the ischemic region and the location of the sensing electrode 
relative to the ischemic zone. For example, a positive deflection (upward shift) occurs if the 
injury current is flowing toward the recording electrode and a negative deflection (downward 
shift) if the injury current is oriented away from the electrode. For electrodes located over 
the heart, ST segment elevation (upward shift) is often thought to represent transmural 
ischemia, usually leading, if untreated within 1-2 hours, to an infarction (heart attack), 
whereas ST segment depression is considered a sign of nontransmural, typically transient 
ischemia.
This diagnostic model for ischemia detection is based in part on the dogma tha t myocar­
dial ischemia arises first in the subendocardium, thus generating intracellular injury current 
flowing towards the endocardium and away from precordial ECG electrodes. Over time or 
under increased stress, the ischemic region expands towards the epicardium, eventually 
becoming transmural, and the injury current begins to flow towards the recording electrode 
and thus produce ST segment elevation.
1 .1 .5  E C G -B a s e d  D e te c t io n  o f  Is c h e m ia
The use of ECG for ischemia diagnosis is critical in two clinical settings: the emergency 
room (ER) and exercise testing (ET). In the ER, a 12-lead ECG with the patient at rest is 
often recorded in patients with symptoms suggestive of ischemia, e.g., chest pain (angina), 
shortness of breath, or dizziness; however, the ECG is normal in up to 50% of the patients 
who actually have chronic stable angina [1]. A further source of confounding error is the 
finding tha t in approximately 70% of cases of true cardiac ischemia, there are no clear 
symptoms of chest pain, a syndrome known as silent ischemia [1]. Exercise testing (ET)
7is a very broadly used method to evaluate the functional reserve present in a patient with 
suspected CAD. It is based on the simple idea tha t by increasing metabolic demand through 
physical or pharmacological stress, it is possible to exceed the coronary flow reserve and 
elicit electrocardiographic symptoms of ischemia. While simple and safe to carry out in 
the carefully controlled conditions of the hospital, ET has poor accuracy (sensitivity of 
approximately 70% and specificity of only 80%) [6], which has motivated the development 
of other, typically slower and/or more costly approaches to ischemia diagnosis.
1 .1 .6  C lin ic a l M o d a li t ie s  fo r D e te c t in g  Is c h e m ia
In large part because of the limited accuracy of ECG-based diagnosis, there are other 
clinical modalities available, both noninvasive and invasive, to establish the diagnosis of 
ischemia with varying degrees of accuracy. Echocardiography (Echo) is a noninvasive 
approach based on ultrasound to evaluate cardiac structure and function with images that 
have limited resolution and high noise levels but can capture two and even three dimensions 
as functions of time. In this way, Echo can establish diagnosis of ischemia based on regional 
systolic or diastolic wall motion abnormalities. Echo has a mean sensitivity of 70% and 
mean specificity of 80%, which is similar to the ECG. Myocardial perfusion imaging (MPI) 
using any one of several imaging modalities is another noninvasive approach available 
for ischemia diagnosis. Single-photon emission computed tomography (SPECT) MPI is 
performed using a scintillation camera and an intravenously injected nuclear tracer (e.g., 
isotope thallium-201) that over time, distributes itself through the heart in proportion to 
the regional myocardial perfusion, thus providing a map of blood flow to the heart. MPI has 
higher sensitivity (90%) and lower specificity (70%) compared to ECG and also requires tens 
of minutes to acquire and so cannot capture rapid changes in ischemia. Biochemical assays 
tha t detect cardiac markers such as creatine kinase (CK) and cardiac troponins T (cTnT) 
and I (cTnI) released into the blood by damaged cardiomyocytes are also used for diagnosis 
of ischemia. These markers have high sensitivity to detect cardiac injury, but they are also 
very slow (typically tens of minutes) and not specific for the etiology of cardiac injury, i.e., 
they may be the result of any number of illnesses, including diabetes, hypertrophy, etc. 
Perfusion can also be traced using coronary angiography, which is a marginally invasive 
procedure that entails passing a catheter through an artery into the heart and uses a 
special dye and x-rays to detect blood flows through the heart and into the myocardium. 
The dye highlights any restrictions or blockages in the coronary blood flow and remains the 
gold standard against which the accuracy of all other CAD diagnostic tools is measured. A
8related, novel approach tha t eliminates the burden of ionizing radiation is angiography and 
perfusion imaging based on MRI [7, 8]. Conceptually similar to X-ray-based approaches, 
MRI perfusion imaging also has poor temporal resolution and high cost and functions poorly 
as a monitoring approach.
1.2 Study Aims
Early and accurate detection of myocardial ischemia remains a key component of manag­
ing this condition. ECG remains the most widely available diagnostic tool tha t is painless, 
noninvasive, safe, and easy to perform. Moreover, the equipment is readily available, 
inexpensive, and portable. However, the clinical performance of ECG in detecting and 
localizing the extent of cardiac ischemia remains unsatisfactory, providing the motivation to 
address some gaps in our understanding of myocardial ischemia and its ECG signature. The 
goal of this research was to characterize the electrocardiographic response of the heart during 
acute myocardial ischemia through a series of acute ischemia studies using high-resolution 
mapping of cardiac potentials. The ischemia studies included canine and swine animal 
models. The study protocol was designed to simulate stress testing and entailed inducing 
demand or supply ischemia by controlling the heart rate and coronary perfusion. During the 
ischemia study, electrograms were recorded from the cardiac surface as well as the intramural 
regions. These recorded electrical potentials were used to generate high-resolution potential 
maps and analyzed to determine the spatial origins and distribution of ischemia, determine 
the spatio-temporal progression of nontransmural ischemia, and finally evaluate the sensi­
tivity of cardiac surface electrograms to variations in location and extent of nontransmural 
ischemia.
To address these research goals, we have carried out studies focused around the following 
three specific aims.
1 .2 .1  A im  1 - S p a t ia l  O r g a n iz a t io n  o f  I s c h e m ia
Current literature suggests tha t myocardial ischemia originates from the subendocardium. 
However, studies done in the past have relied on measurements primarily on the epicardial 
and endocardial surfaces. Moreover, those relatively few reported cases of intramural 
measurements have been limited by sparse spatial resolution. The goal of this study 
was to characterize the electrocardiographic response of the heart during acute myocardial 
ischemia through a series of acute ischemia studies using high-resolution mapping of cardiac 
potentials. We investigated the spatial origins of different types and degrees of acute 
myocardial ischemia. Despite widespread use, the link, especially quantitatively, between
9the direction and extent of ST segment shifts and the putative mechanisms of ischemia is 
equivocal and thus the cause of persistent clinical error. Based on our findings, we suggest 
an alternative formulation tha t better supports the available data and provides a better 
understanding of bioelectric sources during cardiac ischemia.
1 .2 .2  A im  2 - S p a t io -T e m p o ra l  E v o lu tio n  o f  Is c h e m ia
Reimer et al. [9] in their study on canine models induced irreversible ischemic injury 
characterized by necrosis and suggested tha t ischemia progresses as a transmural wavefront 
from the subendocardium to subepicardium. We profiled the spatio-temporal progression of 
acute ischemia in order to characterize the way ischemia develops over the acute time frame 
and determine whether it follows a similar pattern of spatial and temporal evolution as is 
seen in myocardial infarction. The high-resolution mapping of cardiac potentials enabled 
us to provide a much more refined description of the progress of nontransmural acute to 
transmural ischemia.
1 .2 .3  A im  3 - S e n s i t iv i ty  o f  E le c tr ic a l  M a rk e r s  to  Is c h e m ia
Classical electrocardiographic theory suggests tha t ST segment elevation on the body 
surface ECG reveals transmural ischemia, whereas ST segment depression is the result of 
subendocardial ischemia [10]. However, numerous clinical and experimental studies suggest 
tha t this theory is, at best, incomplete. Some studies have suggested tha t ST segment 
depression is “reciprocal” to the presence of ST segment elevation [11]. Li et al. used a 
sheep model in their acute ischemia studies and showed tha t reducing flow in two different 
major coronary arteries produced similar epicardial ST segment potential distribution, even 
though intramural recordings showed that occlusion of different arteries resulted in distinctly 
different ischemic zones [12]. We evaluated the sensitivity of cardiac surface electrograms to 
localize acute myocardial ischemia. The goal of this study was to evaluate different electrical 
markers for their potential to detect the earliest phases of acute myocardial ischemia. Our 
findings indicate that a combination of markers may provide a more reliable index of acute 
ischemia.
1.3 Organization of the Dissertation
The dissertation is divided into seven chapters. Chapter 1 provides an overview of the 
dissertation. Chapter 2 includes background on cardiac anatomy, physiology, electrophysiol­
ogy, pathophysiology of myocardial ischemia, and patient evaluation tools to diagnose CAD 
and a review of relevant literature to appreciate the subsequent chapters. Chapter 3 provides
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an overview of the study design including the data acquisition and processing pipeline. 
Chapter 4 is a journal paper that has been submitted to the Journal of Electrocardiology 
and presents the results from spatial organization of myocardial ischemia. Chapter 5 is a 
journal paper tha t has been submitted to the Journal of Electrocardiology and deals with 
the spatio-temporal progression of ischemia. Chapter 6 is a paper published in the Journal 
of Electrocardiology 2014 and presents the results of a sensitivity study of cardiac surface 




This chapter provides the necessary background to appreciate the research behind the 
electrocardiographic characterization of acute myocardial ischemia. Accordingly, we cover 
elements of cardiac anatomy and physiology, include an overview of cardiac electrophysiol­
ogy, describe the pathophysiology of myocardial ischemia, highlight the clinical diagnostic 
tools and techniques used to evaluate and treat patients with myocardial ischemia, and 
finally include a summary of the literature relevant to this research.
2.1 Cardiac Anatomy
The heart is a hollow, cone-shaped muscular organ that serves as the blood circulatory 
pump for the body. It is located in the thoracic cavity medial to the lungs and behind 
the sternum. The heart has four chambers: the right atrium, left atrium, right ventricle, 
and left ventricle. The atria act as receiving chambers for blood and pass blood through 
one-way valves to the ventricles. They are the pumping chambers tha t carry blood through 
arteries to the rest of the body. To prevent blood from flowing backwards or regurgitating 
back into the heart, a system of four one-way valves is present in the heart: atrioventricular 
valves (tricuspid, mitral) and semilunar valves (pulmonary, aortic). We briefly cover the 
structural and functional anatomy of the heart below.
2 .1 .1  P e r ic a r d iu m  a n d  H e a r t  W a ll
The heart sits within a fluid-filled sac-like membrane known as the pericardium, as 
shown in Fig. 2.1. The pericardium is a type of two-layer membrane tha t produces fluid 
to lubricate the heart and prevent friction between the beating heart and the surrounding 
organs. The two layers of the pericardium are the outer fibrotic layer and the inner, serous 
layer, which, in turn, consists of parietal and inner visceral layers [1]. The fibrous parietal 
pericardium envelopes the heart and attaches to the great vessels and to the delicate parietal 
layer of the serous layer. The inner visceral layer of the serous pericardium forms the outer
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Fig. 2.1. Structure of heart wall. Reprinted with permission from Wikimedia and Bruce 
Blausen. Retrieved from h ttp ://com m ons.w ik im ed ia .o rg . Used under creative commons 
attribution-noncommercial-sharealike 3.0 generic license (h ttp ://c re a tiv e c o m m o n s .o rg /) .
lining of the heart and great vessels. Besides lubrication, the pericardium also serves to 
hold the heart in position and maintain a hollow space for the heart to expand into when 
it is full. The heart wall contains three loosely defined concentric regions: the epicardium, 
midmyocardium, and endocardium. The epicardium is the outermost layer of the heart 
and is just another name for the visceral pericardium [1]. The myocardium is the muscular 
middle layer of the heart and makes up the majority of the thickness and the mass of the 
heart wall. The endocardium forms the inner lining of the heart.
2 .1 .2  C a rd ia c  C e ll T y p e s
The heart is composed of different types of cells including epicardial cells, working 
cardiomyocytes, smooth muscle cells, cardiac fibroblasts, endothelial cells, pacemaker cells, 
Purkinje fibers, and the other elements of the conduction system [13], as shown in Fig. 2.2.
All these cell types play a role in the structural, biochemical, and electrical functioning
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Fig. 2.2. Cardiac cell types. Reprinted with permission from Nature Publishing Group. M. 
Xin, E. Olson, and R. Bassel-Duby, “Mending broken hearts: Cardiac development as a 
basis for adult heart regeneration and repair,” Nature Reviews Molecular Cell Biology, vol. 
14, pp. 529-541, 2013.
of the heart. The epicardium is derived from a cluster of mesothelial cells, called the 
proepicardium [1]. The proepicardium gives rise not only to the epicardium but also to 
epicardium-derived cells: smooth muscle cells, cardiac fibroblasts, and possibly endothelial 
cells [13]. The myocardium is composed of cardiomyocytes, which are the cells tha t generate 
contractile force in the heart required for pumping blood. The atrial and ventricular 
myocytes are rod shaped and contain a large amount of contractile proteins, organized 
in clearly periodic myofibrils, a large number of mitochondria, and glycogen deposits [14]. 
Smooth muscle cells contribute to the formation of coronary arteries, as well as the inflow 
and outflow vasculature [13]. Cardiac fibroblasts play an important role in maintaing 
normal cardiac function (e.g., synthesis and deposition of extracellular matrix, cell-cell 
communication with cardiomyocytes), as well as in cardiac remodeling during pathological 
conditions such as myocardial infarction [15]. Endothelial cells line the endocardial region, 
the interior lining of the blood vessels, and cardiac valves [13]. Pacemaker cells (SA and 
AV nodal cells) and Purkinje fibers are specialized cardiac cells that form the electrical 
conduction system in the heart. The SA and AV nodal cells are small and generally spindle
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shaped with little contractile material (myofibrils) but a high density of mitochondria. 
Moreover, in lieu of a less-developed T-tubule system, they have many caveolae that contain 
a high density of receptor and channel proteins [16]. The Purkinje cells are similar in shape 
to contractile myocytes but are larger, have less contractile material, and contain a high 
concentration of glycogen deposits [14]. The pacemaker cells generate and conduct electrical 
impulses but due to the lack of contractile machinery do not contract like the atrial and 
ventricular cardiomyocytes.
The cardiac chambers are shown in Fig. 2.3. The right atrium  (RA) is the first cardiac 
structure to receive blood returning from the body. It has a prominent internal muscle 
ridge, the crista terminals, which is nonconductive and separates the right atrial free wall 
into a smooth-walled posterior region tha t receives the venae cavae and coronary sinus [1]. 
There is also a muscular anterior region lined by parallel pectinate muscles and from which




Fig. 2.3. Cardiac chambers. Reprinted with permission from leavingcertbiology.net (John 
Loughlin). Retrieved from h t tp : / / le a v in g c e r tb io lo g y .n e t , 2015.
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the right atrial appendage emanates. The right atrial appendage abuts the right aortic 
sinus and overlies the right coronary artery [1].
The atrial septum (AS) divides the right and left atrial chambers. It is composed of 
interatrial and atrioventricular regions. The interatrial portion is highlighted by the fossa 
ovalis [1]. During the fetal development of the heart, the fossa ovalis is known as the foramen 
ovale and serves as an opening between the right and left atria, allowing blood to pass from 
the right to left atrium and into the left ventricle, effectively bypassing the lungs [1]. After 
birth, the opening closes as the blood flow shifts through the right ventricle into the lungs 
and enters the left atrium by way of pulmonary veins. The atrioventricular (AV) portion of 
the atrial septum is made up of major muscular and minor membranous components and 
separates the right atrium from the left ventricle. It corresponds roughly to the “triangle of 
Koch,” which contains the AV node and the proximal portion of the AV (His) bundle [1].
The left atrium (LA) usually receives four pulmonary veins that connect to the posterior 
wall of the chamber. The atrial appendage arises anterolaterally and lies atop the proximal 
portion of the left circumflex coronary artery [1]. The left atrial appendage is smaller, more 
tortuous, and less pyramidal than its right atrial counter part and is often multilobed [1]. 
In contrast to the right atrial free wall, the left has no crista terminals and no pectinate 
muscles outside its appendage. The coronary sinus travels along the posterior wall of the 
left atrium.
The right ventricle (RV) receives blood from the right atrium. It is composed of an 
inlet and trabecular and outflow segments [1]. The inlet component extends from the 
tricuspid annulus to the insertions of the papillary muscles. An apical trabecular zone 
extends inferiorly beyond the attachments of the papillary muscles toward the ventricular 
apex [1]. The outflow portion, also known as the conus or the infundibulum, is a smooth- 
walled muscular subpulmonary channel. A prominent arch-shaped muscular ridge known 
as the crista supraventricularis separates the tricuspid and pulmonary valves and is made 
up of four distinct components: parietal band, infundibular septum, septal band, and the 
moderator band [1]. These components encircle the main region of the right ventricle.
The left ventricle (LV) is the largest and the strongest chamber of the heart and like 
the right ventricle is made of an inlet portion composed of the mitral valve apparatus, a 
subaortic outflow portion, and a finely trabeculated apical zone [1]. The upper aspect of 
the ventricle, the area where the mitral and aortic valves are located, is referred to as the 
base of the chamber. At the far end of the chamber is the ventricular apex. The LV free 
wall is thickest towards the base and thinnest towards the apex. The LV free wall is nearly
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three times thicker than the right ventricular free wall [1]. The LV apex shows much less 
trabeculation than its counterpart on the right. LV false tendons are discrete, thin, cordlike 
fibromuscular structures tha t connect two walls, the two papillary muscles, or a papillary 
muscle to a wall, usually the ventricular septum [1].
The ventricular septum (VS) is a complex intracardiac partition separating the left and 
right ventricles. It is slanted backwards and to the right, and it also curves to the right 
following the course of an inverted S (moving from apex to aortic valve) [1]. The VS can also 
be divided into muscular and membranous portions. The upper portion, which separates 
the aortic vestibule from the lower part of the right atrium and the upper part of the right 
ventricle, is much thinner and fibrous and is termed the membranous VS [1]. The greater 
part of the VS is thick and muscular and constitutes the muscular VS. The basal half of 
the VS is smooth-walled, whereas the apical half is characterized by numerous small and 
irregularly arranged trabeculation [1].
2 .1 .4  C a rd ia c  S k e le to n  a n d  C a rd ia c  V alv es
The cardiac valves are anchored to their annuli or valve rings. These fibrous rings, at 
the base of the heart, join to form the fibrous skeleton of the heart. The centrally located 
aortic valve forms the cornerstone of the cardiac skeleton, and its fibrous extensions abut 
each of the other three valves. The four rings are mutually supported and held together by 
the right and left fibrous tissues and by the conus tendon [1]. From the right side of the 
aortic ring, the membranous portion of the interventricular septum extends downward to 
meet the muscular portion of the septum. The central fibrous body joins the aortic, mitral, 
and tricuspid valve annuli [1]. The aortic and pulmonary valve rings are joined together by 
a stout band of fibrous tissue, the tendon of the conus [1]. Other than the atrioventricular 
Bundle of His, the fibrous cardiac skeleton serves to electrically isolate the atria from the 
ventricles.
The tricuspid valve allows the blood to flow from the right atrium into the right ventricle. 
It is so called because it is made of three cusps (leaflets) tha t separate to allow the blood to 
pass through and connect to block regurgitation of blood. The tricuspid valve is composed 
of five components, i.e., annulus, leaflets, commissures, chordae tendinae, and papillary 
muscles [1]. The anterior tricuspid leaflet is the largest and most mobile. The posterior 
leaflet is usually the smallest. The septal leaflet is the least mobile because of its many 
direct chordal attachments to the ventricular septum [1]. The commissures are cleftlike 
splits in the leaflet tissue tha t represent the sites of separation of the leaflets, as shown 




Fig. 2.4. The four cardiac chamber valves including tricuspid valve, bicuspid valve, aortic 
valve, and pulmonary valve. Reprinted with permission from Wikimedia and OpenStax 
College. Retrieved from h ttp ://com m ons.w ik im ed ia .o rg . Used under creative commons 
attribution-noncommercial-sharealike 3.0 generic license (h ttp ://c re a tiv e c o m m o n s .o rg /) .
the chordae tendinae. The chordae tendinae anchor and support the leaflets and keep 
them from folding backwards (prolapse) and allowing blood to regurgitate past them. The 
chordae tendinae are attached to papillary muscles, which are fingerlike projections arising 
from the ventricular wall. Papillary muscle contraction pulls the leaflets toward one another 
and thereby promotes valve closure [1].
The mitral valve allows blood to flow from the left atrium into the left ventricle. It 
is composed of the same five components as the tricuspid valve. Unlike the other cardiac 
valves, the mitral valve has only two leaflets. The anterior leaflet is large and semicircular. 
The posterior mitral leaflet is rectangular and usually divided into three scallops [1].
The aortic valve prevents blood from regurgitating back into the left ventricle. It is 
composed of three components: annulus, cusps or leaflets, and commissures. In contrast 
to the mitral and tricuspid valves, the aortic valve has no tensor apparatus (i.e., chordae 
tendinae or papillary muscles) [1]. The commissures form tall, peaked spaces between the 
attachment of adjacent cusps. The three half-moon shaped (semilunar) aortic cusps — left, 
right, and posterior — form pocketlike tissue flaps tha t are avascular [1]. The pulmonary
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valve prevents the back flow of blood from the pulmonary trunk into the right ventricle.
2 .1 .5  C o ro n a ry  A r te r ie s  a n d  V e in s
The patterns of coronary distribution are highly variable and as such the correlations 
between coronary vessel architecture and the regions of the heart they supply are not 
precise [1]. The right and left coronary arteries arise from the right and left aortic sinuses, 
respectively. The right coronary artery (RCA) arises nearly perpendicular from the aorta 
and is embedded in the adipose tissue throughout its course within the right atrioventricular 
groove, as shown in Fig. 2.5.
The first branch of the RCA is typically the conus artery, which supplies the right 
ventricular outflow tract and forms an important collateral anastomosis, just below the 
pulmonary valve, with an analogous branch from the left anterior descending coronary 
artery (LAD) [1]. Among the numerous marginal branches of the RCA tha t supply the 
remainder of the RV wall, the largest branch travels along the acute margin from base 
to apex. The posterior descending and distal posterolateral branches of what is known 
as a “dominant” RCA supply the basal and middle inferior wall, basal inferior septum, 
right bundle branch, AV node, AV bundle, posterior portion of the left bundle branch, and
Fig. 2.5. Coronary arteries and veins. Reprinted with permission from Springer. J. Lee 
and N. Smith, “The multi-scale modeling of coronary blood flow,” Annals of Biomedical 
Engineering, vol. 40(11), pp. 2399-2413, 2012.
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posteromedial mitral papillary muscle [1].
The left main coronary artery (LCA) travels a very short distance along the epicardium 
between the pulmonary trunk and left atrium before dividing into the anterior descending 
and circumflex arteries. The LAD courses within the epicardial fat of the anterior inter­
ventricular groove and travels a variable distance along the inferior interventricular groove 
toward the cardiac base [1]. Its septal perforating branches supply the anterior septum 
and apical septum. The epicardial diagonal branches of the LAD supply the anterior LV 
free wall, part of the anterolateral mitral papillary muscle, and the medial one-third of the 
anterior RV free wall [1]. The left circumflex coronary artery (LCX) courses within the 
adipose tissue of the left atrioventricular groove and commonly terminates just beyond its 
large obtuse marginal branch. It supplies the lateral LV free wall and a portion of the 
anterolateral mitral papillary muscle [1].
The coronary veins typically run parallel to the entire course of the coronary arteries. 
The coronary venous circulation is composed of the coronary sinus, cardiac veins, and 
thespian venous systems. The great cardiac vein travels in the anterior interventricular 
groove beside the LAD and in the left anterior interventricular groove beside the LCX [1]. 
The great cardiac vein and other cardiac veins, such as the left posterior and middle cardiac 
veins, drain into the coronary sinus, which courses along the posteroinferior aspect of the 
left atrioventricular groove and empties into the right atrium [1].
Collateral channels provide blood flow between the major coronary arteries and their 
branches. If stenosis of an epicardial coronary artery produces a pressure gradient across 
such a vessel, the collateral channel can dilate with time and provide a bypass avenue for 
blood flow beyond the obstruction. Such functional collaterals can develop between the 
terminal extensions of two coronary arteries, between the side branches of two arteries, 
between branches of the same artery, or within the same branch [1]. These collaterals are 
common in the ventricular septum, ventricular apex, anterior RV free wall, anterolateral 
LV free wall, and along the atrial surfaces [1].
The microcirculation is composed of arterioles (10-150 ^m  in diameter), capillaries (0.5­
0.8 ^m), and venules (10-40 ^m). The independent vasoactivity of different-sized arterioles 
affects the flow of blood to the tissue locally [1]. The flow of blood through the arterioles is 
usually rapid, continuous, and unidirectional, whereas capillary flow can be highly variable. 
Oxygen and nutrients diffuse through the capillaries into surrounding tissues, whereas 
venules are involved in the transvascular exchange of fluid and macromolecules [1]. The 
veins collect blood that is eventually returned to the heart.
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2 .1 .6  E le c tr ic a l  C o n d u c t io n  S y s te m
The cardiac conduction system consists of the sinus node, internodal tracts, AV node, 
AV (His) bundle, and the right and left bundle branches, as shown in Fig. 2.6. The sinus 
node is located subepicardially in the terminal groove, close to the junction between the 
superior vena cava and right atrium, whereas the AV node is a subendocardial structure 
that is located within the triangle of Koch [1]. The AV (His) bundle arises from the distal 
portion of the AV node and travels along the ventricular septum. The right bundle branch 
emanates from the distal portion of the AV bundle and forms a cordlike structure that 
travels towards the anterior tricuspid papillary muscle. The left bundle branch represents 
a broad fenestrated sheet of subendocardial conduction fibers that spread along the septal 
surface of the left ventricle [1].
2 .1 .7  C o m p a ra t iv e  C a rd ia c  A n a to m y
As most mechanistic research studies depend on animal models of healthy and diseased 
organs, it is critical to appreciate variations in structure and function between humans and 
the typical animal species. All mammals (including dogs, pigs, and sheep) have principally
------------------ Bachmann's




Fig. 2.6. Cardiac conduction. Reprinted with permission from Wikimedia and Madhero. 
Retrieved from h ttp ://com m ons.w ik im edia.o rg . Used under creative commons attribu- 
tion-noncommercial-sharealike 3.0 generic license (h ttp ://c re a tiv e c o m m o n s .o rg /) .
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the same atrial and ventricular architecture. However, they do not have the same degree 
of trabeculation, which is coarser compared to adult human hearts [17]. Differences in 
aortic valve anatomy have also been reported in the literature relative to the shape of the 
leaflets [17]. Additional differences exist with respect to coronary structure and perfusion. 
Dogs and sheep typically have a left coronary type of supply, such tha t the majority of 
the myocardium is supplied via branches arising from the LCA. In contrasts, pigs and 
humans typically have a coronary supply balanced between the LCA and the RCA, and in 
some cases even a supply dominated by the RCA [18]. In addition, human and pig hearts 
have only a sparse coronary collateral network located subendocardially. In contrast, an 
extensive collateral network located near the epicardial surface can be seen in dogs [19]. 
However, with CAD and over time, collateral vessels become prevalent in humans [20]. All 
mammalian hearts have a similar conduction system except for differences in the transmural 
penetration of the Purkinje network between pigs and other species (e.g., dog and human). 
All Purkinje system fibers originate in subendocardium, but in pigs they penetrate more 
deeply than in other species and thus alter the time of activation in different depths of the 
ventricles [21].
2.2 Cardiac Electrophysiology
The heart can be construed as mechanical pump driven by an internal electrical system 
tha t generates the power and determines the timing necessary for the heart to eject blood 
effectively. Myocytes represent the functional unit of this system, and collectively myocytes 
form tissues tha t behave as an electrical syncytium [14]. In this section, we explore the basic 
mechanisms behind the electrical activity of the cardiomyocytes including action potentials, 
excitation-contraction coupling, cardiac excitation, repolarization, and automaticity.
2 .2 .1  C a rd io m y o c y te
The working myocytes of the atria and ventricles are roughly rectangular in shape, 
50-200 ^m  long and 10-40 ^m  wide; they generate force only along the long axis [22]. 
Individual cells often bifurcate, with the result tha t a single cell may connect with more 
than one neighboring cell. Myocytes contain a specialized cisternal system, the sarcoplasmic 
reticulum (SR), in which Ca++ is actively accumulated by ATP-driven transport. Most of 
the internal volume is devoted to a cytoskeletal lattice of contractile proteins tha t gives rise 
to a striated appearance. The contractile proteins are organized into sarcomeres, which are 
contractile functional units, bordered on each end by a protein matrix known as the “Z 
line,” as shown in Fig. 2.7.
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I band A band 1 band
Fig. 2.7. Cardiomyocte. Reprinted with permission from American Society for Biochemistry 
and Molecular Biology. Y. Peng, Z. Gregorich, S. Valeja, H. Zhang, W. Cai, Y. Chen, et 
al., “Top-down proteomics reveals concerted reductions in myofilament and Z-disc protein 
phosphorylation after acute myocardial infarction,” Molecular Cell Proteomics, vol. 13(10), 
pp. 2752-2764, 2014.
The Z lines are primarily composed of the protein a-actinin. W ithin each sarcomere, 
there is an interdigitating lattice of thick and thin protein filaments. The thin filaments 
extend from the Z line for about 1 ^m  toward the center of the sarcomere and are polymeric 
assemblies of globular subunits of protein actin [22]. The thick filaments are bipolar 
assemblies of the protein myosin.
Myosin molecules have long a  helical tails tha t form the backbone of thick filaments, and 
each has two globular head domains, which possess the ability to form cross-bridges with
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the actin filaments. Upon binding with actin, the cross-bridges act as molecular motors 
responsible for contraction [22]. The region of the sarcomere in which the myosin filaments 
reside is known as the “A band.” The area between the A bands of adjacent sarcomeres 
is known as the “I band.” This area is bisected by the Z lines and is traversed by actin 
thin filaments tha t extend from the Z line toward the center of both sarcomeres [22]. The 
thin actin filaments also carry regulatory proteins tropomyosin and troponin. Tropomyosin 
is a double-stranded, a  helical, coiled-coil protein that spans seven actin monomers [22]. 
Troponin is a globular protein complex with three subunits: 1) TnC, a calcium binding 
subunit, 2) TnI, a subunit tha t inhibits muscle contraction, and 3) TnT, a subunit that 
connects the troponin complex to tropomyosin and actin [22]. Tropomyosin molecules are 
aligned end to end around the helical coil of the thin filament with the troponin complex 
attached to each tropomyosin molecule.
In relaxed muscle, tropomyosin binds to actin and impedes the binding of myosin heads 
to actin binding sites. However, on muscle activation and subsequent increase in myoplasmic 
calcium concentrations, free calcium binds to troponin, inducing a conformational change 
tha t is transm itted to tropomyosin. It shifts the position on the actin thin filament to 
reveal the site on actin required for strong myosin binding. Myosin can then bind to the 
thin filament in a manner conducive to force production.
Force production occurs as follows. First, during muscle relaxation, myosin can bind 
to ATP and hydrolyze it, but cannot use the energy released during hydrolysis to create 
force because of the inhibition of its binding to the thin filament by tropomyosin and 
troponin [22]. Next, after calcium binding to troponin has released the inhibition of the 
tropomyosin-troponin complex on the thin filament, an energized myosin crossbridge can 
attach to the thin filament. This association with actin catalyzes the release of the products 
of hydrolysis (ADP and inorganic phosphate) and a concomitant conformational change of 
myosin head occurs while it is bound to actin [22]. This conformational change pulls the 
actin thin filament past the thick filament. Once this is completed, myosin can rebind ATP, 
which reduces the affinity of myosin for actin and allows for crossbridge detachment. The 
subsequent hydrolysis of ATP in turn  reenergizes the myosin crossbridge and prepares it 
for the next force generating cycle. As long as the calcium concentration is high enough to 
keep tropomyosin-troponin complexes from blocking the myosin binding sites on actin, the 
cycle continues [22].
There is a direct connection between the overlap of thick and thin filaments and the 
resultant force developed by cardiac muscle cells. Sarcomere length is defined as the distance
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between Z lines. In general, maximal isometric force can be elicited when this distance is 
approximately 2.2 ^m  [22]. Force generation is decreased when the sarcomere length is 
reduced as the contractile proteins are too crowded to work optimally. Likewise, force 
is reduced if the sarcomere length is increased because of the decrease in the overlap of 
thick and thin filaments, reducing the potential for possible crossbridge formation. This 
association between myocyte length and amount of force that can be generated is called the 
length-tension relationship and plays an important role across scales to explain the response 
of the heart to changes in ventricular filling [22].
Sarcomeres are linked end to end into assemblies known as myofibrils, which run the 
length of the long axis of the cardiac cell and are also placed side to side to fill most of the 
internal volume of the cell. The nucleus is found on the periphery of the cell along with the 
sarcoplasmic reticulum (SR), which is a vesicular structure that acts as an internal calcium 
store [22].
Cardiac cells are connected and communicate with one another by junctions of two types. 
First, intercalated discs form strong mechanical bonds between myocytes that allow force to 
be transm itted across the myocardium. These structures are formed by the protein-protein 
associations at the membrane surface of the neighboring cells [22]. Second, gap junctions 
form an electrical connection between the cardiac cells. They provide direct electrical 
and chemical communication between the cytoplasmic spaces of the adjoining cells. The 
electrical communication facilitates the coordinated contractions of the cardiac muscle [22].
2 .2 .2  C a rd ia c  C e ll M e m b ra n e
While contraction occurs mostly inside a cardiac myocyte, the electrical function of that 
cell is largely determined by the membrane tha t surrounds it, hence the overwhelming focus 
in electrophysiology on membrane structure and function. The plasma membrane defines 
the exterior of the cell and controls the movement of molecules between the cytosol and 
the extracellular medium. It also facilitates cell-to-cell signaling and cell adhesion [22]. 
The basic structural component of the cell membranes is a phospholipid bilayer, formed by 
molecules in opposing orientation tha t contain a hydrophilic head and a hydrophobic tail, 
as shown in Fig. 2.8.
The hydrocarbon chains of the phospholipids in each layer form a hydrophobic core 
within a lipid bilayer tha t has two important properties: 1) The hydrophobic core is an 
impermeable barrier tha t prevents diffusion of water soluble solutes across the membrane. 
Moreover, this simple barrier is modulated by the presence of membrane proteins that 
mediate transport of specific molecules across this otherwise impermeable bilayer [22]. 2)
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Fig. 2.8. Plasma membrane structure and function. Reprinted with permission from Wiki­
media and Mariana Ruiz (LadyofHats). Retrieved from h ttp ://com m ons.w ik im edia.o rg . 
Used under creative commons attribution-noncommercial-sharealike 3.0 generic license 
(h ttp ://c re a tiv e c o m m o n s .o rg /) .
The bilayer is stable. The bilayer structure is maintained by hydrophobic van der Waals 
interactions between lipid chains. Even though the exterior aqueous environment can vary 
widely in ionic strength and pH, the bilayer has the strength to retain its characteristic 
architecture [22]. A typical biomembrane is assembled from phosphoglycerides (at high 
concentrations in cardiac cells), sphingolipids, and steroids (Cholesterol). All three classes 
of lipids are amphiphatic molecules with a polar head and hydrophobic tail [22]. Natural 
biomembranes have fluidlike consistency, which is decreased by sphingolipids and cholesterol 
and increased by phosphoglycerides [22].
The sarcolemma forms multiple invaginations perpendicular to the long cell axis, named 
“T-tubules,” which serve as extensions of the cell surface and host a large density of 
transport proteins. The T-tubules are well developed in ventricular myocytes but poorly so 
in atrial myocytes [14]. The cell membrane usually contains both integral (transmembrane) 
and peripheral membrane proteins, which do not enter the hydrophobic core of the bilayer. 
Most integral proteins contain membrane-spanning hydrophobic a  helices and hydrophilic 
domains tha t extend from the cytosolic and exoplasmic faces of the membrane [22]. The 
binding of a water soluble enzyme (e.g., phospholipase, kinase or phosphatase) to a mem­
brane surface brings the enzyme close to its substrate and in some cases activates the 
substrate. Such interfacial binding is due to the attraction between positive charges on 
basic residues in the protein and negative charges on phospholipid head groups in the
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bilayer [22].
The selective permeability of the plasma membrane allows the cell to maintain a con­
stant internal environment. The cell membrane is permeable to gases, small hydrophobic 
molecules, and small uncharged polar molecules via passive diffusion. It is slightly permeable 
to water due to specialized aquaporins embedded in the membrane and urea, and essentially 
impermeable to ions and to large polar molecules [23]. Thus, the cell membrane, due to 
its ability to keep ions separated across its phospholipid bilayer, functions as an electrical 
capacitor. The specific capacitance is approximately constant across all cell membranes at 
1^F/cm 2 [14, 22].
The transport of most molecules into and out of cells requires the assistance of special­
ized transport proteins (transmembrane proteins) including ATP powered pumps, channel 
proteins, and transporters. ATP powered pumps are ATPases that use energy to move ions 
or small molecules across the membrane against a chemical gradient, electrical gradient, 
or both [22]. This process is referred to as active transport. Channel proteins form 
a hydrophilic passageway and transport water or specific types of ions and hydrophilic 
small molecules down their concentration or electrical gradient [24]. Such protein-assisted 
transport is referred to as facilitated diffusion. Some ion channels are nongated (open 
much of the time), but most are open only in response to specific chemical or electrical 
signals (gated). Transporters (carriers) move a wide variety of ions and molecules across 
cell membranes. Three types of transporters have been identified: uniporters, antiporters, 
and symporters [22]. Uniporters transport a single type of molecule down its concentration 
gradient via facilitated diffusion (e.g., glucose, amino acids). In contrast, antiporters and 
symporters couple the movement of one type of ion or molecule against its concentration 
gradient with the movement of one or more different ions down its concentration gradi­
ent [22]. These proteins, often called cotransporters, transport two solutes simultaneously 
using energy stored in the electrochemical gradient. This latter process is sometimes called 
the secondary active process [22].
2 .2 .3  R e s t in g  P o te n t ia l
The movement of ions across membranes is influenced by two energetic factors: chemical 
gradient and electrical gradient. Consider a two-compartment system, with both compart­
ments containing KCl, but in compartment 1 at a higher concentration. If the membrane 
allowed K  + and C l-  ions to cross, they would diffuse from compartment 1 to compartment
2. If, however, the membrane were permeable only to K +, it would tend to diffuse from 
compartment 1 to 2, but C l-  ions would be left behind. As soon as this happens, there
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will be a net transfer of positive charge from compartment 1 to 2 (carried by K  + ions), and 
consequently compartment 2 will become electrically positive with respect to compartment 
1. The resulting electrical gradient will push K  + ions from compartment 2 to compartment
1. Very quickly an equilibrium will be established where the electric gradient will be just 
large enough to move K  + ions to the left at the same rate as they tend to diffuse to the 
right due to the concentration gradient. The potential at which the electrical gradient and 
the concentration gradient balance each other is called the equilibrium potential or the 
Nernst potential for tha t specific ion. In this instance, the membrane potential is equal to 
potassium equilibrium potential, because only K+ ions can cross the membrane and thus 
influence the electrical gradient. The Nernst potential for a specific ion is given by
E  _  > ( f t l  ■ ( 2 . )
where R is the universal gas constant, T is the absolute temperature, z is the valance, i.e., 
the charge of the ion, F is the Faraday constant, [C]o is the concentration of ions outside 
the cell, and [C]j is the concentration of ions inside the cell.
The resting membrane potential of a cell is the voltage difference between the interior 
and exterior of the cell under resting conditions. It is calculated as a weighted average 
of the equilibrium potentials of the individual ions. The size of each weight is the relative 
permeability (Pi) of each ion and the result is given by the Goldman-Hodgkin-Katz equation.
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Neutral ions do not contribute to the membrane potential. In a cardiomyocyte, four ions— 
potassium (K), sodium (Na), calcium (Ca), and chloride (Cl)—contribute to the membrane 
potential, as shown in Fig. 2.9. Thus, the resting potential is given by
e  _ + e  i PNa+ e  i PCa++ e  i PCl e  (2 3)Em _  P ---- E K+ +  P -----E Na+ +  —5 ------E Ca++ +  P -----E Cl-  . (2.3)P total P total P total P total
A central concept in cellular electrophysiology is that of “driving force,” a measure of the 
potential energy for a particular ion. Driving force describes the impetus for an ion to move 
across the cell. The driving force for an ion increases or decreases depending upon how
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Fig. 2.9. Cardiac cell ions: (a) Cardiac cell model, (b) ionic concentrations of the major ions 
and the corresponding equilibrium potentials. Reprinted with permission from Circulation 
Research. R. Shaw and Y. Rudy, “Electrophysiologic effects of acute myocardial ischemia,” 
Circulation Research, vol. 35, pp. 256-272, 1997.
close its equilibrium potential is to the membrane potential and is given by the equation
Vd =  Vm -  Veq, (2.4)
where Vm is the membrane potential and Veq is the equilibrium potential.
At rest, the membrane potential of a cardiomyocyte is close to E K+ (-94 mV), as 
potassium has the highest permeability compared to other ions. The equilibrium potential 
for N a+, is +70 mV, for Ca++, it is +132 mV and for C l-  it is -90 mV [25]. The resulting 
cardiac membrane potential is approximately -85 mV. Thus, the driving force for K  + (9 mV) 
is smaller than tha t for C l-  (5 mV), which in turn  is much smaller than the driving force
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for Na+  (-160 mV), which is smaller than tha t for Ca++ (-222 mV). The sign indicates the 
direction of the driving force. Outward (-) and inward (+). The resulting current due to a 
specific ion is given by Ohm’s law
r. — Vm -  Veq (2 5)rion — jy t (2.5)
Rm
where Rm is the membrane resistance. One consequence of this behavior is that if the 
membrane is not permeable to the ion, there will be no ionic current generated regardless 
of the driving force.
2 .2 .4  A c tio n  P o te n t ia l
Action potentials (AP) are the result of transient changes in the cellular permeability 
to sodium, calcium, and potassium—charged ions capable of facilitated diffusion through 
ion channels. A brief increase in Na+  permeability depolarizes the cell and drives the 
membrane potential toward the N a+ equilibrium potential, which activates the voltage- 
gated calcium and potassium channels. The subsequent opening of calcium channels allows 
calcium to enter the myocyte and sustain the depolarized state. The opening of potassium 
channels allows potassium efflux from the cell and thus drives the membrane potential 
back toward the potassium equilibrium potential. The timing of these changes depends 
on isoforms of channel proteins present in each cell. For example, the most numerous 
ventricular myocytes, have durations of approximately 250 milliseconds, whereas sinoatrial 
and atrial muscle action potentials last approximately 150 milliseconds and Purkinje cells 
about 300 milliseconds.
Another morphological feature of action potentials tha t differs across cell types and has 
direct impact on macroscopic tissue behavior is the rate of rise, also known as “Phase 0” 
of the action potential. Atrial and ventricular muscle and Purkinje cells have an extremely 
rapid Phase 0, as shown in Fig. 2.10. As a result, they also conduct excitation more rapidly 
than other myocyte types.
Before discussing additional specific mechanisms and features, we outline the nomencla­
ture and descriptions of the phases of the action potential:
• P h ase  0: Phase 0 is supported by activation of two inward (depolarizing) currents, 
INa and IcaL. Membrane depolarization rapidly activates these channels and with 
a delay of several milliseconds for INa and tens of milliseconds for ICaL inactivates 
them [14].
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Fig. 2.10. Cardiac action potentials: Different action potentials seen within the my­
ocardium. Reprinted with permission from Springer. A. Amin, A. Asghari-Roodsari, and 
H. Tan, “Cardiac sodium channelopathies,” European Journal of Physiology, vol. 460(2), 
pp. 223-37, 2010.
P h ase  1: As the sodium channels begin to close, an initial, brief repolarization 
occurs tha t is labeled Phase 1. This transient event is primarily supported by I to, a 
K+ current tha t is activated and quickly inactivated by depolarization.
P h ase  2: The opening of L-type calcium channels and voltage-gated potassium 
channels results in a calcium influx tha t balances potassium efflux, which results in the 
positive plateau (Phase 2) of the action potential profile. This phase is perhaps the 
most varied across different myocytes types, lasting from just a few to several hundred 
milliseconds. This variation arises because the net current flow in this phase is the 
result of a dynamic balance of inward and outward currents. The inward currents are 
mainly carried by and ICaL [26]. The outward currents include the rapid (IKr) and 
slow (Ik s) components of delayed rectifier K  + currents [27]. As long as the currents 
in both directions are balanced, there is an approximately constant transmembrane
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potential, but this balance is tenuous and varies across cell types and also across the 
regions of the heart and even in time through physiological changes, like ischemia.
•  P h ase  3: Phase 3 is the fast repolarization phase. As the calcium channels close 
and inward currents diminish, the potassium currents begin to dominate, and full 
repolarization of the cells occurs. IK1 takes over during the final part of Phase 3 and 
returns the membrane potential back to its resting (diastolic) value [28].
• P h ase  4: Phase 4 represents the membrane resting potential during diastole. After 
repolarization, the N a + /K  + ATPase extrudes the accumulated intracellular Na+  ions 
and pumps the extracellular K  + into the cell. The N a+ /C a+ +  exchanger and the 
Ca++ ATPase also contribute to the ionic balance across the cell membrane.
The expression of channel proteins is not uniform throughout even regions containing 
otherwise identical cell types. As a result, there are associated regional variations in 
action potential morphology. For example, I to is expressed more in the subepicardial 
region compared to subendocardial region, and as a result, Phase 1 is more prominent 
in the subepicardial cardiomyocytes [29]. A lower expression of IKs in the midmyocardial 
layers [30] may also contribute to electrical heterogeneity across the ventricular wall.
The cells of the working myocardium have stable resting potentials, i.e., the cell has to 
be stimulated to induce an action potential. In contrast, cells of the specialized conduction 
systems, such as sinoatrial and atrioventricular nodal cells, have unstable resting potentials 
(-60 to -40 mV), which allows them to serve as pacemakers. The mechanism of this behavior 
is that they lack I K 1 expression [31]. Moreover, at these relatively positive resting potential 
values, INa cannot fully recover and so becomes inactive, so tha t depolarization is mainly 
driven by ICaL [14]. The resulting sequence of events is as follows: I f  is activated by 
IKACh-induced [32] membrane hyerpolarization [33], which causes the membrane potential 
to begin depolarizing, thereby initiating Phase 4. At -60 mV, the I f  inward current (funny 
currents) carried by N a+ begins to flow [34]. The resulting gradual rise in resting potential 
crosses the threshold (-50 mV) for opening T-type calcium channels and the resulting inward 
ICaT. A further depolarization to about -40 mV causes the inward ICaL to activate and 
an action potential to fire. The resulting Phase 0 depolarization is primarily induced by 
ICaT. The other inward currents including I f  and ICaT, decline as their respective channels 
close. The influx of calcium is slow, resulting in a slower rate of depolarization compared to 
other contractile myocytes and Purkinje cells. No initial repolarization or plateau occurs,
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so Phases 1 and 2 are said to be absent. Repolarization (Phase 3) is accomplished through 
the opening of voltage-gated potassium channels (IKi).
During Phases 0, 1, 2 and part of Phase 3, the cell is refractory to the activation by 
depolarizing signals. This stability is described by the wavelength (A) as
WL =  E R P  x CV, (2.6)
where CV is the conduction velocity. This is termed the “effective refractory period” (ERP) 
and is attributed to the slow recovery of the inactivated N a+ channels [34]. The ERP acts 
as a protective mechanism and ensures cardiac electrical stability and protection against 
premature reexcitation.
Table 2.1 shows a summary of the key currents in the cardiac action potential and their 
contributions to each phase, including those responsible for maintaining homeostatic ion 
concentrations. Membrane depolarization rapidly activates the I Na and ICaL channels. As 
the calcium and sodium channels close, the potassium currents begin to dominate, and full 
repolarization of the cells occurs. The N a+ /C a+ +  exchanger and the Ca++ ATPase also 
contribute to the ionic balance across the cell membrane.
Table 2.1. Cardiac ion currents for a ventricular action potential.
Ion C u rre n t T ra n sp o r ta tio n P h a s e /ro le
N a+ INa Facilitated diffusion via ion 
channels
Phase 0
Ca++ I Ca(L) Facilitated diffusion via ion 
channels
Phase 0-2
K + I to1 Facilitated diffusion via ion 
channels
Phase 1, notch
K + I Ks Facilitated diffusion via ion 
channels
Phase 2-3
K + I Kr Facilitated diffusion via ion 
channels
Phase 3





I NaCa Na-Ca exchanger (cotrans­






I NaK Na-K ATP pump 3:2 ratio 
in favor of Na
ion homeostasis
Ca++ IpCa Ca ATP pump ion homeostasis
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2 .2 .5  E x c i ta t io n - C o n tr a c t io n  C o u p lin g
Excitation contraction (EC) coupling describes the process from electrical excitation of 
the myocyte to its eventual contraction [35], as shown in Fig. 2.11. During the cardiac 
AP, Ca++ enters the cell through activated L-type calcium channels (LTCC), also called 
dihydropyridine receptors (DHPRs). These channels are located in the T-tubules at the 
sarcolemmal-SR junctions, where the SR calcium release channels, also called ryanodine 
receptors (RyRs), are also found [36]. RyRs are arranged in large organized arrays at the 
junctions between SR and sarcolemma beneath DHPR (on the surface of and in T-tubules) 
and form a large functional Ca release complex at the junction called the couplon [37].
SR calcium release is triggered by the Ca++-induced Ca release (CICR) mechanism 
mediated by IcaL [35]. Activation of one local DHPR channel can trigger the calcium 
release for all the RyRs at the couplon. Typically, there are 10-25 DHPR for every 100 
RyR, which provides the safety margin for the couplon to function properly [35]. Even so, 
only a small fraction of DHPRs and RyRs in a cell or couplon needs to fire to generate 
measured Ca++ fluxes. The calcium release from the sarcoplasmic reticulum(SR) increases
3Na 2K
2QQ ms
Fig. 2.11. Mechanism of EC coupling in a contractile myocyte. Reprinted with permission 
from Nature Publishing Group. D. Bers, “Cardiac excitation-contraction coupling,” Nature, 
vol. 415, pp. 198-205, 2002.
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the intracellular calcium concentration from about 10-4 to 10-2 mM [34].
A high load of SR Ca++ directly increases the amount of Ca++ released for a given 
ICaL because of the potentiating effect of high [Ca]SR on the open probability of RyRs [38]. 
SR Ca++ content can be increased by increasing Ca++ influx, decreasing Ca++ efflux, or 
enhancing Ca++ uptake into the SR [35]. The combination of calcium influx and release 
increases the cytosolic calcium concentration, allowing Ca++ to bind to myofilament protein 
troponin C, which activates the contractile machinery.
The strength of contraction, which is graded, can be regulated by altering the amplitude 
or duration of Ca++ transient and also by altering the sensitivity of myofilaments to 
calcium [35]. Myofilament Ca++ sensitivity is enhanced dynamically by stretching the 
myofilaments (due to preload), resulting in stronger contraction. On the other hand, myofil­
ament sensitivity is reduced by acidosis, elevated phosphate, and magnesium concentrations 
(all of which occur during ischemia), and P adrenergic activation, enhanced by caffeine and 
certain inotropic drugs [35].
The SR calcium release contributes to calcium-dependent inactivation of ICaL [39]. 
Moreover, Ca++-dependent inactivation at the cytosolic side also limits the amount of 
Ca++ entry during the AP. When there is high concentration of cytosolic Ca++, further 
influx of Ca is suppressed. Thus, SR Ca++ release and I CaL provide a local negative 
feedback on Ca++ influx [35].
Terminating calcium release is needed for diastolic refilling of the heart and is achieved 
by inactivation of RyR [35]. During relaxation, cytosolic calcium declines, allowing Ca++ 
to unbind from troponin. Calcium is then transported out of the cytosol primarily through 
the SR Ca++ ATPase. Phospholamban is an inhibitor of the SR Ca++ ATPase and its 
phosphorylation by cAMP-dependent or calmodulin-dependent protein kinases (PKA or 
CaMKII) removes this inhibition, allowing more rapid SR uptake of Ca++ and subsequent 
decline of [Ca]j [35]. There are also other pathways for calcium transport out of the cytosol: 
N a+ /C a+ +  exchanger, sarcolemmal calcium ATPase, and mitochondrial Ca++ uniport. In 
human, canine, and rabbit ventricle myocytes, SR Ca ATPase removes 70% of activator 
Ca++ and the N a+ /C a+ +  exchanger removes 28% and 1% each for the sarcolemmal Ca++ 
ATPase and the mitochondrial Ca++ uniporter [35]. For homeostasis, the amount of calcium 
influx must be equal to the calicum efflux for each beat.
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2 .2 .6  G a p  J u n c t io n s
The propagation of action potentials from cell to cell occurs through specialized, non- 
selective large-conductance ion channels packed in arrays called gap junctions [40], as shown 
in Fig. 2.12. Each cardiac gap junction channel is composed of 12 connexin molecules, with 
6 embedded in the cell membranes on each side of the junction. The heart expresses 
three connexin isoforms, Cx40, Cx43, and Cx45, which are available to form heteromeric 
channels [41]. Six connexins form a hemichannel called the connexon, which faces another 
connexon in the neighboring myocyte. In combination, they function as a complete channel 
enabling electrical continuity between neighboring myocytes. The gap junctions are located 
within the intercalated disks connecting myocytes along the ends of the cell long axis, but are 
also present albeit in lower density along the sides of the cells, to provide some side-to-side 
connections. These intercalated disks also provide the physical framework for mechanical 
force of contraction generated by each myocyte to be transm itted [14].
Fig. 2.12. Gap junctions: Structure of a gap junction. Reprinted with permission from Wiki- 
media and Mariana Ruiz (LadyofHats). Retrieved from h ttp ://com m ons.w ik im edia.o rg . 
Used under creative commons attribution-noncommercial-sharealike 3.0 generic license 
(h ttp ://c re a tiv e c o m m o n s .o rg /) .
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2 .2 .7  M y o c a rd ia l  A n is o tro p y
Myocardial anisotropy refers to directionally dependent variation in properties such as 
conduction velocity [42] and repolarization [43]. The structural determinants of anisotropy 
include cell geometry, cell size, and distribution of gap junction and ion channels. More­
over, since gap junctions behave as voltage- and chemically-gated ion channels, there is 
dynamic regulation of gap junction conductance, which contributes to transient anisotropy 
modulation [44].
The myocardial fiber orientation within myocardial tissue is anisotropic, as shown in 
Fig. 2.13. In ventricles, the fiber inclination angle ranges from 90-180 degrees of rota­
tion. Moreover, the rate of rotation is slightly more rapid near ventricular walls. This 
three-dimensional spatial organization of myocardial fibers influences electrical propaga­
tion [44] and mechanical contraction [45]. Alterations in fiber architecture can occur during 
pathological conditions such as cardiac infarction [46], which may predispose the heart to 
arrhythmias.
z
Fig. 2.13. Myocardial anisotropy. Reprinted with permission from Wolters Kluwer Health, 
Inc. D. Streeter, H. Spotnitz, D. Patel, J. Ross, and E. Sonnenblick, “Fiber orientation in 
canine LV during diastole and systole,” Circulation Research, vol. 24, pp. 339-347, 1969.
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2 .2 .8  C a rd ia c  P r o p a g a t io n
When a cardiomyocyte is depolarized to a positive membrane voltage, it creates a 
difference in membrane potential with respect to the neighboring myocytes, which are 
still at the negative resting potential. This potential difference causes the intracellular 
depolarizing currents to flow across the gap junctions into the unexcited cells. Thus, the 
positive charge moves from the depolarized cell to the resting cells. At the same time, in the 
extracellular space, the local current flows in the opposite direction, as the extracellular site 
is made negative by the flow of Na+  ions into the depolarized cell, thus forming a complete 
propagation circuit, as shown in Fig. 2.14.
As the positive charge continues to accumulate in the resting cell, its membrane potential 
starts rising and when the excitation threshold is reached, triggers an action potential. The 
newly excited cell now serves as a source for exciting the next neighboring cell. This wave of 
propagation from cell to cell is called the “activation wavefront,” which eventually spreads 
through the heart. The spread of activation wavefront continues as long as the depolarizing 
charge supplied by the excited cell is enough to activate the neighboring resting cells.
Cardiac propagation is influenced by many factors, including the action potentials of
Cell Membrane
Fig. 2.14. Propagation circuit: Spread of excitation from one cardiac cell to another.
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the individual cells, the tissue structure and connectivity, and can be captured by the value 
of the conduction velocity. One way to capture electrical connectivity in the myocardium is 
the “space constant” (A), which describes how far along the tissue current can travel before 
it dissipates into the extracellular space. The space constant is defined by the equation
R r -  (2.7)R i
where Rm is the specific membrane resistance per cross-sectional area and Ri is the specific 
axial resistance per cross-sectional area.
Conduction velocity is faster along the longitudinal direction than in the transverse 
direction of the myocardium as the current crosses more cell borders and thus gap junctions 
to cover the same distance [47]. This difference in conduction velocities is referred to as 
“electrical anisotropy.” Conduction velocity is also influenced by the amount of electrical 
source (higher I Na density in contractile myocytes and relatively lower ICaL density in 
pacemaker cells) [14]. Conduction velocity is approximated using the equation
K D dV
V =  , (2.8)
V RiCm.m
where K is a constant, D is the diameter of the fiber, dV. is the rate of rise of action potential, 
R i is the intracellular resistivity, and Cm is the membrane capacitance.
A related parameter known as the “propagation safety factor” is determined by the 
electrical source and electrical load ratio. Under normal conditions, the current size in 
a single cell is large enough to depolarize a number of connected cells [14]. Source/load 
mismatch, perhaps due to depressed charge (INa or ICaL) or expanded load (e.g., patchy 
fibrosis), can trigger arrhythmias resulting from unidirectional block (reentry) (described in 
more detail below).
2 .2 .9  C a rd ia c  A c tiv a t io n  S e q u e n c e
The cardiac electrical impulse originates in the SA node and propagates through the 
entire heart, as shown in Fig. 2.15. Through connections from the SA node fibers, the 
action potentials travel outwardly into adjacent atrial muscle fibers and spread rapidly over 
the entire atria with conduction velocities of 0.3 m /s [22]. The SA node is also believed to 
be connected to the AV node via internodal pathways. The conduction of impulse across
A
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Fig. 2.15. Spread of excitation through the heart. The cardiac electrical impulse originates 
in the SA node and propagates through the entire myocardium. Reprinted with permission 
from Wikimedia and OpenStax College. Retrieved from h ttp ://com m ons.w ik im ed ia .o rg . 
Used under creative commons attribution-noncommercial-sharealike 3.0 generic license 
(h ttp ://c re a tiv e c o m m o n s .o rg /) .
these specialized fibers is more rapid, at about 1 m /s [22]. The electrical impulse from the 
SA node reaches the AV node in about 30 milliseconds [22]. In the AV node, the electrical 
impulse is delayed by another 90 milliseconds before an impulse enters the distal portion of 
the AV bundle and into the ventricles [22]. The slow conduction in the AV node is attributed 
to the low density of gap junctions, resulting in higher intracellular resistance to conduction. 
This delay allows the atria to contract following excitation and pump a small amount of 
blood into the ventricles. Normally, the only pathway for electrical impulses to travel from 
the atria into the ventricles is through the AV node due to the electrical insulation provided 
by the cardiac skeleton. Moreover, under normal physiological conditions, the electrical 
impulse cannot travel back from the ventricles to the atria.
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The cardiac impulse exits the AV node and travels through the Bundle of His, the 
right and left bundle branches, and the Purkinje system for another 30 milliseconds before 
reaching the ventricles [22]. The Purkinje fibers have higher density of gap junctions and 
as result, the conduction velocity reaches 1.5-4 m /s [22]. As the Purkinje fibers penetrate 
into a large portion of the endocardial myocardium and become continuous with cardiac 
muscle, they provide for almost instantaneous propagation of cardiac impulse throughout 
the remainder of the ventricles.
The conduction velocity of propagation within the ventricles is between 0.3 to 0.5 m /s [22]. 
The cardiac impulse spreads generally from the apex to the base, anterior to posterior, and 
from endocardium to the epicardium [48]. The transmission of cardiac impulse from the 
endocardium to the epicardium takes another 30 milliseconds [22] so that the total time of 
propagation from the SA node to the last of the ventricular muscle fibers is approximately 
190 milliseconds. The penetration and spread of Purkinje fibers into the ventricular my­
ocardium varies across species, affecting the ventricular activation sequence. For example, 
in pigs, the endocardium and the epicardium get activated more simultaneously than in 
other species [49].
2 .2 .1 0  E le c t r o c a r d io g r a m  (E C G )
The ECG represents the electrical activity of the heart recorded using body-surface 
electrodes as potential differences over time. To understand the complex relationship 
between the ECG and the electrical activity of heart, we first look at the potential field 
generated by a single cell, then a single fiber, a tissue composed of many fibers, and finally 
the integrated heart and torso volume conductor model.
For a single cell model as shown in Fig. 2.16, the potential, 0 ( r ') at some external 
observation point, r ' is given by the equation
0 ( r ') =  j 1 -Oi{Vd -  VrM r ' ), (2.9)
4n & e
where Vd and Vr denote the transmembrane potentials over the depolarized and resting 
regions of the cell and & and ae denote the homogeneous isotropic electrical conductivity 
inside and outside the cell. The term Q (r ') represents the solid angle subtended by the 
cross-section A at the external observation point r ' . Moreover, the expression Ui(Vd — 
Vr ) represents the equivalent current density double layer and thus a distributed current 
dipole source [50]. If the cell is completely depolarized or completely repolarized, the
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Fig. 2.16. Cardiac cell model: Cell model to evaluate a theoretical external potential field.
transmembrane voltage Vm over the entire closed surface, S , is a constant, and thus the 
potential field in the exterior region is zero. It is only when the part of the cell is depolarized 
and the other part is at rest tha t we see an external potential field.
Expanding this same concept to the single fiber model, the depolarizing wave produces 
a current entering the extracellular space just ahead of the depolarizing wavefront. There 
is also a current sink just behind it. The intracellular current Ii travels down the gradient 
from the location of the (extracellular) sink to the (extracellular) source.
Outside the fiber, a passive return current travels from the source to the sink, taking 
more than one path, and thus generating an external potential field throughout the external 
volume by passive current flow. For the observation points at some distance from the fiber, 
the potential field is indistinguishable from the one created by lumping the inward currents 
together into a single monopole - I o (sink) and all the outward currents into a single current 
monopole Io (source) separated by a distance d. Moreover, at distances from the monopole 
pair tha t are much greater than d, the external potential field can be approximated as one 
generated by a dipole (D  =  Iod) [14], as shown in Fig. 2.17. The external potential field 
can now be expressed as
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where D is the magnitude of the dipole, p  is the angle between the dipole direction (from 
sink to source) and the line from dipole location to the field point, and R is the distance 
from the dipole location to the field point.
Expanding the concept further to many fibers or a tissue model, the first simplification 
is to sum the potentials generated by each fiber by viewing the collection of elementary 
dipoles distributed over the surface S(t) of the wavefront at time t.
Another simplification step is to assume tha t the direction of dipole density is aligned 
with the direction of the propagation wavefront and has a uniform strength, thus forming 
a uniform double layer (UDL) [14]. The external field can then be expressed as
0e(r ; t) = M s
4nae
Q(r ; t), (2.11)
where M s is the dipole density and Q (r '; t) is the solid angle subtended by the entire 
wavefront S(t) from the observer point.
The expression of external fields assumes a uniform medium of homogeneous conductiv­
ity around the active cell, fiber, and tissue [51]. In actuality, the cardiac sources are in a 
volume conductor with different conductivities attributed to lungs, blood, skeletal muscle, 
fat, etc. Moreover, instead of an infinite medium, the volume conductor has a sharp torso-air 
boundary, as shown in Fig. 2.18. The distance between the cardiac current source location
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Fig. 2.18. Cardiac tissue model: External potential field generated by distributed sources.
and observation point (electrode location) plays a critical role in determining the magnitude 
of potentials recorded on the body surface. Since the potential field from a dipole source 
declines as 1 /R 2, the ability of the body surface ECG to measure potential fields from 
smaller current sources is diminished greatly [52, 14]. Moreover, the ECG measures the 
potential difference between two recording sites (electrodes), with one being used as a 
reference. However, this assumption is inaccurate for a bounded volume conductor [53].
The normal ECG waveform is shown in Fig. 2.19, and the key features include the 
P-wave, QRS complex, ST segment, T-wave, and the U-wave. The P-wave represents 
atrial depolarization. The QRS complex reflects the ventricular repolarization, and the T- 
wave indicates ventricular repolarization. The U-wave is believed to represent isovolumetric 
relaxation [14].
The P-wave has a relatively a small amplitude (60-120 ^V), which can be attributed 
to smaller current sources (as the atria are smaller in size with thin walls). The P-wave is 
followed by an interval of approximately 70 milliseconds referred to as the “PQ segment” and 
corresponds to atrial repolarization [54] as well as the excitation wave progressing through 
the AV node and the His-Purkinje system [55]. Because of the small magnitudes of current 
generated during this interval, it registers minor, if any, deflection on the ECG.
QRS complex deflections are the result of ventricular depolarization, and since the RV 
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Fig. 2.19. Electrocardiogram (ECG) features including the ST segment, and the T-wave. 
Reprinted with permission from Wikimedia and Anthony Atkielski (Agateller). Retrieved 
from h ttp ://com m ons.w ik im ed ia .o rg . Used under creative commons attribution-noncom- 
mercial-sharealike 3.0 generic license (h ttp ://c re a tiv e c o m m o n s .o rg /) .
of both wavefronts, which often results in electrical cancellation [56]. Moreover, since the 
RV wall is thinner, its excitation wavefront terminates earlier than the LV wavefront. 
Consequently, the early portion of the QRS complex receives contributions from both 
ventricles, whereas the latter portion of the QRS complex waveform is driven primarily 
by LV excitation.
Following the QRS complex deflection, the ECG reflects a relatively quiet period rep­
resented by the ST segment. The J-point is marked as the time point when the tracing 
changes slope sharply at the end of the S-wave [14] and is believed to represent the end of 
ventricular depolarization and the beginning of ventricular repolarization. As such, there 
is a period of overlapping potentials between regions at the end of depolarization and those 
at the beginning of repolarization. Moreover, this potential difference is relatively small,
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resulting in the ECG returning to a voltage near baseline [14]. The primary reason for the 
isoelectric potentials during the ST segment in the normal ECG is that all action potentials 
have such similar plateau potentials that there is no current flow in the heart and hence no 
body-surface voltage.
The T-wave is produced by the repolarization of ventricular myocytes and is attributed 
to transmural dispersion of repolarization from the epicardium (shorter APD) to endo­
cardium (longer APD) [14]. Moreover, the repolarization appears to occur earlier at the 
base than at the apex [57]. The U-wave is a low amplitude, usually monophasic ECG feature 
following and often partly merged with the T-wave [14]. The origins of U-wave remain 
controversial, although a negative U-wave, if present, is believed to signify the presence of 
cardiac diseases: ischemia, hypertension, and aortic regurgitation [58].
2.3 Cardiovascular Physiology
The cardiovascular system is designed to deliver oxygen and nutrients to the cells of 
the body and remove carbon dioxide and metabolic wastes from the cells. It is made up 
of two major circulatory systems working in tandem: pulmonary circulation and systemic 
circulation. The low resistance pulmonary circulation constitutes the right side of the 
heart pumping the deoxygenated blood to the lungs through the pulmonary artery and 
pulmonary capillaries and then returning the oxygen-rich blood to the left atrium through 
the pulmonary veins. The high-resistance systemic circulation is composed of the left 
side of the heart pumping oxygenated blood to the rest of the body through the aorta, 
arteries, arterioles, and systemic capillaries and subsequently returning deoxygenated blood 
to the right atrium through the venules and veins. We briefly cover the key concepts of 
cardiovascular physiology in this section.
2.3.1 C a rd ia c  C ycle
The cardiac cycle describes the pressure, volume, and flow in the atria and ventricles as 
a function of time, as shown in Fig. 2.20. A single cycle of cardiac activity is composed of 
two phases: diastole and systole. Diastole constitutes the time period when the ventricles 
are relaxed, whereas systole represents the time during which the ventricles contract. The 
cardiac cycle diagram highlights the changes in aortic pressure, left ventricular pressure, 
left atrial pressure, and left ventricular volume and their relation to the heart sounds and 
the morphology of the electrocardiogram. The cardiac cycle is typically divided into five 
phases: atrial contraction, iso-volumetric contraction, ventricular ejection, iso-volumetric 
relaxation, and ventricular filling. The phases are detailed in the following:
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Fig. 2.20. Cardiac cycle: Wiggers diagram highlighting various events of a cardiac cycle. 
Reprinted with permission from John Wiley and Sons. B. Smith, “Classifying processes: 
An essay in applied ontology,” Ratio, vol. 25(4), pp. 463-488, 2012.
• A tria l C on trac tion  Phase: The atrial contraction phase is initiated by the P- 
wave on the ECG, reflecting the atrial activation, which causes the atria to contract. 
The pressure in the atrial chambers increases, forcing rapid flow of blood into the 
ventricles across the open atrio-ventricular valves. Following atrial contraction, the 
atrial pressure begins to fall, which causes the AV valves to float upwards before 
closure [34]. The ventricular volume is maximal at this stage and is called the end- 
diastolic volume (EDV), representing the ventricular preload. At resting heart rates, 
the atrial contraction accounts for 10% of the left ventricular filling as most of the 
ventricular filling happens before atrial contraction through the passive flow of blood 
through the open valves. However, at high heart rates, it can rise to as much as 40% 
of ventricular filling [34].
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• Iso-volum etric C on trac tion  Phase: The iso-volumetric contraction phase coin­
cides with the QRS complex on the ECG representing ventricular activation, which 
triggers EC coupling, ventricular contraction, and a rapid increase in intraventricular 
pressure corresponding to maximal dP/dt. The AV valves close as the intraventricular 
pressure exceeds the atrial pressure, resulting in the first heart sound (Si). During 
this time period, there is an increase in pressure without a change in volume as 
the ventricles contract, hence the iso-volumetric contraction. However, individual 
myocytes and fibers may contract isotonically (shortening), isometrically (no change), 
or eccentrically (lengthening), resulting in the heart becoming more spheroid with 
circumference increases and atrial base-to-apex shortening [34].
• V entricu lar E jection Phase: The ventricular ejection phase represents the ejection 
of blood from the ventricles. The intraventricular pressure exceeds the aortic and 
pulmonary pressures, causing the semilunar valves to open, and blood is rapidly 
ejected into the aorta from the left ventricle and into the pulmonary artery from the 
right ventricle. Approximately 200 milliseconds after the QRS complex, the ventricles 
begin to depolarize, which coincides with the T-wave on the ECG [34]. Ventricular 
pressure begins to fall, whereas atrial pressure begins to rise due to continued venous 
return from the lungs and systemic circulation.
• Iso-volum etric V entricu lar R elaxation  Phase: The iso-volumetric ventricular 
relaxation coincides with the closure of the semilunar valves, which causes the second 
heart sound (S2). Valve closure is associated with a small back flow of blood into the 
ventricles characterized by the dicrotic notch [34]. Although the ventricular pressures 
decrease during this phase, the volumes remain constant as all the valves are closed. 
The volume of blood that remains in the ventricle is called the end-systolic volume 
(ESV). Moreover, the difference between EDV and ESV represents the stroke volume 
(SV). The atrial pressure continues to rise.
• V entricu lar F illing Phase: The ventricular filling phase represents the opening of 
AV valves as the atrial pressure exceeds the intraventricular pressure. Despite the 
inflow of blood, the intraventricular pressure continues to fall briefly as ventricles 
are still undergoing relaxation. Once the ventricles are completely recovered, their 
pressure begins to rise slowly. As the ventricles continue to fill with blood and expand, 
the intraventricular pressure rises. During this time period, the aortic and pulmonary
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arterial pressure continues to fall. In normal hearts, 90% of the ventricular filling 
occurs by the end of this phase [34].
2 .3 .2  H e m o d y n am ics
Hemodynamics constitutes the physical factors that govern cardiac output and blood 
flow: blood flow velocity, pressure, and resistance. Cardiac output (CO) is the amount of 
blood pumped by the ventricles in 1 minute and is given by the equation: Cardiac Output 
(Q) =  SV x Heart Rate (HR). Blood flow refers to the bulk flow of fluid during circulation. 
Blood flow velocity refers to the speed with which the blood moves during circulation and 
is directly related to blood flow and inversely related to the cross-sectional area, as shown 
in Fig. 2.21.
The systolic blood pressure decreases as the blood flows from the aorta (120 mmHg) 
through the arteries (100 mmHg), arterioles (80 mmHg), capillaries (35 mmHg), and venules 
(5 mmHg), and falls to near atmospheric pressure in the veins (1 mmHg) [1]. Moreover, 




Fig. 2.21. Circulatory system. Reprinted with permission from Vascular Cell. M. Scioli, 
A. Bielli, G. Arcuri, A. Ferlosio, and A. Orlandi, “Ageing and microvasculature,” Vascular 
Cell, vol. 16, pp. 6-19, 2014. ©  2014 BioMed Central Ltd.
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circulation. The arterial pulse is altered by such factors as heart rate (increased diastolic 
pressure), stroke volume (increased systolic pressure), and arterial compliance (decreased 
systolic pressure) [1]
Resistance (R) to blood flow is affected by vessel radius (r) and fluid viscosity (n) such 
that R is given by Poiseuille’s law R  =  8n L /n r 4. Thus, when the vessel radius is halved, 
resistance increases by a factor of 16. Viscosity is affected by temperature, red blood cell 
mass, and protein concentration [1].
2 .3 .3  C o ro n a ry  C irc u la tio n
Coronary circulation is of special interest in the setting of this research as it is closely 
tied to ischemia. The energy requirements of the heart include basal metabolism (20%), 
electrical activation (5%), and mechanical contraction (75%). The major determinants of 
local metabolic rate and oxygen delivery are shown in Fig. 2.22.
Myocardial oxygen demand is directly related to heart rate, wall tension, and contractile 
state. Wall tension is related to ventricular volume (preload) and ventricular pressure. 
Contractility is related to the maximal rate of increase in systolic pressure. There is also 
a transmural gradient of wall tension, with greater tension in the subendocardium relative 
to subepicardium. Moreover, the basal oxygen demand is believed to be higher in the 
subendocardial region [59]. Major oxygen supply determinants include local perfusion and 
the amount of oxygen extraction from the blood. Moreover, oxygen extraction is influenced 
by oxygen content in the arterial blood, oxygen diffusion gradient, and blood flow velocity 
through the capillaries. At rest, oxygen extraction is near 75% and can rise to 90% under
Fig. 2.22. Myocardial oxygen determinants: Major determinants of oxygen demand and 
supply to the heart.
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stress conditions. Since the oxygen extraction is already high, any increase in metabolic 
demand must be met by a corresponding increase in coronary blood flow.
The heart relies primarily on continual resynthesis of mitochondrial ATP for its energy 
supply. At rest, the energy substrates include oxidation of free fatty acids (60-70%) 
and metabolism of carbohydrates (30%) [1]. During exercise, oxidation of free fatty acids is 
inhibited, and carbohydrates become the primary mode for ATP production. The heart has 
reserves of high-energy phosphates (HEP) and phospocreatine (PCr), which can be used to 
generate ATP, but they can buffer the ATP levels for only a short period (15-30 seconds) in 
the absence of coronary blood flow [1]. Coronary flow is regulated variously by metabolic, 
mechanical, autonomic, and endothelial controls.
“Autoregulation” refers to the phenomenon in which a change in aortic pressure is met by 
the adjustment of coronary vascular resistance to ensure constant blood flow and is effective 
only in the range of 60-140 mmHg of systemic arterial pressure [1]. “Autoregulatory reserve” 
is a related term that refers to the maximal degree of vasodilation in the coronary perfusion 
bed and determines the perfusion pressures over which coronary flow is maintained. Thus, if 
a vascular bed is already maximally vasodilated, the capacity to autoregulate in the face of 
a further decrease in perfusion pressure is severely limited. Autoregulation is largely a local 
phenomenon mediated by myogenic tone (a change in tone in response to changes in pressure 
and flow) and metabolic means (washout of vasoactive metabolites such as adenosine) [1].
Most coronary flow occurs during diastole, when the perfusion pressure is greater than 
the intramyocardial pressure [60]. During ventricular systole, the intramyocardial tissue 
pressure gradient (decreasing towards the epicardium), through extravascular compression, 
causes a parallel gradient in systolic coronary vascular resistance [61]. Moreover, as the 
intramyocardial tissue pressure is greater than the coronary driving pressure, the coronary 
flow decreases and may cease in the subendocardium during systole. During ventricular 
diastole, the intramyocardial tissue pressure is similar across the myocardium, and the gra­
dient in diastolic coronary vascular resistance exists (decreasing towards the endocardium) 
due to dilation of subendocardial coronary vessels [62]. The result is greater diastolic 
flow in the subendocardium over subepicardium. Thus, the subepicardium receives 90% 
of flow during systole and 10% during diastole. The midmyocardium receives an equal 
amount of blood flow in systole and diastole while the subendocardium is perfused primarily 
during diastole [1]. Moreover, the ratio of subendocardial flow to subepicardial flow is 
approximately 1.1:1, as the intrinsic coronary vascular resistance in the subendocardial 
arteries is lower.
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2.3 .4  In te g ra te d  C o n tro l o f C a rd io v asc u la r  P h y sio lo g y
The autonomic nervous system (ANS) influences the smooth muscle tone of coronary 
arteries to modulate coronary flow, as shown in Fig. 2.23. The epicardial coronary arter­
ies have both a-adrenergic (vasoconstriction) and ^-adrenergic receptors (vasodilation) to 
mediate coronary flow. The a-adrenergic receptors mediate the release of norepinephrine 
(NE) during sympathetic stimulation, which can cause vasoconstriction of arteries. The 
stimulation of ^2-adrenergic receptors by circulating catecholamines results in coronary 
vasodilation. That said, the role of ANS in coronary flow regulation is often overshadowed 
by metabolic and mechanical factors [1].
An endothelium-dervied relaxing factor (EDRF) such as nitrous oxide (NO) is a powerful 
vasodilator and its release is triggered by a number of stress signals (e.g., hypoxia) and 
distending forces in the vascular wall [1].
The ANS influences vasomotor tone and cardiac function through its sympathetic (SNS) 
and parasympathetic (PNS) divisions to achieve an integrated and dynamic response, 
which entails integrating inputs from the cerebral cortex and specialized sensors (e.g., 
mechanoreceptors) into brain regions (hypothalamus, pons, medulla) and transmitting
Fig. 2.23. Integrated control of cardiovascular physiology: Schematic of the CNS control. 
Reprinted with permission from American College of Cardiology Foundation. D. Linz, C. 
Ukena, F. Mahfoud, H. Neuberger, and M. Bohm, “Atrial autonomic innervation: A target 
for interventional anti arrhythmic therapy?” Elsevier (2014). Journal of American College 
of Cardiology, vol. 63(3), pp. 215-224, 2014.
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efferent nerve impulses to the periphery over sympathetic and parasympathetic systems [1].
The parasympathetic system plays a relatively minor role in arterial pressure mediation, 
but an important role in modulating heart rate. The heart rate is maintained at a constant 
value (typically approximately 70 bpm in humans) via a continuous firing of the vagus nerve. 
Parasympathetic discharge increases potassium ion permeability in cardiac myocytes, thus 
increasing the threshold for depolarization to occur spontaneously in the SA node. As a 
result, the heart rate declines (negative chronotropic effect) and, with it, the cardiac output. 
This autonomic neural input predominates during sleep and other sedentary states, eliciting 
an increase in cardiac cycle time and therefore enabling the heart to expend less energy. 
Parasympathetic stimulation also slows conduction velocity (negative dromotropic effect) 
and decreases contractility (negative inotropic effect) although its impact on heart rate is 
much more potent.
Increased sympathetic activity increases heart rate by releasing norepinephrine, which 
causes a rise in the SA node depolarization rate (positive chronotropic effect). The increase 
in heart rate is due to an increase in activated calcium channels, which increases the speed 
at which depolarization occurs. This increased sympathetic outflow can be initiated by a 
large array of internal and external stimuli: exercise, increase in body temperature, trauma, 
or stress. Cardiac output is also increased with increased SNS activity by increasing stroke 
volume. The underlying mechanism for this increased SV is the enhanced cardiac myocyte 
contractility. Myocytes usually increase in length in proportion to their preload, and because 
they become more elongated, they also have the capability to shorten over a greater distance. 
This increased shortening leads to enhanced strength of contraction. The sympathetic 
excitation also facilitates a larger and more rapid calcium influx, which further augments 
the degree of overall contraction during systole. The time necessary for the heart to contract 
and relax fully decreases under sympathetic stimulation due to a larger proportion of the 
cardiac cycle that is made available for filling. Although an increase in heart rate makes 
the total duration of the cardiac cycle shorter, there is a decrease in the amount of time 
necessary for contraction of the heart. Thus, the heart is relaxed for a greater portion of 
the cycle, enabling enhanced filling to provide a greater volume of blood ejected for each 
contraction. Epinephrine also increases calcium influx and uptake by SR by stimulating the 
P receptors and thus acts a positive inotropic agent.
The stimulation and withdrawal of SNS activity are also powerful regulators for periph­
eral coronary circulation. Changes in blood supply to local tissue or organs are mediated by 
changes in resistance of peripheral vasculature in response to the need for blood elsewhere.
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Control of the vascular peripheral resistance is achieved by varying the firing frequency with 
these sympathetic fibers. More specifically, postganglionic fibers release norepinephrine, 
which binds to ai-adrenergic receptors within the smooth muscle cells in the arteriolar 
walls and causes an overall decrease in the diameter of arterioles (vasoconstriction). In 
contrast, lowering the basal tonic activity causes vasodilation since less norepinephrine is 
available for binding, causing the smooth muscle cells to relax. Sympathetic stimulation 
of a subset of fibers originating in the cerebral motor cortex releases epinephrine (instead 
of norepinephrine), which stimulates both a  and fi receptors. The effect of epinephrine 
at low concentrations is to produce vasodilation and at high concentrations is to induce 
vasoconstriction [1].
The arterial baroreceptor system regulates arterial pressure in the short term. The 
baroreceptors are primarily located in the walls of the aorta and carotid arteries. They 
sense both the magnitude and rate of stretch of arterial walls because of pressure fluctuations 
within the vessels. The afferent fibers projecting from the baroreceptors convey this infor­
mation to the ANS, which in turn responds by either increasing or decreasing sympathetic 
or parasympathetic drive. The baroreceptor reflex functions as a negative feedback system, 
such that a decrease in arterial stretch induces an increased sympathetic discharge, resulting 
in raising the cardiac output. The increase in cardiac output increases the blood delivered 
to vessels containing baroreceptors, increasing arterial pressure, and, in turn, decreasing the 
tonic activity of these receptors. Homeostatic control of arterial pressure is managed because 
a decreased baroreceptor discharge rate causes a lower degree of sympathetic activity and 
results in cardiac slowing and a decrease in blood pressure. Long-term pressure regulation 
is not accomplished via baroreceptor input because of the adaptive nature of baroreceptors 
as described above. If the pressure in the aorta and carotid arteries remains elevated for 
sustained periods, the tonic firing rates will eventually return to resting values regardless 
of whether the pressure remains elevated. Long-term pressure regulation involves complex 
hormonal mechanisms administered by medullary cardiovascular centers.
2.4 Coronary Heart Disease (CHD) and Ischemia
Nearly 30% of deaths worldwide can be attributed to cardiovascular diseases [1]. More­
over, CHD afflicts nearly 13.7 million Americans, and the socioeconomic costs associated 
with CHD amounted to $165 billion dollars in 2009 [1].
CHD represents a spectrum of disease pathologies: chronic CHD, acute coronary syn­
dromes (ACS), and sudden cardiac death. ACS represents all forms of myocardial ischemia
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(e.g., atherosclerosis, coronary thrombosis, vasospasm) and myocardial infarctiona. Al­
though CHD is typically attributed to coronary arterial disease (CAD) [63], other causes 
(e.g., congenital defects) can also precipitate an ACS event [1].
Myocardial ischemia is defined as an imbalance between the supply of oxygenated blood 
and the oxygen requirements of the heart [3], as shown in Fig. 2.24. The degree of imbalance 
between blood supply and demand varies and is qualified accordingly as mild, moderate, and 
severe [64]. Complete abolition of blood flow is termed “total ischemia.” When myocardial 
ischemia is limited to a region of the heart and not the whole heart, the term “regional 
ischemia” is used. If the entire heart becomes ischemic (e.g., due to aortic stenosis), the 
term used is “global ischemia” [5].
A major component of ischemia is hypoxia, which refers to an imbalance between oxygen 
supply and oxygen requirements of the heart. In addition, ischemia is characterized by a 
reduction in the supply of metabolic substrates as well as a reduction in removal of catabo- 
lites. The onset of ischemia has immediate cellular consequences: metabolic (e.g., anaerobic 
glycolysis), structural (e.g., cell swelling), ionic (e.g., hyperkalemia), neurohumoral (e.g., 
release of catecholamines), electrical (e.g., rise in resting potential), and functional (e.g., 
contractile dysfunction) consequences.
Initially, cellular consequences of myocardial ischemia are reversible, but eventually 
damage occurs to critical subcellular organelles that is irreversible, which results in cellular 
necrosis, followed by an inflammatory response, macrophage removal of dead myocytes, and
A) Myocardial Ischemia B) |schemia Trigger
Fig. 2.24. Myocardial ischemia: (a) Schematic of supply and demand imbalance, (b) various 
ischemia triggers.
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replacement by scar [5]. Restoration of blood flow (reperfusion) during the reversible phase 
of ischemia prevents cell death, and cellular structural, functional, and metabolic properties 
eventually recover. Conversely, reperfusion after cell death occurs often exacerbates the 
situation by causing cell swelling, massive calcium overload, disruption of the contractile 
apparatus, and damage to the microvasculature.
2.4.1 D e fin itio n  a n d  C lass ifica tio n
ACS includes all forms of acute myocardial ischemia (atherosclerosis, thrombosis, va­
sospasm, etc.), acute myocardial infarction including NSTEMI (non-ST segment elevated 
myocardial infarction) and STEMI (ST segment elevated myocardial infarction), and un­
stable angina.
2 .4 .1 .1  A th e ro sc le ro s is , C o ro n a ry  T h ro m b o s is ,
A th e ro th ro m b o s is
Atherosclerosis is a preexisting condition in the setting of ACS, described as a lipid- 
induced, inflammatory, systemic vascular disease leading to plaque formation [65]. Such 
plaque deposits typically form in locations associated with low shear stress (e.g., bifur­
cations, inner wall of curvatures) and regions with intimal thickenings [66]. They are 
heterogeneous in size and in their composition (fibrous tissue, necrotic lipid-rich core, foam 
cells, macrophages, and calcium deposits) [1].
Coronary thrombosis is the release of a free floating plaque (or “thrombus”) in the 
vasculature, typically induced by plaque rupture [65] or plaque erosion [67]. When these 
thrombi eventually lodge in a vessel narrowing, they cause obstruction of coronary blood 
flow to the affected region and trigger the onset of myocardial ischemia and acute coronary 
syndrome (ACS). Atherothrombosis is atherosclerosis superimposed with thrombosis and is 
associated with high-risk or vulnerable plaques.
2 .4 .1 .2  A n g in a  P e c to ris
Angina pectoris (chest pain) is characterized by a crushing, burning, or squeezing type of 
discomfort that may spread to the lower part of the neck and also radiate down the left arm. 
Typically, the pain lasts for 5-10 minutes and is attributed to the stimulation of sensory 
nerves surrounding the coronary arteries, possibly by adenosine [1]. In the clinical setting, 
angina pectoris is categorized as primary angina, secondary angina, unstable angina, or 
syndrome X.
Demand ischemia or effort induced angina is the result of increased metabolic demand
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on the heart (e.g., due to exercise) and the inability of the coronary blood flow to keep 
up. It is also called secondary angina as ischemia is secondary to increased oxygen demand 
and is relieved when the patient stops exercising, leaves the stressful situation, or receives 
a vasodilator (e.g., nitroglycerin) [1].
Supply ischemia or primary angina is the result of a decrease in coronary flow (e.g., 
due to atherosclerosis or vasospasm) without a change in myocardial metabolic demand. 
Primary angina due to vasospasm is also called variant angina or Prinzmetal angina. The 
precise mechanism behind coronary vasospasm is not completely understood but is generally 
attributed to vasoconstrictors such as norepinephrine or epinephrin [1]. Primary angina can 
also be relieved through administration of vasodilators.
Unstable angina, also known as preinfarction angina, intermediate coronary syndrome, 
and acute coronary insufficiency, is manifested as a sudden worsening of chronic angina and 
may occur at rest or with exertion [1].
Syndrome X  is a condition in which patients with angiographically normal coronary 
arteries test positive for ischemia during an exercise stress test and perfusion defects [1]. 
Although the exact mechanism behind this condition is not fully understood, it is commonly 
attributed to microvascular dysfunction [68].
Silent ischemia is a condition in which the patient with myocardial ischemia does not 
experience any chest pains. On the other hand, anginal pain can occur in the absence of 
ischemia, perhaps due to some form of gastrointestinal disorder.
2 .4 .1 .3  M y o ca rd ia l In fa rc tio n , S T E M I, N S T E M I
Myocardial infarction refers to irreversible ischemia and results from severe and pro­
longed ischemia as a result of severe atherosclerosis or thrombosis. It is characterized by 
cell death.
N STE M I or non-ST segment elevated myocardial infarction is a diagnosis of acute MI, 
in which the patient has chest pain and shows elevated levels of myonecrosis biomarkers 
such as troponin and creatine kinase myocardial band (CK-MB), but ST segment elevation 
or Q-waves indicative of myocardial infarction are not evident on the ECG [1].
STE M I or S T  segment elevated myocardial infarction refers to the most severe mani­
festation of ACS and results in a manifestation of ST segment elevation and Q-waves on 
the ECG in addition to the presence of angina and elevated serum troponin and CK-MB 
levels [1].
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2.4.2 M e ta b o lic  C o n seq u en ces
In the absence of blood flow, the relatively small quantities of oxygen remaining in the 
capillary red blood cells (RBCs) get used up, and the decreasing tissue oxygen content is 
reflected in the appearance of cyanosis of the myocardium within the first 5-15 seconds of 
moderate to severe ischemia [5].
Without oxygen as the final electron receptor, oxidative mitochondrial metabolism is 
inhibited, and the glycogenolysis and anaerobic glycolysis are accelerated. However, this 
form of HEP production is inefficient as only two molecules of ADP can be phosphorylated 
per molecule of glucose converted to lactate. This amount is in contrast to 38 molecules 
of ATP created by complete oxidation of glucose to carbon dioxide and water [5]. In the 
end, anaerobic glycolysis can produce only about 7% of HEP needed by normal working 
myocardium [69].
Myocardial reserve stores of HEPs are limited and are sufficient for approximately 30 sec­
onds of normal myocardial activity [4]. The contractile function is rapidly downregulated 
during ischemia. Even so, electrical activity and minimal mechanical activity use up the 
HEP reserves. Creatine phosphate is completely depleted within the first 3 minutes [70], 
and ATP content declines more slowly to about 35% of control by 15 minutes [71]. After 10 
minutes of severe ischemia, declining ATP content is matched by declining levels of ADP [5]. 
Thus, there is rapid degradation of total adenosine nucleotide pool.
Severe ischemia also activates other forms of energy production, including lipid and 
protein metabolism, with diminishing returns. During ischemia, there is an accumulation 
of small quantities of fatty acids [72]; however, oxidation of fatty acids to carbon dioxide and 
water is again a mitochondrial process requiring oxygen. On the other hand, increased fatty 
acid and ampiphiles concentration in the plasma membrane, gap junction, and intracellular 
membranes of the SR and the mitochondria [73] has other detrimental cellular consequences: 
contractile dysfunction, inhibition of various enzymes, gap junction inhibition, and even cell 
membrane degradation [74]. Protein synthesis and protein degradation are energy-requiring 
processes and thus terribly inefficient [75].
Cessation of blood flow also implies nonremoval of catabolic waste products. There is a 
rapid accumulation of lactate (end product of anaerobic glycolysis), purines (breakdown 
of adenine nucleotides), and other catabolites [5]. Tissue acidosis increases rapidly as 
a result of several catabolic processes (e.g., glycolysis, lipolysis, and ATP hydrolysis), 
which has deleterious consequences, including inhibition of various metabolic pathways [76]. 
The inhibition of the metabolic pathways creates a cascading effect, including contractile
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dysfunction, aggregation of nuclear chromatin, and formation of mitochondrial amorphous 
matrix densities [77].
Ischemia also increases the production of free radicals (e.g., superoxides), and their high 
reactive nature causes detrimental alterations in proteins, nucleic acids, and lipids [78]. 
They block most K  + currents and activate SR Ca++ release channels, thus reducing AP 
upstroke and conduction velocity and increasing APD [4]. The activation of SR calcium 
release eventually triggers mitochondrial calcium overload and signals cell death.
2.4 .3  S tr u c tu ra l  C o n seq u en ces
During the first 15 minutes of severe ischemia (reversible phase), the principal ultra- 
structural changes include mild edema of the sarcoplasm, diminution of glycogen deposits, 
relaxation or stretching of myofibrils, and mild margination of nuclear chromatin [79]. 
In addition, mitochondria show loss of normal matrix granules and disorganization of 
cristae [80].
Longer periods of ischemic insult result in more marked changes. Nuclear chromatin is 
aggregated along the nuclear membrane, glycogen becomes severely depleted, mitochondrial 
swelling and loss of cristae become severely pronounced, and cell swelling is accentuated [81]. 
Amorphous densities develop within the matrix space of mitochondria and breaks in the 
plasmalemma of the sarcolemma appear, signaling the onset of irreversible phase of my­
ocardial injury [64].
2 .4 .4  Io n ic  C o n seq u en ces
Myocardial ischemia triggers changes in intracellular and extracellular concentrations of 
various ions: increases in extracellular K+, intracellular N a+ , intracellular and extracellular 
H  +, intracellular Ca++, and intracellular Mg++.
2.4 .4 .1  E x tra c e llu la r  K  + A c cu m u la tio n
The onset of ischemia results in an increase in the extracellular K  + concentration and 
occurs in three phases [82]. The initial phase begins within 20 seconds of the ischemia 
onset and lasts from 3 to 10 minutes, resulting in K  + levels rising to 15 mM [83] (from 
approximately 4 mM), which is followed by a second phase (10-15 minute period), during 
which K  + does not change or may actually decline slightly, which is attributed to the 
activation of the Na+ — K  + pump [5]. Following this plateau phase, K  + rises again, but at 
a slower rate, which is believed to mark the transition to irreversible myocardial ischemia 
or cell necrosis. The rise in extracellular K  + is attributed to shrinkage in the extracellular
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space (ECS), inhibition of active K  + influx, and an increase in passive K  + efflux [4]. The 
shrinkage in ECS is due to osmotic movement of water into the capillaries. The K  + influx 
is reduced due to partial inhibition of Na+ — K  + pump activity. The increased K  + efflux is 
attributed to increased conductance due to the ionic currents I k a t p , I k a a , IKNa and also 
to the existence of an inward leak current (INa, INsc  , I ci) [4]
The increase in extracellular K  + depolarizes the resting membrane, reduces the maxi­
mum rate of rise of the AP upstroke (Vmax), lowers the AP amplitude and plateau potential, 
accelerates the slope of rapid repolarization, and in Purkinje fibers, decreases the rate of 
spontaneous diastolic depolarization [84]. The change in resting membrane potential is 
attributed to the change in the potassium equilibrium potential (EK), and the change in 
Vmax is due to inactivation of the rapid Na+ inward current, which is dependent on the 
membrane potential at the onset of depolarization [5]. The increase in extracellular K + 
also delays the recovery of Vmax, which prolongs the recovery of excitability [4].
Increasing extracellular K  + has a biphasic effect on excitability and conduction. During 
the initial phase of K  + efflux, the rising resting potential also decreases the threshold for 
excitability so that excitability and conduction are increased [4]. At higher levels of K +, 
however, the rise in resting potential exceeds the threshold potential. Moreover, the slowing 
of Vmax secondary to inactivation of Na+  current becomes dominant, resulting in a decrease 
in excitability and a slowing of conduction [5].
If the blood flow is restored before the irreversible phase, the extracellular K  + rapidly 
recovers to normal levels, but full recovery can take up to 60 minutes [64].
2 .4 .4 .2  In tra c e llu la r  a n d  E x tra c e llu la r  A cidosis
There is also a fall in extracellular pH concomitant to rising extracellular K +. However, 
the pH level falls continuously and without a plateau until the maximum level of 6.0 is 
reached and remains constant thereafter [85]. The fall can be attributed to increased 
production and the inability to remove the accumulating protons due to dysfunction of 
Na+-H  + exchanger, Na+-H CO -  cotransport, and CO2 removal [4].
Extracellular and intracellular acidosis impairs the functioning of most cell membrane 
channels, except IKa TP and I k a a , by decreasing single channel conductance and reducing 
tissue oxygen, which leads to a rise in resting membrane potential [4]. Acidosis also results in 
a decrease in conduction velocity, a decrease in Vmax, and an increase in internal longitudinal 
resistance, which collectively are responsible for cellular uncoupling and thus a slowing of 
conduction [5]. The prolongation of AP (due to slower recovery of Na+ channels) and 
the occurrence of extra afterdepolarizations (EADs) that are thought to be responsible for
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ectopic electrical activity are more likely to take place during reperfusion [4]. Recovery of 
pH is rapid (3-5 minutes), if blood flow is restored before irreversible injury sets in [4].
2 .4 .4 .3  In tra c e llu la r  Na+  A c cu m u la tio n
The intracellular Na+  concentration nearly doubles (10 to 20 mM) due to impairment 
of the normal functioning of the N a+ -K  + pump that uses ATP to transport Na+  out of 
the cell [4]. Moreover, there is an increased influx of Na+  via the Na+  - H  + exchanger and 
other inward leak currents: INa, INSC, and ICl. The accumulation of Na+ is higher in the 
supepicardial cells compared to subendocardial cells [85]. Intracellular Na+ accumulation 
reduces excitability due to hyperpolarization by triggering activation of multiple outward 
K  + channels: IKNa, IKs, and IKACh. However, if blood flow is restored during the reversible 
phase, the intracellular Na+  concentration is restored within 5 minutes [4].
2 .4 .4 .4  In tra c e llu la r  C a++ A c cu m u la tio n
Calcium is stored intracellularly in the SR and mitochondria, in addition to being 
available in the cytoplasm. There is an increase in systolic Ca++ that occurs within the first 
minutes of ischemia, and the mitochondrial Ca++ follows the systolic changes in cytosolic 
Ca++. The increase in diastolic Ca++ is seen 10-20 minutes into the ischemic injury [4]. The 
increase in intracellular calcium can be attributed to the reduced ability to remove calcium 
through the Na+-Ca++ exchanger (due to increased intracellular Na+), reduced Ca++ 
uptake by the SR (through Ca++-ATPase), an increase in inward leak current (activated 
by free radicals and mechanical stretch), and displacement by H  + from the calcium binding 
sites (due to intracellular acidosis) [4].
An increase in cytosolic Ca++ modulates the number of channels, carriers, and enzymes 
and results in the shortening of APD (due to inactivation of ICaL) and the occurrence of 
EAD, DAD, and arrhythmias upon reperfusion (due to premature SR release of calcium 
or increased conductance of leak currents) [4]. Depending on the severity and duration of 
the ischemic insult, the cytosolic Ca++ may normalize rapidly, fall to an intermediate level, 
and then eventually return to normal value or not recover at all and rather rise to more 
elevated levels, leading to cell death.
2 .4 .4 .5  In tra c e llu la r  Mg++ A c cu m u la tio n
During ischemia, there is an increase in intracellular Mg++ due to ATP hydrolysis, to 
which Mg++ is bound, and also due to inefficient removal of Mg++ via Mg++-ATPase 
and Na+-Mg++ exchanger [4]. Increased intracellular affects normal channel and
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carrier function by its effect on phosphorylation, blocking of Na+  and Ca++ channel pores, 
and by reducing outward K  + currents through open channel block, thus triggering inward 
rectification [4]. The blocking of Ca++ channel pores has a protective effect by preventing 
mitochondrial calcium overload. Due to its effect on both Ca++ and K  + channels, it may 
cause AP shortening or lengthening depending on which currents are most affected.
2 .4 .4 .6  A c tiv a tio n  o f S tre tc h -S e n s itiv e  C h an n e ls
Stretch, whether induced by tension or an increase in volume (e.g., cell swelling), 
results in activation stretch-sensitive inward currents (In s c , I c i, I c aL) and outward K + 
currents [4]. Cumulatively, these currents can result in depolarization or shortening of 
AP based on which currents are dominant. In any case, these changes are conducive to 
arrhythmias.
2 .4 .4 .7  In c re a se  in T issu e  R e s is tiv ity
The onset of ischemia brings about an increase in tissue resistance: an increase in 
longitudinal extracellular resistance and longitudinal intracellular resistance [86]. This 
increase in resistance occurs in three phases. The first phase occurs immediately, resulting 
in an increase in extracellular resistance by 30%, and remains at that plateau level for 
approximately 5 minutes [87]. The second phase is characterized by a steady rise to nearly 
160% of normal extracellular resistance and occurs over 10 minutes [87]. The third phase 
coincides with the irreversible phase (15-20 minutes after the onset of ischemia) and is 
characterized by an increase in intracellular resistance due to the closure of gap junctions. 
The increase in extracellular resistance is associated with cell swelling and shrinkage of 
extracellular space [88].
2 .4 .5  N e u ro h u m o ra l C o n seq u en ces
The onset of ischemia triggers the release of catecholamines in the systemic circulation 
and subsequently a delayed local release. a-receptor stimulation activates PKC phospho­
rylation that increases some K  + currents (IKs, IKa Ch, I k a t p , I k a a ) but decreases others 
(Ito, IKur, IK1) [4]. It also causes a decrease in gap junction conductance, while potentiating 
the function of exchangers: Na+-Ca++, N a+ -K  + and Na+-H  + exchangers [4]. The varied 
effect on K+  currents can cause the cells to depolarize or hyperpolarize, whereas APD is 
increased due to its effect on the Na+-Ca++ exchanger. If delayed afterdepolarizations 
(DADs) are already being caused by inward calcium leak, a -receptor stimulation increases 
the rate of occurrence. On the other hand, if DADs are being triggered by N a+ -K  + pump
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inhibition, the stimulating effect on the pump by a-receptor diminishes their incidence [4].
ft- receptor stimulation activates most outward and inward cell membrane currents, gap 
junction channel conductance, and the SR calcium release channel [4], which leads to an 
increase in pacemaker activity (due to increased Ioah) and increased AP amplitude (due 
to increased I ^ a) and AP duration (due to increased Io aL). In contractile cells, the AP 
amplitude is increased and the AP duration is shortened (stimulation of I k a t p ). However, 
excessive ft receptor activity can lead to calcium overload [4].
Adenosine and ACh release is enhanced during ischemia, and the effect is generally 
opposite to ft-receptor stimulation. The gap junction conduction is reduced as are inward 
currents: Io a, Io i , and I f  [4]. On the other hand, I kach and I k a t p  are enhanced. 
Cumulatively, these effects result in hyperpolarization, shortening of AP, reduced pacemaker 
activity, and inhibition of afterpolarizations (EAD and DAD) [4].
2 .4 .6  E le c tr ic a l C o n seq u en ces
The electrical consequences of ischemia that most influence tissue level behavior include 
a rise in resting potential, shortening of AP amplitude and duration, prolongation of ERP, 
a decrease in conduction velocity, and a change in excitability. Some of these changes 
also manifest on the ECG as changes in the morphology, amplitude, or polarity of various 
features: ST segment, T-wave, and the QRS complex. Moreover, ischemia also enables the 
development of arrhythmias.
2 .4 .6 .1  E C G  C h an g es
Fig. 2.25 summarizes the most important ischemia induced changes in the ECG. The 
rise in resting potential (due to increased K  + efflux) causes a TQ segment shift [89]. The
A) Action Potential Changes B) ECG Changes
Diastole Systole Diastole
Fig. 2.25. Electrophysiological consequences of ischemia: (a) Change in action potential 
duration and amplitude, (b) corresponding changes on the ECG.
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shortening of AP duration due to activation of I k a t p  causes an ST segment shift [90]. The 
T-wave inversion is associated with reversal in transmural dispersion of repolarization due 
to shortening of the APD in the ischemic regions [91]. The slowing of conductance due to 
the fall in Na+  and later an increase in longitudinal resistance corresponds to broadening 
of the QRS complex. The ERP is prolonged due to the slower recovery of inactivated Na+ 
channels.
2 .4 .6 .2  A rrh y th m ia s
Arrhythmias require automacity, i.e., triggered activity (EAD or DAD), and a pathway 
for reentry, as shown in Fig. 2.26. During ischemia, automacity can be achieved in multiple 
ways: EAD and DAD (due to Ca++ overload and catecholamines release), excessive stretch­
ing of border zone cells, and activation of I f  in atrial and ventricular cells. The heterogeneity 
of ERP and slowed conduction also enhance the likelihood of there being a viable pathway 
for reentry during ischemia. Arrhythmias that occur during the first 30 minutes of ischemia 
typically fall into the category of are known as“ Ia and Ib arrhythmias.” [86] Phase Ia is 
initiated through intramural border zone reentry and evolves into multiple wavelets. Phase 
Ib mechanisms are believed to be associated with a combination of Ca++ overload, release 
of catecholamines, and increase in longitudinal resistance [4].
A  B  normal conduction C  - w  depolarizing current
Fig. 2.26. Ischemia induced arrhythmias. Reprinted with permission from Oxford University 
Press. H. D. Den Ruijter, G. Berecki, T. Opthof, A. Verkerk, P. Zock, and R. Coronel, “Pro 
and anti arrhythmic properties of a diet rich in fish oil,” Cardiovascular Research, vol. 73(2), 
pp. 316-325, 2007.
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2 .4 .7  F u n c tio n a l C o n seq u en ces
Myocardial ischemia is the consequence of an imbalance between blood flow to the 
heart and its metabolic requirements (heart rate, wall stress, contractility). Contractile 
dysfunction is one of the earliest functional consequences occurring within 5-10 seconds after 
the onset of ischemia [92]. Moreover, depending on the degree and duration of the ischemic 
injury, myocardial region affected, and the presence of collateral vessels from the adjacent 
vascular bed, ischemia has a variety of consequences: angina pectoris, myocardial stun­
ning, myocardial hibernation, pre- or postconditioning, and under critical circumstances, 
myocardial infarction with subsequent heart failure [1].
2 .4 .7 .1  M y o ca rd ia l S tu n n in g
Myocardial stunning refers to a prolonged and fully reversible myocardial dysfunction 
even after restoration of normal blood supply to the ischemic heart [1]. Myocardial stunning 
is generally attributed to the effect of reactive oxygen species (ROS) released during the 
first minutes of reperfusion and subsequent impairment of calcium handling in the affected 
myocytes [93].
2 .4 .7 .2  M y o ca rd ia l H ib e rn a tio n
Myocardial hibernation refers to a chronic ventricular dysfunction in patients with 
chronic ischemic disease that becomes reversible after revascularization [94]. Myocardial 
hibernation is believed to result from a prolonged subacute or chronic state of myocardial 
ischemia that does not progress to necrosis but leads to a downregulation of myocardial 
metabolism and function to compensate for reduced coronary blood flow, thus achieving a 
new equilibrium [1].
2 .4 .7 .3  M y o ca rd ia l P re c o n d itio n in g , M y o ca rd ia l P o s t­
co n d itio n in g , R e m o te  P re c o n d itio n in g
Myocardial preconditioning refers to the phenomenon where brief episodes of ischemia 
produce a cardioprotective response during a subsequent longer episode of ischemia [95]. 
The ischemic preconditioning occurs in the two phases: acute ischemic preconditioning 
(first window) and delayed ischemic preconditioning (second window). The first window is 
characterized by the release of ischemia-stimulated mediators such as adenosine, opioids, 
etc., that activate the mitochondrial K a t p  channel, which prevents the opening of the 
mitochondrial permeability pore at reperfusion and thus prevents triggering apoptosis and 
necrosis. The acute phase of ischemic preconditioning is believed to last 60-120 minutes [96].
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The second window is more persistent and is believed to last 3-4 days [96]. Myocardial post­
conditioning refers to cardioprotective response due to brief periods of ischemia alternated 
with brief periods of reperfusion following lethal ischemia (e.g., infarction) [1]. Remote 
preconditioning refers to ischemia in one organ producing a protective response in another 
distal organ.
2 .4 .7 .4  M y o ca rd ia l In fa rc tio n  (M I)
The irreversible phase of ischemia typically sets in 15-20 minutes following coronary 
occlusion and is marked by cell death that can be triggered by cell necrosis (physical 
disruption of sarcolemma) or cell apoptosis (programmed cell death) [9]. In the longer term 
(weeks to months and even years after the insult), the myocardium undergoes structural 
and functional remodeling to compensate for loss of cardiac muscle, which leads to scar 
formation and may eventually result in heart failure [1].
2 .4 .8  D iagnosis
Early and accurate detection of myocardial ischemia is an essential component of man­
aging CHD. Various noninvasive (e.g., ECG, Echo, SPECT) and invasive diagnostic tools 
(e.g., angiography) are available for CAD detection. Moreover, treatment options vary 
from pharmacologic (e.g., nitrates) to revascularization (e.g., PCI, CABG) depending on 
the severity of the ischemia.
2 .4 .8 .1  P a t ie n t  H is to ry  a n d  P h y s ic a l E x a m in a tio n
Past episodes of unstable angina or myocardial infarction, family history of premature 
atherosclerosis, and presence of CHD risk factors such as hypertension, diabetes, obesity, 
etc., provide valuable information and indicate a higher risk of ACS.
Chest pain or discomfort is a common manifestation of myocardial ischemia. The chest 
pain tends to radiate across the chest into the arms (left more than right) and neck, jaw, and 
back [1]. The pain lasts for 5-10 minutes and goes away after cessation of activity or with 
use of sublingual nitrates. The onset of shortness of breath, nausea, and vomiting during or 
after chest discomfort also suggests severe myocardial ischemia or myocardial infarction [1].
However, myocardial ischemia and myocardial infarction can manifest without chest 
pain. Such silent ischemia and even painless MI occur in up to 40% of CAD patients [1]. 
Moreover, chest pains are not specific to ACS and can be caused by other cardiac (e.g., 
pericarditis, mitral valve prolapse) and noncardiac events (e.g., anxiety, gastrointestinal
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disorder) [1]. Finally, the description of pain is subjective and relies on the ability and 
willingness of the patient to share information.
2 .4 .8 .2  E x e rc ise  E C G  S tre s s  T es tin g  (E T )
Exercise stress testing is a noninvasive tool that uses exercise (e.g., running, biking) as 
the physiologic stress to monitor and evaluate the response of the cardiovascular system. 
The physiologic principle behind exercise testing is that total body oxygen uptake (VO2) and 
myocardial oxygen uptake are distinct [1] and that patients experience significant shortfalls 
in myocardial oxygen supply before their total oxygen becomes critical. VO 2 is defined as 
the amount of oxygen extracted from inspired air as the body performs work and is estimated 
as the product of external work (cardiac output) and arteriovenous oxygen difference (A — 
VO 2). Since arteriovenous oxygen difference is approximately 15-17% at maximal exercise, 
VO 2max is then an indirect estimate of cardiac output [1]. Myocardial oxygen uptake is 
the amount of oxygen required only by the heart and is given as the product of heart rate 
and systolic blood pressure. During exercise, any unmet needs in cardiac demand can help 
identify abnormalities in myocardial perfusion and function such as myocardial ischemia. 
Moreover, ischemia produces changes in the body surface ECG (e.g., ST segment shifts, 
T-wave changes).
Exercise protocols either on a treadmill or a bicycle ergometer are designed to progres­
sively ramp up speed and grade and last for 8-12 minutes [1]. The protocols are often 
individualized based on factors such as subject’s physical abilities, age, and gender. The 
metabolic equivalent of the task (MET) is a commonly used metric for oxygen requirement 
of work rate during an exercise test. 1 MET is equated with the resting metabolic rate (3.5 
mL of O2/kg/min), and a MET value achieved from an exercise test is a multiple of resting 
metabolic rate, either measured directly through oxygen uptake or from maximal workload 
calculated using standard equations [97]. Typically, achieved maximal MET values less 
than 10 are associated with a poor prognosis [1].
ST segment depression on the ECG is typically the metric for exercise testing. The 
standard criterion for a positive test is 1 mm of horizontal or downsloping ST segment 
depression (in lead V5) below the baseline or a further 1 mm if the baseline is already 
depressed [1], as shown in Fig. 2.27. ST segment elevation is indicative of severe transmural 
ischemia.
While ST segment depression is a marker of acute ischemia, it has a very poor ability 
to localize the size or extent of myocardial tissue that experiences ischemia. Moreover, ST 
segment depression in inferior leads (e.g., II, aVF) need not be indicative of myocardial
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Fig. 2.27. ST segment depression: Patterns of ST segment depression during a stress test. 
Reprinted with permission from Wolters Kluwer Health, Inc. R. Rijneke, C. Ascoop, and 
J. Talmon,“Clinical significance of upsloping ST segments in exercise electrocardiography,” 
Circulation, vol. 61(4), pp. 671-678, 1980.
ischemia, and the inclusion of these inferior leads can result in false positives [98]. Exercise- 
induced R-wave and S-wave amplitude changes are also not correlated with ischemia [1], 
further reducing specificity of this diagnostic test. Confusion can also arise because exercise- 
induced ST segment depression is not specific to myocardial ischemia and can also be 
attributed to left bundle branch block (LBBB), Wolff-Parkinson-White (WPW) syndrome, 
electronic pacemakers, and intraventricular conduction defects (IVCDs) [1]. As a result of 
these ambiguities, the mean sensitivity and mean specificity of ET to detect CAD remain 
at 68% and 77% [6], respectively.
2 .4 .8 .3  R e s t a n d  S tre ss  E c h o c a rd io g ra p h y
Echocardiography refers to an evaluation of the myocardium with images produced by 
ultrasound and is also used for ischemia diagnosis. Images can be recorded through the 
chest wall (transthoracic echocardiography) or via a probe placed in the esophagus (trans­
esophageal echocardiography). The primary application of echocardiography in patients 
with CHD is to detect the effects of myocardial ischemia and myocardial infarction on LV
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structure and function [1]. The echocardiographic indicators of CAD include a reduction in 
systolic thickening, abnormal segmental wall motion during systole or diastole, alterations 
in acoustic properties of myocardium, and diminished regional blood flow (measured after 
intravenous echo contrast injection) [1].
The combination of stress testing and echocardiography (stress echocardiography) has 
become an important diagnostic tool for the detection of CAD. The technique is based on the 
concept that stress-induced ischemia will result in abnormalities of regional wall motion that 
can be identified by echocardiography. The location of wall motion abnormality can help 
identify the culprit coronary vessel(s), and the ratio of dyssynergic to normal myocardium 
can provide a quantitative assessment of LV ischemia [1]. Stress echocardiography is more 
sensitive and specific than ECG stress for detection of CAD [1]. However, high-quality 
ultrasound images can be difficult to acquire due to a poor signal to noise ratio. Moreover, 
considerable expertise is needed to acquire and to interpret the results.
In lieu of exercise stress testing, pharmacologic stress, which employs vasodilator agents 
(e.g., adenosine) or inotropic agents (e.g., dobutamine), can also be used. A vasodilator 
induces disproportionate and heterogenous myocardial perfusion, which can produce is­
chemia. On the other hand, an inotropic agent increases metabolic oxygen demand and 
thereby produces ischemia [99].
2 .4 .8 .4  M y o ca rd ia l P e rfu s io n  Im ag in g  (M P I)
MPI with single photo emission computed tomography (SPECT) entails using a scintil­
lation camera and an intravenous radiopharmaceutical (e.g., technetium -99m 99mTc) that 
is distributed to the heart in proportion to regional perfusion [1]. Since the radiopharma­
ceutical accumulates in the myocardium in proportion to regional blood flow, CAD can be 
detected by identifying a reduction in accumulation in a region supplied by a stenosed (at 
least 70%) vessel compared with a normal region during hyperemia [100]. The ability of 
SPECT MPI to assess hyperemic response is based on the degree of extraction of the tracer 
during its first pass through the myocardium. The amount of injected tracer in the heart at 
the time of imaging (net extraction) is proportional to that extracted by the myocardium 
(extraction fraction) and the amount retained at the time of imaging [101].
For exercise stress SPECT MPI, the tracer is injected at maximal stress and exercise is 
continued for an additional 1 minute of peak load [1]. Postexercise stress imaging commences 
usually 15 minutes to 2 hours after the stress injection to allow the patient to recover fully 
from stress, which prevents artifactual defects related to increased depth of respiration early
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after stress [102]. The mean sensitivity and specificity for exercise SPECT MPI are reported 
at 87% and 73% [1], respectively.
2 .4 .8 .5  P o s itro n  E m issio n  T o m o g rap h y  (P E T )
PET imaging can evaluate functions ranging from blood flow to biochemical reaction 
rates, substrate fluxes, and neuronal activity. For CAD detection, PET is used with 
pharmacologic stress agents such as adenosine and dipyridamole. Positron-emitting flow 
tracers 82Rb and 13N-ammonia are retained in the myocardium in proportion to blood flow 
so that the resulting images display the relative distribution of blood flow at rest and during 
hyperemia [1]. The images are interpreted visually and also using quantitative methods.
The mean sensitivity and specificity of PET are 87% and 100% [1], respectively, more 
specific than SPECT.
2 .4 .8 .6  C o ro n a ry  A r te ry  C a lc if ica tio n  S core  (C A C S )
An electron beam computed tomography (EBCT) scanner is employed to obtain high- 
resolution static images and to evaluate coronary artery calcification (CAC). The standard 
EBCT protocol is to acquire 40 consecutive images from the base of the heart to just below 
the carina [1].
A calcified lesion is defined as either two or three adjacent pixels of > 130 Hounsfield units 
(HU). In one common risk quantification scheme, each calcified lesion is then multiplied by a 
density factor and the total coronary artery calcium score (CACS) calculated as the sum of 
each calcified lesion in the four main coronary arteries over all the consecutive tomographic 
slices [1].
Coronary calcification is believed to begin early in life and is an actively regulated 
process occurring during atherosclerotic plaque development [103]. Although the absence 
of calcification does not exclude the presence of atherosclerotic plaque, calcification is not 
found in normal arteries. The mean sensitivity and specificity for detecting CAD using this 
combination of CT imaging and CACS scoring are reported at 97% and 39% [1], respectively.
2 .4 .8 .7  Invasive  C o ro n a ry  A n g io g ra p h y
Coronary angiography remains the current gold standard for definitive CAD diagnosis. It 
entails vascular access to coronary arteries using catheterization and acquiring radiographic 
images of the vascular conduits and networks connected to internal structures (organs) [1].
Angiography provides an anatomic map of the site, severity, shape, and distribution of 
stenotic lesions, distal vessel size, intracoronary thrombus, diffuse atherosclerotic disease,
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mass of myocardium served, an approximate index of coronary flow, and identification of 
collateral vessels [1]. The evaluation of a stenosis relates the percentage reduction in the 
diameter of a narrowed vessel to the adjacent unobstructed vessel and also includes the 
length of the stenosis (e.g., LAD proximal stenosis diameter 35%, long or short). Given the 
subjective nature of visual lesion assessment, there is variation in interpretations of lesions. 
Moreover, angiographic narrowing of 40-75% does not always correspond to abnormal 
physiology and myocardial ischemia [1].
2 .4 .8 .8  C o ro n a ry  C o m p u te d  T o m o g rap h y  A n g io g ra p h y  
(C C T A )
CCTA relies on multidetector CT (MDCT) scanners to noninvasively detect coronary 
atherosclerosis approximating the invasive catheter-based coronary angiography. In addi­
tion, it can also provide information on plaque extent, distribution, location, and composi­
tion, in contrast to coronary angiography. The mean sensitivity and specificity for CCTA 
are 94% and 89% [104], respectively. CCTA with a high negative predictive value (99%) is 
a useful tool to exclude CAD in patients with a low pretest likelihood of disease [1]. CCTA 
also offers a time-efficient and cost-effective alternative to SPECT for initial evaluation of 
patients without known CAD.
The limitations of CCTA include decreased accuracy in patients with elevated heart rate 
(>90 BPM), irregular rhythm, extensive CACs, and an obese body type. The radiation 
exposure is two to four times that of invasive coronary angiography. The spatial and 
temporal resolution is also lower compared to coronary angiography.
2 .4 .8 .9  C a rd ia c  M ag n e tic  R eso n a n ce  (C M R )
The strength of CMR is its ability to evaluate pathological processes using several pulse 
sequences—each tuned to different biological properties—during a single examination [1]. 
Two main CMRI approaches to evaluating CAD are stress testing with imaging of myocar­
dial contraction (e.g., dobutamine stimulation) or perfusion (e.g., adenosine stimulation). 
The dobutamine stress CMR is analogous to echocardiography and can be used to detect 
ischemic-induced wall abnormalities. However, there are logistical challenges to using this 
technique, including the potential for an ischemic event while the patient is inside the MRI 
scanner as well as distortion of the ECG by the magnetic field [1].
The adenosine stress CMR is the more commonly preferred approach for CAD assess­
ment. Perfusion MRI has better spatial resolution than SPECT and does not subject the 
patient to ionizing radiation. Moreover, the examination time is 30-45 minutes versus 2-3
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hours for SPECT [1]. The mean sensitivity and specificity for CMR are 85% and 81% [1], 
respectively. However, CMR is somewhat limited in patients with metallic hardware such 
as pacemakers.
2 .4 .9  T re a tm e n t
The treatment selection for patients with CHD is based on the magnitude of risk and 
severity of the ischemia. Treatment options include pharmacological, percutaneous, and 
surgical approaches, the primary goal of which is to reduce ischemia symptoms and prevent 
adverse and potentially fatal events such as acute MI and sudden cardiac death.
2 .4 .9 .1  P h a rm a c o lo g ic  T h e ra p y
• A n ti-p late le t th e rap y  is designed to prevent coronary thrombosis by inhibiting the 
production of thromboxane and includes agents such as aspirin, thienopyridines, and 
glycoprotein (GP) IIb/IIIa inhibitors [1].
• A nticoagulation  T herapy  is also designed to reduce the ability to form blood 
clots by targeting clotting factors and includes agents such as warfarin (vitamin K 
antagonist) and heparin [1].
• F ibinolytic  th e rap y  is focused on restoring blood flow by converting plasminogen 
to plasmin, which cleaves fibrin, resulting in clot dissolution. Streptokinase (SK), a 
tissue type plasminogen activator, is a commonly used fibrinolytic agent [1].
• Lipid-lowering th e rap y  is geared toward reducing low-density lipoprotein (LDL) 
cholesterol production that is part of the plaque formation and includes agents such 
as 3-hydroxy-3-methylglutarly coenzyme reductase inhibitors (HMG-CoA), also called 
statins. Statins also have anti-inflammatory and antithrombotic properties [1].
• fi-adrenergic recep to r an tagonists  work by reducing heart rate, contractility, 
systemic arterial pressure, and LV wall stress, thereby reducing metabolic demand. 
Moreover, the slowing of heart rate also enables longer diastolic filling times, thus im­
proving coronary blood flow. Propanolol is an example of a nonselective beta-blocker.
• C alcium  channel blockers act as negative inotropic agents. They also lower 
systemic vascular resistance and mean arterial blood pressure to decrease LV after­
load, thus reducing myocardial oxygen demand [1]. Diltiazem is an example of a 
nondihydropyridine calcium channel blocker.
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• A ngiotensin-converting enzym e (ACE) Inh ib ito rs  work by reducing the pro­
duction of angiotensin II, thereby inducing vasodilation and lowering blood pressure, 
which in turn reduces myocardial oxygen demand. Ramipril is an example of an ACE 
inhibitor.
• O rganic n itra te s  work by causing venodilation, which reduces end diastolic volume 
and pressure, leading to increased myocardial perfusion. Moreover, they also dilate 
epicardial coronary arteries to improve coronary blood flow and recruit coronary 
collaterals [1]. Nitroglycerin is a commonly used nitrate.
• R anolazine is a sodium channel I ^ a blocker and exerts an anti-anginal effect without 
affecting heart rate and blood pressure, by selectively inhibiting late sodium influx 
into myocytes, which leads to reduced contractility [105].
2 .4 .9 .2  C o ro n a ry  A r te ry  R e v a sc u la riz a tio n
For patients with an elevated risk profile and suitable coronary anatomy, revascular­
ization with percutaneous coronary intervention (PCI) or coronary arterial bypass graft 
(CABG) surgery are possible procedures [106]. PCI is employed to restore coronary blood 
flow without open-heart surgery. Briefly, a balloon catheter is inserted into the culprit 
artery past the blockage and then inflated. The balloon inflation compresses the fatty 
tissue (plaque), thereby making the arterial lumen larger for improved coronary blood flow. 
In certain instances, tiny blades attached to the balloon can be used to break up the plaque 
(atherectomy). A tiny expandable metal coil (stent) is often placed in an opened area of the 
artery to provide structural support and help prevent the artery from narrowing or closing 
again. Moreover, these stents can be coated with medication (drug eluting stents) to help 
prevent scar tissue buildup inside the stent.
CABG entails taking a healthy artery or vein from one part of the body and connecting 
(grafting) it to the blocked coronary artery. The grafted artery (or vein) bypasses the 
blocked portion of the coronary artery and thereby creates a new route for the blood to 
flow.
2.4.10 P re v e n tio n
The goal of the preventative strategies is to affect modifiable CHD risk factors and thus 
reduce the incidence of preventable CHD, which is responsible for approximately 1.2 million 
myocardial infarctions and 500,000 deaths every year [107]. Common risk factors associated 
with CHD, physical inactivity, obesity, diabetes, hypertension, etc., can be behaviorally
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modified and thus reduce the incidence of CHD [1]. Moreover, the slow progression of 
the disease allows for time to adopt preventative strategies, which can result in reduced 
CHD mortality. The CHD risk factor reduction guidelines are based on various clinical 
epidemiological studies and can be summarized into the “ABCDE” approach to preventative 
cardiology [108]. The abbreviation stands for Assessment of CHD risk, antiplatelet and 
anticoagulant therapy, Blood pressure, Cholesterol and cigarette smoking cessation, Diet 
and weight management and diabetes prevention and treatment, and Exercise. Treatment 
of patients with CHD is associated with high costs, and the patients often retain residual 
risk [1].
2.5 Literature Review
The study of cardiovascular diseases has been an active research area for over a century, 








Fig. 2.28. Century of research: The timeline highlights major publications in myocardial 
ischemia research.
74
2.5.1 P re -1 9 5 0 s
The term angina pectoris to describe chest pain due to coronary artery disease was 
coined in 1893 [109]. Moreover, Strascheskow later discovered that myocardial ischemia 
and myocardial infarction could occur without causing pain [109]. Collateral vessels were 
also discovered when postmortem studies on canine hearts revealed that coronary arteries 
were not end-arteries; rather they have many collateral connections at all levels of atria and 
ventricles [20].
The first ECG was recorded using a string galvanometer by Willem Einthoven in 1901. 
As the ECG became more widespread, changes in the ST segment were noted in patients 
with CAD [110]. Moreover, it also became evident that ECG morphology could be affected 
by heart position [111]. The two-step exercise tolerance test was introduced by Arthur 
Master to diagnose patients with ischemic heart disease in 1929 and served as the antecedent 
to the present-day exercise stress testing [112]. The ECG limb lead recordings with an 
inversion of T-wave or ST segment changes in leads I and II were accepted as standard 
markers for a positive diagnosis of ischemia, but the mechanisms behind the ECG changes 
were unresolved at the time [113].
DiPalma showed the presence of an intramyocardial pressure gradient from epicardial to 
endocardial regions [114], suggesting that the inner layers of the heart muscle are reached 
by arterial blood only in diastole, during which the local coronary pressure exceeds the local 
intramyocardial pressure.
The concept of “injury current” was introduced by Bayley in 1942 [115]. Accordingly, 
the ischemic “injured” area was considered electrically negative relative to the surrounding 
noninjured myocardium during diastole and positive during systole. The resulting potential 
difference gave rise to injury currents that produced ST segment shifts on the ECG, such 
that the injured area would be characterized by ST segment elevation on the surface, whereas 
the adjacent regions would be expected to exhibit ST segment depression. Moreover, ST 
segment depression was categorized into two types: reciprocal ST segment depression that 
overlay normal muscle remote from a large ischemic region and the other ST segment 
depression that could be found over the boundary physiologically impaired muscle and 
normal myocardium [116].
2 .5 .2  1950s - 1990s
The spatial orientation of myocardial fibers in the myocardial wall was characterized, 
as a well-ordered fiber continuum of interconnecting fibers with gradual changes in fiber 
angles from endocardium to epicardium [117]. It was noted that CAD led to an increase
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in collaterals in both epicardial and endocardial regions, but the increase was greater in 
the subendocardial region [118]. Experimental studies on dogs suggested that immature 
collateral channels conductance is not maximal immediately after occlusion but increases 
with time [119].
The concept of acute coronary insufficiency (ACS) distinct from acute coronary occlusion 
(ACO) was well documented [120]. It was commonly accepted that ACS was associated 
with subendocardial ischemia and characterized by ST segment depression and T-wave 
inversion, whereas ACO was marked by ST segment elevation and Q-waves, signaling 
infarction spreading all the way to the pericardium. However, newer studies suggested that 
ACS can also produce transient and reversible ST segment elevation. Moreover, negative 
exercise tests or normal ECG did not preclude ACS [121]. It was also noted that induced 
tachycardia could produce ST segment depression [122].
The clinical treatments for angina pectoris included the use of vasodilators such as 
nitrites, beta-blockers such as propanolol, and newly introduced carotid sinus nerve electrical 
stimulation, which was shown to reduce heart rate by muting adrenergic discharges [123].
The field of vectorcardiography was established as a means to quantify abnormalities 
in ECG markers [124]. However, clinical studies suggested that ischemic ECG changes 
could also be affected by age as well as noncardiovascular disorders: pulmonary embolism, 
endocrine disorders, and acute infections among others [125]. The notion that atheroscle­
rosis was a physiological aging process and thus irreversible was being discarded with the 
realization that it was a metabolic disease caused by accumulation of lipids, cholesterol, 
and lipoproteins and thus could be prevented or reversed. However, the exact pathogenesis 
was not understood [126].
Cellular electrophysiological studies using microelectrodes to record action potentials 
(AP) from strips of papillary muscle suggested that in the absence of coronary perfusion, 
the electrical changes included shortening of AP duration, followed by the progressive fall 
of the AP amplitude. These changes were attributed to shortening of the repolarization 
phase due to the rapid efflux of potassium (K +) ions and impairment of Na/K pump due to 
changes in resting potential. Moreover, the falling resting potential was marked by similar 
changes in creatine phosphate and ATP [127].
Experimental studies conducted to measure epicardial electrograms using a wick elec­
trode suggested that epicardial ECG changes were seen only in the presence of large 
ischemic regions, where coronary flow was reduced by at least 70% [128], and thus epicardial 
ST segment changes showed relative insensitivity as an index of acute regional ischemia.
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However, intramyocardial electrograms were found to be sensitive to local ischemia [129].
Electrograms recorded using DC coupled amplifiers showed that ST segment elevation 
recorded by AC coupled amplifiers was the result of a combination of TQ segment shifts and 
true ST segment elevation. The TQ segment shifts were attributed to changes in the resting 
potential resulting from potassium efflux due to activation of KATP channels [90], whereas 
true ST segment elevation was attributed to changes in the AP amplitude [110]. Body 
surface potential maps were introduced as another tool to provide additional information 
not available on 12-lead ECG recordings [130]. Myocardial perfusion imaging (MPI) to 
track coronary blood flow was also demonstrated [131]. Moreover, atrial pacing as a means 
to induce ischemia in lieu of exercise was also noted [132].
Histological studies on canines by Jennings et al. suggested that the subendocardial 
layers in the left ventricle are more vulnerable to ischemia, since necrotic areas were more 
prevalent in the subendocardium relative to subepicardium [62]. Moreover, it was also noted 
that myocardial stress is maximal at the internal surface of the normal ventricle, implying 
that the subendocardial region requires more oxygen than subepicardium [133]. Stud­
ies investigating hemodynamic factors causing ischemia suggested that reduced coronary 
perfusion combined with elevated intramyocardial pressure reduced blood to inner layers 
of the heart, resulting in ischemia [114]. On the other hand, radioactive labeled blood 
studies suggested the accumulation of luminal blood in the inner layers of the ventricular 
myocardium by an ebb and flow into the sinusoids [134].
Studies on Purkinje fiber-myocardium junctions suggested the presence of low resistance 
intercellular connections, resulting in a flow of current during repolarization between neigh­
boring cells [135]. Ischemia-reperfusion studies by Jennings suggested a reversible phase 
of ischemia of up to 18 minutes, if arterial flow was restored [136]. Electrophysiological 
responses to ischemia in canine model suggested that excitability was more depressed in 
the epicardium and papillary muscle tip than in the endocardium and Purkinje fibers, 
and was attributed to intrinsic differences in membrane responsiveness, in part due to the 
presence of Purkinje fibers in the subendocardial region [85]. Myocardial infarct studies in 
canines suggested that a narrow rim of subendocardium several cells thick survived exten­
sive infarction [137]. Moreover, temporary occlusion experiments often yielded islands of 
necrotic cells interspersed with regions of surviving cells in the midmyocardium, suggesting 
a nonuniformity of ischemic injury [64].
During the early phase of occlusion in isolated rabbit hearts, the conduction delay 
was greater in the subepicaridum than in subendocardium, due to greater resistance of
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subendocardial cells to effects of hypoxia, elevated potassium, and acidosis. Moreover, in 
the first 10 minutes of acute ischemia, an endocardial border zone of 40-60 cell layers existed 
where the transmembrane potentials were relatively little affected by ischemia [138].
Reimer et al. showed the progression of cell death following coronary occlusion in dogs as 
transmural wavefront from the subendocardium towards the subepicardium [9]. Steinberg et 
al. showed that in rat hearts ischemia resulted in discrete heterogeneous regions of anoxic 
tissue surrounded by normoxic region [139]. The ischemia border zone studies on pigs 
suggested that it was a mixture of normal and ischemic cells, characterized by an area with 
gradients in local blood flow, lactate content, HEP, and ST segment potentials [140]. Studies 
by Austin et al. suggested that even with global factors such as elevated diastolic ventricular 
pressure and reduced perfusion pressure placing subendocardium at risk of ischemia, there 
are islands of relatively greater vulnerability within the inner layers of the heart [141].
The protective effect of ischemic preconditioning was discovered, wherein brief ischemia 
episodes (1-2 minutes) in canines followed by a long LAD/LCX occlusion (40 minutes) 
delayed cell death and thus allowed greater salvage of the heart through reperfusion ther­
apy [95]. The protective effect of preconditioning was attributed to a reduction in myocardial 
energy demand during ischemia, which reduced the rate of HEP utilization as well as the 
rate of anaerobic glycolysis [142]. It was noted that preconditioning was not an all or nothing 
phenomenon. A different magnitude of protection was induced based on the duration and 
number of preconditioning episodes [143].
Gradual reduction in myocardial blood flow in pigs produced a muted response in the 
metabolic markers of ischemia such as ATP content compared to sudden reduction in blood 
flow of 20-50%, which suggested a tightly regulated feedback or feed forward mechanism in 
maintaining a balance between oxygen demand and supply, such that the downregulation 
of metabolic energy requirements could almost keep pace with a gradual decline in coronary 
blood flow [144]. Moreover, the ATP was better maintained in demand ischemia than in 
supply ischemia for a given tissue receiving equal blood flow [145].
Ischemia studies on pigs by Holland noted that ischemic TQ and ST segment shifts 
were affected by the duration, size, and shape of the ischemic region as well as the location 
of the recording electrode. Moreover, the shape of the ischemic region was influenced 
by size, intraventricular pressure, wall tension, and location of anastomoses [10]. The 
spatial relationship between metabolites and epicardial electrocardiographic changes during 
reversible LAD ligation suggested that sites of ST segment elevation were associated with 
higher lactate concentrations and reduced HEP concentrations and thus could be construed
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as reflecting transmural ischemia. However, isoelectric sites could reflect no ischemia or 
very mild ischemia [146].
The intramural ST segment changes were more sensitive than corresponding epicardial 
ST segment changes [147] to regional ischemia. Moreover, the epicardial ST segment 
shifts were more sensitive than precordial ST segment shifts [148]. There was a general 
nonlinear correlation between epicardial ST segment elevation and biochemical changes, 
regional myocardial blood flow (RMBF), and myocardial electrolyte alterations during the 
reversible phase of ischemia [149]. Endocardial and midmyocardial ST segment changes 
were more sensitive than epicardial ST segment changes and strongly correlated with 
changes in extracellular K and PCO2 [150]. The lack of clear correlation between ECG 
ST segment to the site of occlusion was attributed to the presence or absence of collateral 
circulation, individual differences in coronary vasculature, heart position in relation to 
electrode locations, and the distance from the heart to the electrodes [151]. Studies by 
Li et al. on sheep ischemia model suggested that distributions of epicardial potentials 
either from LCX or LAD ischemia source were similar. Moreover, ischemic epicardial ST 
segment depression was attributed to injury current flowing along the lateral boundary of 
subendocardial ischemia [152]. However, the inability of epicardial ST segment depression 
to localize nontransmural ischemia could not be explained [153].
2 .5 .3  2000s - P re s e n t
Studies by our group using a canine ischemia model showed that heart rate also in­
fluences epicardial potential distribution. Moreover, induced demand and supply ischemia 
produced differing epicardial potential distribution patterns for the same level of ischemic 
stress [154]. In related studies, Shome et al. [155] used canine ischemia model studies 
to suggest that epicardial and transmural potential distribution during demand ischemia 
arose from complex sources, such that a severe demand ischemia evoked heterogeneous 
transmural potential distribution, which influenced the epicardial potential distribution 
pattern. Moreover, the epicardial potential distribution reflected the local fiber orientation 
at the ischemic boundary [156].
Our research builds on the work done by these researchers and many others as they 
contributed to the cumulative knowledge on myocardial ischemia. Specifically, this disser­
tation seeks to characterize the complex bioelectric sources of acute myocardial ischemia, 
how they evolve spatio-temporally, and the sensitivity of epicardial electrical markers to 
detect these ischemic sources.
CHAPTER 3
DESIGN OF EXPERIMENTS
This chapter provides details on the research methodology as well as the rationale 
behind the choices made including selection of animal species, experimental setup, and 
study protocols. Moreover, a description of data acquisition, data processing, and data 
visualization pipeline is also included as shown in Fig. 3.1, which will provide the context 
for interpreting the results from the research.
3.1 Animal Models
The animal models used for these studies included both canines and swines. Each 
species has certain attributes that make it relevant. Canines have relatively well-developed 
coronary collateral vasculature compared to swines and humans [157]. Indeed, humans
Fig. 3.1. Image and signal processing pipeline: The figure shows workflow from data 
acquisition to data processing and finally data visualization.
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have few collaterals during the early phase of CAD [18]. Thus, swines, with their sparse 
collateral vasculature, are an appropriate animal model for ischemia research. On the other 
hand, patients with chronic CHD develop a more extensive network of collateral circulation 
as an adaptive response [18] so that canines represent a more relevant model. Given that 
no one animal model can entirely mimic human pathophysiology, we used both the animal 
models to study and characterize myocardial ischemia. All studies were approved by the 
Institutional Animal Care and Use Committee at the University of Utah and conformed to 
the Guide for Care and Use of Laboratory Animals.
3.2 Experimental Setups
Most ischemia studies were conducted in anesthetized animals in in situ, open-chest 
preparations, which have a number of advantages over alternatives. First this preparation 
involves opening the chest cavity through a midsternal incision and thus provides ready 
access to the heart. This generous access to the heart provides the ability to acquire 
electrical signals from the epicardium by means of multielectrode sock electrodes, as well 
as the intramural regions by means of electrodes embedded in thin, flexible needles. This 
configuration allows a high and controllable degree of spatial resolution, which is not possible 
with a closed-chest model. A second advantage of this extensive access to the heart is that 
the site and extent of ischemia can be varied and more finely controlled compared to the 
closed-chest preparation. Third, the preparation provides flexible options for controlling 
coronary blood flow, for example a hydraulic occluder or a glass or plastic cannula, as 
described in more detail in a later section. Achieving coronary flow control in a closed-chest 
preparation is more difficult and less precise.
The open-chest preparation also has some disadvantages, however. There is trauma 
associated with surgical preparation that would not arise in the closed-chest model [158]. 
This trauma can also lead to elevated ST segments and thus confound the interpretation 
of ischemia-induced changes. A final disadvantage of the open chest preparation is that it 
requires extensive anesthesia, which reports suggest may influence the response of the tissue 
to occlusion [159].
The left anterior descending (LAD) coronary artery was used to produce regional is­
chemia as it has been shown that LAD occlusion produces greater impairment of global LV 
function than LCX occlusion especially in humans and swines [18].
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3.2.1 In  S itu  S e tu p
In this setup, a midsternal thorocotomy allowed direct access to the heart for recording 
epicardial potentials from the entire surface of both ventricles and capturing intramural 
potentials from the anterior aspects of the right and left ventricles. The animals were 
anesthetized by bolus injection of sodium pentobarbital (30 mg/kg) for canines or isoflurane 
gas (1-3% inhalant to effect) for pigs, followed by maintenance doses administered as needed.
After the thorocotomy, the heart was suspended in a pericardial cradle. Ventilation was 
room air mixed with oxygen adjusted to maintain physiological blood gas parameters and 
pH. A heated and automatically monitored table ensured physiological body temperature 
and insulation, and monitoring maintained stable cavity temperature to minimize any ther­
mally induced repolarization changes. A pacing clip attached to the right atrial appendage 
provided control of heart rate above the intrinsic rate for each animal.
A suitable left anterior descending (LAD) segment was then dissected and freed from 
the underlying tissue. The flow through the dissected LAD was regulated using either a 
hydraulic occluder, a cannula inserted into the vessel and connected by hose to a blood 
pump, or a snare, as shown in Fig. 3.2.
A heat exchanger ensured that the perfused blood was maintained at physiological 
temperatures. A measurement of coronary flow and intrinsic heart rate at the start of 
each experiment determined default resting values.
3 .2 .2  Iso la te d  H e a r t  P e rfu se d  by  S u p p o r t  A n im a l
Some studies were conducted by removing the entire heart from a donor animal and 
maintaining its blood supply, which is a modified version of the Langendorff prepara-
A) C annulation B) H ydrau lic  O ccluder C) Snare
Plunge needles
Fig. 3.2. In situ preparation: Panel A highlights cannula setup. Panel B shows hydraulic 
occluder setup. Panel C shows the total occlusion snare setup.
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tion [160, 154], as shown in Fig. 3.3. This preparation has been successful using dogs 
only for both the donor and support animals.
Once extracted and connected to a support animal, the isolated heart was suspended in 
a torso tank filled with electrolyte composed of NaCl (1.35 gm/l) and sucrose (89 gm/l) 
(adjusted for isotonicity and a bulk conductivity of 500 Ocm).
The study protocol was designed to simulate two forms of acute ischemia: 1) a stress 
test with pacing as a surrogate for exercise and 2) episodes of reduced coronary perfusion 
to simulate coronary artery disease. Mirvis et al. have shown that tachycardia increases 
oxygen demand that is unaffected by mode of tachycardia induction such as exercise or 
pacing [161]. Similarly, by combining elevated heart rate and reduced coronary perfusion 
in different protocols, we were able to simulate both of what are known as “demand” and 
“supply” types of ischemia.
For demand ischemia, characterized by progressively elevating metabolic demand under 
stable perfusion conditions, the coronary perfusion was held constant and the pacing rate 
was increased in a stepwise manner in increments of the pacing interval of 30-50 milliseconds.
For supply ischemia, in which demand is stable but blood supply is reduced, ischemia 
was induced by keeping the pacing rate constant and decreasing the perfusion rate in steps 
of 7-10 ml/min for the cannulated LAD and steps of 25% perfusion deficit when using the
3.3 Study Protocols
FLOW REGULATOR
Fig. 3.3. Isolated heart preparation: The figure shows the schematic of the isolated heart 
perfused by a support animal.
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hydraulic occluder, as shown in Fig. 3.4.
Each resulting ischemic episode lasted 2-10 minutes, depending on the protocol, the 
intrinsic heart rate and coronary flow values of the animal, and the maximum heart rates 
tolerated. Each experiment consisted of four to six such episodes separated by recovery 
periods of approximately 25-30 minutes.
3.4 Data Acquisition
Data acquisition included recording of bioelectric signals from epicardial and intramural 
regions of the heart as well as geometric information through imaging and mechanical 
digitization of electrode locations. If the experimental setup included a torso tank, we also 
acquired electrical recordings from the torso surface and the location of the heart within the 
torso tank. In addition, we collected blood gases, pH, and electrolyte information during 
the experiment.
3.4.1 T im e  S ignal A cq u is itio n
Epicardial potentials were recorded from the surfaces of both ventricles using a 247- 
electrode flexible sock array, the construction of which is described elsewhere [162]. Briefly, 
a nylon stocking material (sock) was placed on a plaster of paris mold of a representative 
heart. The 247 electrode locations were marked on the sock with an approximate mean 
interelectrode spacing of 8 mm. The electrodes (0.003 inch insulated silver wire) were sewn
A) Supply Ischemia B) Demand Ischemia
Duration (min) Duratl0n (min)
Fig. 3.4. Study protocol. By altering either heart rate or perfusion rate in regularly spaced 
increments and for set durations (typically 2 minutes), we were able to simulate both supply 
(Panel A) and demand (Panel B) forms of ischemia.
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into the sock at the marked locations. Finally, a tiny section of the insulation in the wire 
was removed to expose the recording electrode.
Up to 26 fiberglass needles, each carrying 10 electrodes along its length spaced at 1.5 mm, 
were used to record intramural potentials, as shown in Fig. 3.5. These small and flexible 
plunge needles [163] were constructed to create less tissue injury and therefore more sensitive 
measurements than previous electrodes with metal shafts. The plunge needles were inserted 
into the ventricles in and around the region presumably perfused by the cannulated or 
occluded LAD, taking care to avoid injuring the epicardial arteries. The spacing between 
needles within the epicardial region they covered did not exceed 10 mm. The perfused region 
was identified before insertion by stopping blood flow through the LAD for 45 seconds 
and recording the resulting epicardial potentials. Localized ST segment elevations were 
considered indications of nearby ischemia.
The potentials from sock and needle electrodes were recorded using a custom acquisition 
system permitting simultaneous acquisition of 1024 channels at 1 kHz sampling rate and 
12 bit resolution [164]. Briefly, the acquisition system consisted of multiplexers, interface 
circuitry, and a personal computer (PC) hosting a custom software written in Labview (Na-
Electrode Sock
Fig. 3.5. Intramural electrodes and recording electrograms: Left hand panels show the 
needle electrodes used for intramyocardial electrodes and the right hand panels show sample 
electrograms recorded from the cardiac surface (upper panel) and intramurally (lower panel) 
using sock and plunge needle electrodes, respectively.
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tional Instruments) that managed the hardware and allowed continuous signal acquisition 
for up to 30 minutes. A band pass filter with cutoff frequencies at 0.03 and 500 Hz avoided 
both DC potentials and aliasing. A single limb lead was used as a remote reference for all 
the unipolar signals recorded from the sock and needle electrodes in the in situ preparations. 
Electrical recordings as were taken for typically 3 seconds every 15-30 seconds during the 
ischemic episode as well as during the recovery period.
3.4.2 Im ag e  A cq u is itio n
Following each experiment, the heart was excised and scanned with a 7-tesla MRI 
scanner (Bruker, Inc., Billerica, MA). Anatomical scans were generated using two pulse 
sequences: fast imaging with steady precession (FISP) and fast low angle shot imagine 
(FLASH). The pulse sequence parameters used were, as shown in Table 3.1. The FISP 
scans were selected for higher contrast, whereas FLASH scans were chosen for a higher 
signal to noise ratio, as shown in Fig. 3.6.
Table 3.1. FISP and FLASH pulse sequence parameters.
P a ram eters F ISP Flash
Echo Time (TE) 5 ms 5 ms
Repetition Time (TR) 10 ms 36.2 ms
Flip Angle (a) 59.5° 30°
Field of View (FOV) 80 mm 80 mm
Spatial Resolution 0.32 mm 0.32 mm
Fig. 3.6. Anatomical scans: The figure shows a slice from the FISP (left) and FLASH scan 
(right).
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3.4 .3  R e g is tra tio n  D a ta  A cq u is itio n
At the end of the experiment, the locations of preselected sock electrodes and all the 
plunge needles on the cardiac surface were digitally recorded using a Microscribe three­
dimensional digitizer (Solution Technologies, Inc., Oella, MD). In addition, landmark sites 
including the location of the occlusion site, distribution of major epicardial coronary arteries, 
and the outline of the myocardial shape were also captured using the digitizer. Once the 
locations of the plunge needles were recorded, they were replaced with plastic spacers, as 
shown in Fig. 3.7. These spacers not only prevented closure of the tissue holes created by 
the needles, but also were visualized in the acquired anatomical MRI scans, thus providing 
information for electrode location (described in a later section).
3.5 Data Processing
Data processing entailed basic signal conditioning and extraction of relevant features 
(e.g., ST40% potentials, T-peak, etc.) from the epicardial and intramural electrograms, 
segmentation of the myocardium and the plunge needle locations from the anatomical scans, 
and geometry processing that included generating tetrahedral volume meshes from the heart 
segmentation and eventual spatial and functional mapping (registration) of the sock and 
plunge needle electrodes to the volume mesh.
Fig. 3.7. Plunge needle locations: The left image shows the plunge needles in place 
immediately after an experiment and, in the right panel after the digitization process, 
when they have been replaced by plastic spacers.
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3.5.1 T im e  S ignal P ro c e ss in g
The electrograms recorded during the study were processed in Matmap, a custom 
MATLAB-based signal processing program developed in our laboratory. The signals were 
first calibrated and the gain adjusted and their baselines corrected. Calibration entailed first 
acquiring a reference signal for each of the 1024 input channels on the acquisition system. 
The reference signal was a sine wave of set amplitude(s), which was then used to extract a 
correction factor to be applied to all the recorded signals, resulting in a gain adjustment.
Baseline drifts that naturally occur during recording of biosignals were corrected by 
selecting two points along the assumed isoelectric portion of the electrogram (e.g., QT 
segment) and drawing a straight line between these points. This line set the baseline for 
the electrograms and was then subtracted from the recorded signals.
Poor quality signals from sock and needle electrodes, for example, due to incomplete 
contact with the tissue, were discarded. Electrograms recorded from needle electrodes near 
the tip that were without positive Q-wave deflection were identified as cavity electrodes and 
also discarded.
The global root mean squared (RMS) signal computed from the electrograms at all the 
sock and needle electrode was used to identify the J-point and T-peak time instants, as 
shown in Fig. 3.8. Subsequently, features such as ST40%, T-peak, QRS amplitude, etc., 
were extracted from the electrograms. The value of potentials at 40% of the ST segment 
between the J-point and the peak of the T-wave (ST40%) provided the metric for local 
ischemia. The peak amplitude of the T-wave also served as a T-wave marker.
2
1: QRS amplitude 
2: ST40%
3: T-peak
Fig. 3.8. Basic signal processing: The figure shows the features extracted from a sample 
recorded electrogram.
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3.5 .2  Im ag e  P ro c e ss in g  (S eg m e n ta tio n )
Segmentation is a process of identifying regions of interest (e.g., ventricles, atria) from 
a given set of image scans and creating what is known as a “mask label” that assigns each 
voxel with a particular region a label associated with that region, as shown in Fig. 3.9. 
The anatomical MRI scans of the heart were segmented to identify the atria, ventricles, 
and locations of plunge needles using Seg3D [165]. Briefly, this entailed first smoothing the 
images using either median [166] and Gaussian anisotropic filters [167] to remove noise (e.g., 
speckle noise), while also trying to preserve edge information. Next, the filtered images were 
thresholded (based on interactively setting the range of intensity values) to identify atria, 
ventricles, and plunge needles. Finally, the selected regions were manually edited as needed 
to capture appropriate anatomical details.
3 .5 .3  G e o m e try  P ro c e ss in g
The geometry processing pipeline included generating a volume mesh based on the 
segmentation and registering the location of the sock and needle electrodes to this mesh, 
which allowed for generating a subject specific spatial and functional map of electrical 
potentials. We generated volume meshes (with tetrahedral elements) derived from the 
segmentation of the anatomical MRI scans, as shown in Fig. 3.10. The mesh was generated 
using a meshing software called BioMesh3D [168].
Registration refers to transformation of two or more sets of spatially organized datasets 
into a given coordinate space [169]. We employed a feature-based registration technique, in 
which landmarks (e.g., plunge needle locations, epicardial coronary arteries, etc.) identified 
(and digitized) at the end of the experiment were aligned with those from the anatomical 
MRI scans and the corresponding volume mesh, as shown in Fig. 3.11. The alignment of
A) Original Image B) Smoothed Image C) Thresholded Mask Label D) Manually Edited Mask Label
Fig. 3.9. Image processing: a) Original image scan, (b) smoothed image, (c) thresholded 
image mask label, (d) manually edited mask label.
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A) Isosurface B) Volume Mesh C) Volume mesh with
tetrahedral elements shown
Fig. 3.10. Volume meshing: Panel A shows the isosurface of the heart based on the 
segmentation. Panel B shows the volume mesh generated from the segmentation using 
BioMesh3D software. Panel C shows the tetrahedral elements of the volume mesh.
Fig. 3.11. Geometry processing: a) Segmentation of the plunge needles, (b) captured 
location and direction of entry of the plunge needles, (c) needle electrodes registered to 
the mesh, (d) sock electrodes registered to the mesh.
landmarks included both rigid and linear transformations [170], as well as scaling and mor­
phing of the geometry with nonlinear transformations [171], depending on the registration 
requirements.
3.6 Data Visualization
We generated volume maps using SCIRun, which entailed interpolating the potential 
distributions throughout the LV wall using the radial basis function (RBF) approximation, 
which generated surface maps from intramural potentials by cutting planes through the
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volume and evaluating the potential distribution at a given snapshot in time. Moreover, we 
could also isolate the ischemic regions, while making the rest of the heart volume semitrans­
parent and track the spatio-temporal evolution, as shown, for example, in Fig. 3.12. The top 
row shows the intramural two-dimensional map and the bottom row shows an intramural 
three-dimensional map of the ST40% potential distribution. The colored region shows the 
sampled perfusion bed, whereas the gray region shows the rest of the heart region that was 
not sampled.
Intramural 2D map - ST40%
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Fig. 3.12. Data visualization: The top row shows the intramural two-dimensional map 
and the bottom row shows an intramural three-dimensional map of the ST40% potential 
distribution.
CHAPTER 4
SPATIAL ORGANIZATION OF 
MYOCARDIAL ISCHEMIA
The goal of the first study was to evaluate the conventionally held mechanisms for 
nontransmural ischemia. The following research has been submitted to the Journal of 
Electrocardiology.
4.1 Abstract
Myocardial ischemia is a pathological condition initiated by supply and demand imbal­
ance of the blood to the heart. Previous studies suggest that ischemia originates in the 
subendocardium, i.e., that nontransmural ischemia is limited to the subendocardium. By 
contrast, we hypothesized that acute myocardial ischemia is not limited to the subendo­
cardium and sought to document its spatial distribution in an animal preparation. The 
goal of these experiments was to investigate the spatial organization of ischemia and its 
relationship to the resulting shifts in ST segment potentials during short episodes of acute 
ischemia.
We conducted acute ischemia studies in open-chest canines (N=19) and swines (N=10), 
which entailed creating carefully controlled ischemia using demand or supply ischemia pro­
tocols and recording intramyocardial and epicardial potentials. Elevation of the potentials 
at 40% of the ST segment between the J-point and the peak of the T-wave (ST40%) provided 
the metric for local ischemia. The threshold for ischemic ST segment elevations was defined 
as two standard deviations away from the baseline values.
Acute ischemia was characterized by pockets of ST-segment elevated regions variously 
distributed in the subepicardial, midmyocardial, and subendocardial regions in 79% of 
canine and 67% of swine ischemic episodes (p <0.05).
Our findings suggest that the spatial distribution of acute ischemia is a complex phe­
nomenon spread throughout the myocardial wall and is not limited to the subendocardium.
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4.2 Introduction
Despite a century of research and practice, the clinical accuracy of the electrocardiogram 
(ECG) to detect and localize myocardial ischemia remains less than satisfactory [172]. 
Myocardial ischemia occurs when the heart does not receive adequate oxygen-rich blood 
to keep up with its metabolic requirements, and severe ischemia can lead to myocardial 
infarction and life-threatening arrhythmias. Early and accurate detection is therefore an 
essential component of managing this condition. In the emergency room (ER), a resting 
12-lead ECG is often recorded in patients with symptoms of angina (chest pain). However, 
such a single resting ECG is normal in up to 50% of patients with chronic, stable angina [1]. 
Far from static, ischemia is known to be a dynamic condition that reflects a changing 
imbalance between blood supply and metabolic demand. This dynamic behavior presents 
diagnostic challenges and encourages continuous monitoring, which is feasible only with a 
technique like the ECG. Outside the emergency room, it is natural that examination of the 
ECG under physical stress conditions, or exercise testing (ET), has long been in widespread 
clinical use. However, ET is characterized by poor sensitivity (68%) and specificity (77%) [1], 
limiting its diagnostic usefulness. Due to the extremely high incidence of ischemia and the 
many practical and economical advantages of ECG based testing, any improvements in this 
technique and the interpretation of the data it gathers will have a profound impact on 
clinical practice.
The most common clinical ECG marker for myocardial ischemia detection is the ST 
segment, that portion of the ECG time signal that lies between the QRS complex and 
the T-wave. Changes in the ST segment can occur within 15-30 seconds after the onset 
of ischemia [173] and hence represent one of the earliest markers of the condition. The 
ST segment represents the period when the ventricles are depolarized, i.e., the ventricular 
action potentials are all in the plateau phase. In a healthy heart, this means that all regions 
of the ventricles have approximately the same transmembrane potential and that this phase 
of the normal ECG is isoelectric. However, the ST segment potential can shift above 
(ST segment elevation) or below (ST segment depression) the baseline during myocardial 
ischemia, depending on the flow of what are known as “injury currents.” These currents 
are the result of voltage gradients between normal and ischemic regions, gradients that 
arise because of differences between the action potentials of ischemic and normal cells that 
include localized shortening, diminishing amplitude, and a decrease (more positive value) 
in resting membrane potential. The resulting injury currents can produce an ST segment 
elevation in an extracellular or body-surface electrode if they are directed towards the
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recording electrode or ST segment depression if they are directed away from the electrode.
Classic electrocardiographic theory builds on these biophysically sound concepts with ad­
ditional assumptions about the spatial distribution of healthy and ischemic tissues; however, 
these assumptions may be too simplified to explain both experimental and clinical observa­
tions. The historical basis for many of these assumptions lies in postmortem examinations of 
infarcted hearts [174, 175] under the additional assumption that the location and extent of 
eventual scar and infarct zones match approximately the ischemic regions that arise acutely 
following onset of ischemia. Careful experimental evaluation of these assumptions has 
become possible only recently with the development of flexible multielectrode needles [163] 
that can capture extracellular potentials throughout the ventricular wall. Previous studies 
of acute ischemia were instead based on measured potentials only from the epicardial 
and endocardial surfaces [176, 177, 138, 178]. While surface potentials are a reflection 
of intramyocardial events, it is only possible to infer the underlying bioelectric sources 
rather than measure them directly.
From these early experiments have come several elements that now make up the pre­
vailing putative explanation for clinical observations of ST segments during acute ischemia. 
Central to this explanation of the spatial dynamics of ischemia is the assumption that 
at low grades of perfusion deficit, myocardial ischemia is localized to the subendocardium 
(innermost region of the heart wall) [173]. Justification for this assertion includes the notion 
that this region has the highest metabolic demand and is the most distal perfusion zone 
and hence most vulnerable [173]. Moreover, with increased stress, ischemia was thought 
to progress over time uniformly towards the epicardium (outermost region), eventually 
becoming transmural (spanning the full thickness of the heart wall). According to this 
theory, ischemia localized to the subendocardium would generate injury currents flowing 
away from the epicardial or body-surface electrodes toward the localized subendocardial 
ischemic region. Thus ST segment depression is thought to indicate subendocardial is­
chemia. Moreover, transmural ischemia would then produce injury currents flowing towards 
the recording electrodes located above the affected region of the heart, resulting in ST 
segment elevations. Many decades of clinical practice and experimental studies have shown 
that, indeed, superficial leads with ST segment elevation can be linked spatially to the 
region of ischemia and thus provide a means to localize transmural ischemia from the body 
surface. However, the same is not true of the ability of ST segment depression to locate 
nontransmural ischemia [179, 180, 152].
Preliminary results from our group using intramyocardial recordings do not support the
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assertion that nontransmural ischemia arises only in the subendocardium [181, 182] and 
have motivated a comprehensive evaluation of the spatial distribution of acute ischemia 
based on high-resolution measurements under a range of conditions. Our goal in this study 
was to evaluate the conventional mechanisms for nontransmural ischemia using intramural 
electrodes to measure three-dimensional potential distributions in the ventricles of animals 
exposed to acute ischemia. We conducted a series of 29 separate experiments under a range 
of acute ischemia conditions using two different in situ animal models. To interpret the 
resulting electrograms, we assumed that localized ischemia causes localized elevations in the 
extracardiac ST segment potentials. We measured three-dimensional surface and transmural 
potential distributions under study protocols that altered both the local coronary supply 
and global metabolic demand.
4.3 Methods
4.3 .1  E x p e r im e n ta l  P re p a ra t io n
The goal of these experiments was to detect the three-dimensional distribution of ischemia- 
induced shifts in ST segment potentials during the acute phase of short episodes of ischemia 
created by reduced coronary flow and an increased rate of contraction. We performed 
experiments on open-chest, intact canines and swines using multipolar intramural needle 
electrodes and epicardial surface electrodes. Study subjects included 29 animals: 19 purpose 
bred dogs and 10 adult mini pigs, following the approval from the Institutional Animal Care 
and Use Committee at University of Utah and conforming to the Guide for the Care and 
Use of Laboratory Animals (NIH Pub. No 85-23, Revised 1996).
An open-chest preparation following midsternal thorocotomy allowed direct access to 
the heart for recording epicardial potentials from the entire surface of both ventricles and 
transmural potentials from the anterior aspects of the right and left ventricles. The animal 
was anesthetized by bolus injection of sodium pentobarbital (30 mg/kg) for canines or 
isoflurane gas (1-3% inhalant to effect) for pigs, followed by maintenance doses adminis­
tered as needed. After the thorocotomy, the heart was suspended in a pericardial cradle. 
Ventilation was with room air mixed with oxygen adjusted to maintain physiological blood 
gas parameters and pH. A heated and automatically monitored heating table ensured 
physiological body temperature, and insulation and monitoring maintained stable cavity 
temperature to minimize any thermally induced repolarization changes. A pacing clip 
attached to the right atrial appendage provided control of heart rate above the intrinsic 
rate for each animal.
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A suitable left anterior descending (LAD) segment was then dissected and freed from 
the underlying tissue. For one set of experiments in which we regulated the coronary flow 
progressively, the LAD was cannulated and perfused by the blood from one of the carotid 
arteries with flow rates controlled by a digital pump. In a second set of experiments, we 
circled the LAD using a snare that we closed completely to create ischemic episodes. In 
a third set of experiments, we circled the LAD using a hydraulic occluder and used it to 
regulate coronary flow. In this third approach, calibration of the fluid volume injected 
into the occluder enabled us to perform graded reductions in coronary perfusion. A heat 
exchanger ensured that the perfused blood was maintained at physiological temperatures. 
A measurement of coronary flow and intrinsic heart rate at the start of each experiment 
determined default resting values.
4 .3 .2  E x p e r im e n ta l  P ro to c o ls  a n d  D a ta  A cq u is itio n
The study protocol was designed to simulate two forms of acute ischemia: 1) a stress 
test with pacing as a surrogate for exercise and 2) episodes of reduced coronary perfusion to 
simulate coronary artery disease. Mirvis et al. have shown that tachycardia increases oxygen 
demand that is unaffected by mode of tachycardia induction, such as exercise or pacing [161]. 
Similarly, by combining elevated heart rate and reduced coronary perfusion in different 
protocols, we were able to simulate both of what are known as “demand” and “supply” 
types of ischemia. For demand ischemia, characterized by progressively elevating metabolic 
demand under stable perfusion conditions, the coronary perfusion was held constant and 
the pacing rate was increased in a stepwise manner in increments of the pacing interval 
of 30-50 milliseconds. Supply ischemia, in which demand is stable but blood supply is 
progressively reduced, was induced by keeping the pacing rate constant and decreasing the 
perfusion rate in steps of 7-10 ml/min for the cannulated LAD and steps of 25% perfusion 
deficit when using the hydraulic occluder. Each resulting ischemic episode lasted 2-10 
minutes depending on the protocol, the intrinsic values of resting heart rate and coronary 
flow of each animal, and the maximum heart rates tolerated. Each experiment consisted 
of four to six such episodes separated by recovery periods (at intrinsic heart rates and 
perfusion) of approximately 25-30 minutes. Electrical recordings (described in detail below) 
were taken for 3 seconds every 15-30 seconds during the ischemic episode as well as during 
the recovery period. Fig. 4.1 contains a schematic of the animal preparation.
Epicardial potentials were recorded from the surfaces of both the ventricles using a 
247-electrode flexible sock array, the construction of which is described elsewhere [162]. 
In addition, up to 26 flexible fiberglass needles [163], each carrying 10 electrodes along
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Fig. 4.1. Experiment setup: (a) Experiment setup, (b) sample study protocol, (c) sample 
epicardial and intramural electrograms, (d) ischemia threshold based on localized ST40% 
potential.
its length, spaced at 1.5 mm, were inserted into the ventricles in and around the region 
presumably perfused by the cannulated or occluded LAD, taking care to avoid injuring 
the epicardial arteries. The spacing between needles within the epicardial region they 
covered did not exceed 10 mm. The perfused region was identified before insertion by 
stopping blood flow through the LAD for 45 seconds and recording the resulting epicardial 
potentials. Localized ST segment elevations were considered indications of nearby ischemia. 
The potentials from sock and needle electrodes were recorded using a custom acquisition 
system permitting simultaneous acquisition of 1024 channels at 1 kHz sampling rate [164]. 
A single limb lead was used as a remote reference for all the unipolar signals recorded from 
the sock and needle electrodes.
4 .3 .3  P o s te x p e r im e n t Im a g in g  a n d  S ignal P ro c e ss in g
The electrograms recorded during the study were processed in Matmap, a custom 
MATLAB-based signal processing program developed in our laboratory. The signals were 
first calibrated and gain adjusted and their baselines corrected. Poor quality signals from
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sock and needle electrodes, for example, due to incomplete contact with the tissue, were 
discarded. Electrograms recorded from needle electrodes near the tip without positive 
Q-wave deflection were identified as cavity electrodes and also discarded. At the end of 
the experiment, the locations of preselected sock electrodes and all the plunge needles 
on the cardiac surface were digitally recorded using a Microscribe three-dimensional dig­
itizer (Solution Technologies, Inc., Oella, MD). Interactive visualization of the resulting 
spatio-temporal maps of cardiac potentials was by means of map3d [183]. Following each 
experiment, the heart was excised and scanned with a 7-tesla MRI scanner (Bruker, Inc., 
Billerica, MA). The resulting image sets were segmented to identify the atria and ventricles 
using Seg3D [165], and the segmentations became the basis of a volumetric tetrahedral 
mesh created using SCIRun. The digitized sock and needle electrodes were then registered 
to this mesh geometry and visualized in SCIRun. Additional visualization and analysis were 
performed by interpolating potentials on parallel cutting planes regularly spaced through 
the volume. We differentiated between subendocardial, midmyocardial, and subepicardial 
regions, as defined by 0-30%, 30-70%, and 70-100% of the distance along those electrodes 
of each transmural plunge needle that were within the myocardium.
Elevation of the value of the potentials at 40% of the ST segment between the J-point 
and the peak of the T-wave (ST40%) provided the metric for local ischemia. The global root 
mean squared (RMS) signal computed from all the sock and needle electrode electrograms 
was used to identify J-point and T-peak fiducials. To minimize the effects of signal noise, 
we first computed the average of 10 potential values around the ST40% time instant. In 
addition, to minimize the influence of beat to beat fluctuations, we further averaged the 
ST40% values from three consecutive beats for each electrode site. The results from initial 
experiments indicated the need to normalize ST segment changes from control recordings 
taken before each intervention. All ST40% values within the same intervention were evalu­
ated relative to these control values. We also defined a threshold for ischemic ST segment 
elevations from these normalized ST40% potentials as two standard deviations away from 
the baseline values.
4 .3 .4  S ta tis t ic a l  A n a ly sis
A chi-square test of goodness-of-fit was performed to determine whether the spatial 
distribution of acute ischemia—subendocardial, and distributed—were equally preferred. 
Statistical significance was set at alpha <0.05.
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4.4 Results
In the experiments, we found examples of ischemia distributed over most of the ven­
tricular wall. We show here three representative examples of ischemia measured in the 
subendocardium, the midwall, and the subepicardium together with statistical summaries 
of relative frequency of occurrence across all 29 experiments.
Fig. 4.2 highlights data from a canine study of supply ischemia in which acute ischemia 
was distributed in multiple, separate regions across the ventricular wall, all within the 
same ischemic intervention. Panel A shows the intramural ischemic volume and associated
Fig. 4.2. Ventricular response to demand ischemia: Panel A shows the intramural ischemic 
volume and potential distributions across three slices. The locations of ST segment elevated 
regions are highlighted in red in the volume and the axial slices through the ST segment 
elevated regions in the subendocardium (S1), subepicardium (S2), and midwall (S3) regions, 
respectively. Panel B shows the canine heart with plunge needle locations. Panel C displays 
the corresponding epicardial ST40% potential difference map. Panel D shows the study 
protocol.
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potentials at three axial slices, marked “S1” “S2,” and “S3” under control conditions and 
at the onset of ischemia, which occurred 30 seconds into the intervention. The onset of 
ischemia was characterized by three ST segment elevated regions (in red) exceeding the 
threshold of two standard deviations from baseline (4 mV). The subsequent columns show 
the location of the ischemic regions in the subendocardium (S1), subepicardium (S2), and 
midwall (S3) regions, respectively. Panel B shows a rendering of the ventricles of this canine 
heart with locations of the plunge needles. Panel C displays the epicardial ST40% potential 
difference map at control and the onset of ischemia, which was nontransmural at this stage 
and showed no meaningful ST-segment shifts on the epicardial surface. The threshold for 
the epicardial ST40% marker was also at 4 mV corresponding to two standard deviations 
from baseline conditions. Panel D shows the study protocol: a sequence of demand ischemia 
with zero perfusion (no flow) through the LAD and increasing the heart rate from 150 to 
200 BPM at 1 minute intervals.
Fig. 4.3 highlights data from another canine study during supply ischemia in which
Fig. 4.3. Ventricular response to supply ischemia: Panel A shows the canine heart with 
plunge needle locations. Panel B shows the study protocol. Panel C and Panel D show 
the intramural ischemic volume and potential distributions across two slices, S1 and S2. 
The locations of ST segment elevated regions are highlighted in red in the volume and the 
axial slices through the ST segment elevated regions in the midwall (S1) and subendocardial
(S2) regions, respectively. Panel E displays the corresponding epicardial ST40% potential 
difference map.
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acute ischemia was also distributed in multiple, separate regions across the ventricular 
wall. Panel A shows a rendering of the ventricles of this canine heart with locations of 
the plunge needles. Panel B shows the study protocol: a sequence of supply ischemia 
with maintained heart rate at 171 BPM and decreasing the LAD perfusion from 100% to 
0% at 2-minute intervals. Panel C shows the intramural ischemic volume and associated 
potentials at two axial slices, marked “S1,” and “S2” under control conditions and at the 
onset of ischemia, which occurred at 50% reduction in LAD perfusion. The onset of ischemia 
was characterized by two ST segment elevated regions (in red) exceeding the threshold of 
two standard deviations from baseline (3 mV). Panel D shows the location of the ischemic 
regions in the midwall (S1) and subendocardial (S2) regions, respectively. Panel E displays 
the epicardial ST40% potential difference map at control and the onset of ischemia, which 
being nontransmural at this stage, is not yet localized on the epicardial surface maps. As in 
the previous figure, there is no apparent change in epicardial ST-segment potential at this 
early phase of ischemia. The threshold for the epicardial ST40% marker was also 3 mV, 
corresponding to two standard deviations from baseline conditions.
Fig. 4.4 shows an example of a single zone of acute ischemia localized in the midwall 
for a swine subject. Panel A shows a rendering of the swine heart with locations of the 
plunge needles. Panel B shows the intramural ischemic volume and associated potentials at 
the axial slice, marked “S1” under control conditions and at the onset of ischemia, which 
occurred at 50% reduction in LAD perfusion. The onset of ischemia was characterized by an 
ST segment elevated region (in red) exceeding the threshold of two standard deviations from 
baseline (3 mV). Panel C shows the location of the ischemic regions in the midwall (S1). 
Panel E displays the epicardial ST40% potential difference map at control and the onset of 
ischemia. The threshold for the epicardial ST40% marker was also at 3 mV, corresponding 
to two standard deviations from baseline conditions. Panel E shows the study protocol: a 
sequence of supply ischemia with maintained heart rate at 133 BPM and decreasing the 
LAD perfusion from 100% to 0% at 2-minute intervals.
We conducted acute ischemia studies on 29 animals (19 animals and 100 episodes in 
canines and 10 animals and 36 episodes in swines). For canines, 81% (81 out of 100), 
and in case of swines, 92% (33 out of 36) of episodes included ischemic regions in the 
subendocardial region. In addition, 75% of canine (75 out of 100), and 64% of swine (23 
out of 36) episodes included ischemic regions in the midwall region. The subepicardium 
was least often represented with only 21% of canine (21 out of 100) and 22% of swine (8 
out of 36) episodes including ischemia in this region. Furthermore, 64% (64 out of 100) of
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Fig. 4.4. A single ischemic zone in the midmyocardium of a pig study: Panel A shows 
the swine heart with plunge needle locations. Panel B and Panel C show the intramural 
ischemic volume and potential distributions across the axial slice (S1). The locations of ST 
segment elevated regions are highlighted in red in the volume and the axial slice through the 
ST segment elevated regions in the midwall (S1) region. Panel D displays the corresponding 
epicardial ST40% potential difference map. Panel E shows the study protocol.
canine, and 56% (20 out of 36) of swine episodes included ischemic regions that overlapped 
both subendocardial and midwall regions. Moreover, 21% of canine (21 out of 100) and 
only 0.02% of swine (1 out of 36) episodes resulted in ischemic regions overlapping both 
midwall and subepicardial regions. Figure 4.5 shows the statistical summary of the spatial 
organization of acute ischemic episodes resulting from the study. The upper histogram shows 
the relative frequency of occurrence of episodes in subendocardial, midwall and subepicar­
dial regions as well as the overlapping regions (subendocardial and midwall, midwall and 
subepicardial) across the two species. The second row of the figure contains a different 
form of summary that indicates the number of episodes that included ischemia in the 
subendocardium or that spanned subendocardial and midmyocardial (blue bars) compared 
to those that included ischemia distributed through the ventricles. The distributed group 
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Fig. 4.5. Statistical summary of ischemia distribution across all studies: The histograms 
(upper row) quantify the relative frequency of occurrence of acute ischemia in each of the 
three defined regions of the ventricular wall as well as the two overlapping regions. The 
figures captures a total of 100 episodes of ischemia in dogs and 36 in pigs. The lower row 
contains a histogram of the distribution of the number of episodes that were localized to 





region in midwall, subepicardial, or overlapping both midwall and subepicardial regions. 
For canines, 79% of episodes (X2 (1, N=100) =  33.64, p < 0.05), and for swines, 67% of 
episodes (X2 (1, N=36) =  4, p < 0.05), produced ischemia distributed across the ventricular 
wall.
4.5 Discussion
The aim of this study was to evaluate the conventionally held assumptions about 
nontransmural ischemia using intramural electrodes to measure three-dimensional potential
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distributions in the ventricles of animals exposed to acute ischemia. To that end, we 
conducted a series of in situ experiments on canine and swine subjects and profiled the 
resulting intramural and epicardial potentials. We captured the spatial distribution of the 
electrocardiographic response acute myocardial ischemia under staged conditions of both 
supply and demand forms of the condition in both dogs and pigs. The consistent finding 
was that under any of these conditions and species, acute ischemia originated not only 
in the subendocardium but throughout the ventricular wall, i.e., in the subendocardium, 
midmyocardium, or the subepicardium. The most important conclusion from this study 
is that the electrical response of the heart to acute ischemic stress is not localized to the 
subendocardium, thus calling into doubt a major tenet of electrocardiography and the 
conventional explanation for primary ST segment depression.
Our choice of animal species follows the example of many past studies of ischemia and 
cardiac electrophysiology. Neither species is a perfect match to humans and so has strengths 
and weaknesses as an experimental model. Dogs have a conduction system more similar to 
that of humans [184], while it is the swine coronary vascular system that is more similar to 
that of humans [184]. The collateral circulation is more extensive in dogs compared to pigs, 
whereas the human collateral network falls somewhere between those two species [184]. 
Hence it is all the more meaningful that the results were consistent across both animal 
models, suggesting a fundamental mechanistic truth.
The study protocol was designed to simulate exercise testing or the very initial phase 
of a coronary spasm or myocardial infarct and thus focused on the most acute phase of 
ischemia. We designed the duration of ischemic episodes (2-10 minutes) to be within what 
is considered the reversible range [64], i.e., a level of insult from which the heart would 
recover fully in a short time. To allow sufficient recovery between ischemic episodes, we 
followed each ischemic episode by 25-30 minutes of recovery. Jennings et al. have shown 
that such a recovery period is enough to restore normal ATP production and achieve reversal 
of changes in cellular ultrastructure [64]. The use of plunge needle electrodes to record 
intramural potentials resulted in some tissue trauma, which resolved quickly with little 
myocardial scarring or LV dysfunction [185].
The findings of this study depend on the assumption that local shifts in extracellular ST 
segment potentials can be detected with sufficient spatial resolution and that they reflect 
nearby ischemia. While an indirect marker of what is fundamentally a perfusion deficit, 
intramural extracellular ST segment potentials have been shown to be a sensitive marker 
for ischemia [129, 150] and correlate well with regional blood flow [147] and local gas tension
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measurements [186]. Moreover, the spatial resolution of our intramural recordings was
1.5 mm along each needle and 10 mm between neighboring needles, thus enabling a precise 
enough identification of intramural ischemia at the several millimeter scale we measured it.
There is some evidence in the literature to support the possibility that ischemia would 
occur first in subendocardial zones. For example, some studies speculate that the subendo­
cardium is the region most vulnerable to ischemia due to transmural gradients in regional 
blood flow [187, 188, 189, 152], and others suggest the existence of intramyocardial pressure 
gradients [190, 191, 60] and greater metabolic stress [192, 64, 193]. Our results, however, 
do not support the resulting hypothesized consequences, none of which have actually been 
supported by measurements of three-dimensional parameters such as our studies describe.
Ours is not the only study to suggest heterogeneity of the ischemic response within 
the endocardium [139, 194, 85, 138, 195, 141, 196]. Steenbergen et al. [139] used NADH 
fluorescence photography in their rat model studies to show that ischemia produced by 
gradual reduction in coronary flow resulted in heterogeneous areas of anoxic tissue and 
attributed this response to intrinsic properties of arterioles. Gilmour et al. [85] studied the 
transmembrane potentials in a canine ischemia model to suggest that epicardial and papil­
lary muscle excitability is more easily depressed during ischemia compared to endocardium, 
which is more responsive due to contact with the Purkinje fibers that provide continued 
electrical stimulation. Wilensky et al. [138] investigated transmembrane potentials in a 
rabbit model and suggested that during the first 10 minutes of ischemia, an endocardium 
rim layer, 60 cells deep (approximately 600 ^), remains unaffected by ischemia and may be 
attributed to multiple factors including diffusion of oxygen and nutrients from the cavity, 
blood transport via luminal vessels towards the subendocardial tissue, electrical coupling 
with Purkinje fibers, and greater resistance of subendocardial cells to effects of hypoxia, 
elevated extracellular potassium, and acidosis. Austin et al. [141], based on measurements 
of canine regional blood flow, suggested spatial heterogeneity of myocardial perfusion within 
the endocardium, resulting in islands of viable subendocardial tissue due to differences 
in local metabolic demand secondary to differences in regional function. Leshnower et 
al. [196], in an irreversible ischemia study on sheep, found that the midmyocardium was 
most vulnerable to ischemia and the subendocardium was most resistant. Even if there 
remains uncertainly as to specific mechanisms, there is emerging agreement from our and 
other findings calling into doubt the prevailing notion that the onset of ischemia is limited to 
the subendocardium. Ours remains the first to measure the electric potentials responsible 
for the ECG and thus capture the consequences of acute ischemia that are likely to be
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clinically meaningful.
Our study suggests that acute ischemia arises throughout the myocardium, with no clear 
link between the type of ischemic insult and the location of electrocardiographic response. 
The experiment protocol was designed to induce reversible ischemic injury and measure 
localized ST segment potentials to determine the spatial distribution of early ischemia. 
Moreover, we benefited from the most detailed and comprehensive electrical measurements 
reported to date: a 247-electrode sock array to record epicardial potentials and up to 260 
needle electrodes to measure intramural potentials, thus providing a high degree of three­
dimensional spatial resolution. Additionally, the plunge needle electrodes were finer than 
previously available, creating less tissue injury, and therefore more sensitive measurements 
than possible in previous studies.
The clinical accuracy of the electrocardiogram (ECG) to detect and localize myocardial 
ischemia remains less than satisfactory [172], and our findings suggest possible mechanisms 
for this poor performance. ECG leads that show ST segment elevation provide a means of 
localizing transmural ischemia from the body surface and are a well-known clinical marker 
of infarction [197]. However, the ability of ST segment depression to locate ischemia is 
considerably less specific [179]. Acute ischemia studies with animal models have shown that 
even on the cardiac surface (epicardium), ST segment changes have poor sensitivity [150]. 
Our studies have shown that acute ischemia is not localized in the endocardium, rather, it 
arises throughout the myocardial wall. It is possible then that the superposition of these 
discrete ischemic sources may attenuate or neutralize resulting injury currents, limiting the 
ability of the epicardial electrograms to detect and localize nontransmural ischemia. Indeed, 
our data suggest that nontransmural ischemia is often undetected on the epicardial surface, 
especially using the ST segment as a marker. The consequences of this ambiguity on the 
body-surface ECG remain unexplored but are likely to be even less predictive than the more 
proximal and spatially resolved epicardial potentials.
4.6 Conclusion
In summary, our results suggest a complex electrocardiographic response to acute is­
chemia characterized by heterogeneous distribution of ST segment elevated regions across 
the myocardial wall. Understanding the spatial and temporal nature of these underlying 
bioelectric sources may provide future insights into ways to localize ischemia from the 
cardiac surface and may impact how we interpret potentials measured on the body surface. 
A possible approach we have also begun to evaluate successfully is to identify other electrical
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markers (T-wave, QRS complex, etc.) in combination with ST segment that could improve 
the ability to detect and localize the extent of myocardial injury [198]. At a minimum, the 
spatial heterogeneity of the ischemic response that we have documented suggests a need to 
refine the current electrocardiographic model of ischemia.
CHAPTER 5
SPATIO-TEMPORAL EVOLUTION OF 
ACUTE MYOCARDIAL ISCHEMIA
The goal of this study goal was to evaluate whether acute myocardial ischemia follows 
a pattern of spatial and temporal evolution similar to that seen in myocardial infarction. 
The following research has been submitted to the Journal of Electrocardiology.
5.1 Abstract
We hypothesize that the spatio-temporal evolution of acute myocardial ischemia is more 
complex than the wavefront phenomenon of ischemic cell death during myocardial infarction. 
The goal of these experiments was to investigate the spatio-temporal progression of ischemia- 
induced shifts in ST segment potentials during short episodes of acute ischemia.
We conducted acute ischemia studies in an open-chest canine model, by creating finely 
controlled demand or supply ischemic episodes, and recording intramyocardial and epi- 
cardial potentials. The shape and size of the ischemic regions were tracked and shape 
analysis done by computing singular value decomposition (SVD) to determine the direction 
of maximal variation. A chi-square test of goodness-of-fit was also performed to determine 
whether the three directions of expansion—circumferential, longitudinal, and radial—were 
equally preferred.
During the early stages of acute ischemia development, the multiple and distinct ischemic 
regions grew in all three directions (radial, circumferential, and longitudinal), with more 
rapid expansion in the circumferential direction (p < 0.05). With increased stress, these 
regions continued to grow and eventually merged into one another, in the extreme becoming 
transmural.
Our findings suggest that the spatial and temporal progression of acute myocardial 




Clinical performance of an electrocardiogram (ECG) to localize and detect the extent 
of myocardial ischemia remains less than satisfactory [172]. Myocardial ischemia occurs 
when the heart does not receive enough oxygen-rich blood to keep up with its metabolic 
requirements. Severe ischemia can lead to a heart attack and life-threatening arrhythmias 
so that early and accurate detection is an essential component of managing this condition. 
In the emergency room (ER), a resting 12-lead ECG is often recorded in patients with 
symptoms of angina (chest pain). However, the resting ECG is normal in up to 50% 
of the patients [1] with chronic stable angina. Moreover, myocardial ischemia occurs in 
approximately 70% of the patients [1] without angina. Exercise ECG stress testing (ET) 
has also been in widespread clinical use in the detection of myocardial ischemia. However, 
ET is characterized by poor sensitivity (68%) [1] and specificity (77%) [1], limiting its 
diagnostic efficacy.
The most common clinical ECG marker for myocardial ischemia detection is the ST 
segment. The changes in the ST segment can occur within 15-30 seconds after the onset of 
ischemia [173] and hence represent one of the earliest ECG markers of myocardial ischemia. 
The ST segment connects the QRS complex (ventricular depolarization) and the T-wave 
(ventricular repolarization) and represents the period when the ventricles are depolarized. It 
is isoelectric in a normal ECG. However, it can shift above (ST segment elevation) or below 
(ST segment depression) the baseline during myocardial ischemia depending on the flow 
of injury currents. These currents are the result of voltage gradients between normal and 
ischemic regions. In particular, the potential difference is caused by the electrical changes 
that occur in ischemic cells: localized shortening of action potential, diminishing amplitude 
of action potential, and a localized decrease in resting membrane potential. The resulting 
injury currents produce an ST segment elevation, if they are moving toward the recording 
electrode, and ST segment depression, if they are moving away from the electrode.
Classic electrocardiographic theory does not account for the clinical error rates. In 
clinical settings, ST segment elevation is closely related to the region of ischemia; however, 
ST segment depression’s ability to locate nontransmural ischemia remains unclear [179]. 
Ischemia is known to be a dynamic condition that reflects the changing imbalance between 
blood supply and metabolic demand. The literature suggests that cell death (necrosis) 
during a myocardial infarction progresses transmurally as a wavefront from the inner (en­
docardium) surface and towards the outer (epicardium) surface [9]. Our goal in this study 
was to evaluate whether acute myocardial ischemia follows a similar pattern of spatial and
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temporal evolution.
We hypothesized that ischemia progression is a more complex phenomenon than pre­
viously believed. To validate our hypothesis, we conducted a series of acute ischemia 
canine model studies under the assumption that localized ischemia causes localized ST 
segment changes. In particular, we measured three-dimensional surface and transmural 
potential distributions under study protocols that varied both local coronary supply and 
global metabolic demand.
5.3 Methods
5.3.1 E xperim en ta l P rep aration
The goal of these experiments was to investigate the spatio-temporal progression of 
ischemia-induced shifts in ST segment potentials during short episodes of ischemia created 
by reduced coronary flow and increased rate of contraction. To this end, we performed 
experiments on open-chest, intact canines using multipolar intramural needle electrodes 
and surface electrodes. This study was performed in 19 animals including 8 mongrel dogs 
and 11 purpose bred dogs, following approval from the Institutional Animal Care and 
Use Committee at University of Utah and conformed to Guide for the Care and Use of 
Laboratory Animals (NIH Pub. No 85-23, Revised 1996).
An open-chest preparation following midsternal thorocotomy allowed easy access to 
the heart for recording epicardial and transmural electrical potentials. The animal was 
anesthetized by bolus injection of isofluorane gas (1-3% inhalant to effect), followed by 
maintenance doses administered as needed. After the thorocotomy, the heart was suspended 
in the pericardial cradle. A suitable left anterior descending (LAD) segment was dissected 
and freed from the underlying tissue. The coronary flow was regulated using a hydraulic 
occluder (Access Technologies Inc) placed around the dissected segment of the left anterior 
descending artery. Calibration of the fluid volume injected enabled us to perform graded, 
reproducible reductions in coronary perfusion. A pacing clip was attached to the right 
atrial appendage to control heart rate. The animal was ventilated with room air mixed 
with oxygen, and regular monitoring of blood gas parameters and pH ensured adequate 
ventilation. Core temperature was continuously monitored and stabilized by a heated table, 
and the cavity temperature was monitored and maintained by insulating the open chest. 
A measurement of coronary flow and intrinsic heart rate at the start of each experiment 
determined default resting values.
The study protocol was designed to simulate two forms of acute ischemia: 1) Demand 
ischemia, as would arise, for example, during a stress test with pacing as a surrogate for
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exercise and 2) supply ischemia, through episodes of reduced coronary perfusion to simulate 
spasm or other transient reduction in coronary artery flow. It has been shown that tachy­
cardia increases oxygen demand and is unaffected by mode of tachycardia induction such 
as exercise or pacing [199]. To create demand ischemia, we progressively elevated metabolic 
demand (by reducing the pacing interval stepwise in 30-50 milliseconds increments) under 
stable (often below normal) perfusion conditions. Supply ischemia was induced by keeping 
the pacing rate constant (but often elevated) and decreasing the perfusion in steps of 25% 
of normal.
Fig. 5.1 contains a schematic of the animal preparation. The experiment setup including 
the cartoon of the hydraulic occluder, 247-electrode epicardial sock, and 25 plunge needles 
is shown in Panel A of the figure. An example study protocol (supply ischemia) can be seen 
in Panel B. Sample epicardial and intramural electrograms recorded during the experiments 
are shown in Panel C. The threshold for localized ST40% potential elevation is calculated 
as shown in Panel D.
Fig. 5.1. Experiment setup: (a) Experiment setup, (b) sample study protocol, (c) sample 
epicardial and intramural electrograms, (d) ischemia threshold based on localized ST40% 
potential.
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5.3.2 E xperim en ta l P ro to co ls  and D ata  A cqu isition
Each resulting ischemic episode was 8-10 minutes in duration depending on the protocol, 
the intrinsic values of the animal, and the maximum heart rates tolerated. Each experiment 
consisted of four to six such episodes and the recovery period (at intrinsic heart rates and 
perfusion) between episodes was approximately 25-30 minutes. Electrical recordings were 
taken for 3 seconds every 15 seconds during the ischemic episode, as well as during the 
recovery period.
Epicardial potentials were recorded from the surfaces of both ventricles using a 247- 
electrode flexible sock array [162]. In addition, 25 flexible fiberglass needles [163], each 
carrying 10 electrodes along its length spaced at approximately 1.5 mm, were inserted into 
the left ventricle (LV) in and around the region presumably perfused by the occluded LAD, 
taking care to avoid injuring the epicardial arteries. The spacing between needles within 
the epicardial region they covered did not exceed 1 cm. The perfused region was identified 
by stopping blood flow for 45 seconds and recording the resulting epicardial potentials. 
Localized ST segment elevations in the needle electrograms were considered indications of 
nearby ischemia. The potentials from sock and needle electrodes were recorded using a 
custom acquisition system [164] permitting simultaneous recordings of 1024 channels at
1 KHz sampling rate. A single limb lead was used as a remote reference for all the unipolar 
signals recorded from the sock and needle electrodes.
At the end of the experiment, the locations of preselected sock electrodes and all the 
plunge needles on the cardiac surface were digitally recorded using a Microscribe three­
dimensional digitizer (Microscribe Inc, Oella, Maryland). Interactive visualization of the 
resulting spatio-temporal maps of cardiac potentials was by means of SCIRun.
5.3.3 P ostexp erim en t Im aging and Signal P rocessin g
Following each experiment, the anatomical MRI scans of the excised heart were seg­
mented to identify the atria and ventricles using the Seg3D [165] program, and the segmen­
tations became the basis of a volumetric tetrahedral mesh created using BioMesh3D [168]. 
The digitized sock and needle electrodes were then registered to this mesh geometry and 
visualized in SCIRun. Visualization of the three-dimensional potential distributions within 
the heart in SCIRun required interpolation of the potential distribution for which we used 
a radial basis function (RBF) approximation.
The electrograms recorded during the study were processed in Matmap, a custom signal 
processing software. The signals were first calibrated and gain adjusted followed by baseline 
correction. Poor quality signals from sock and needle electrodes, perhaps due to bad contact,
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were discarded. Electrograms recorded from needle electrodes without positive Q-wave 
deflection were identified as cavity electrodes and also discarded. The global root mean 
squared (RMS) signal computed from the electrograms at all the sock and needle electrode 
were used to identify the J-point and T-peak time instants. The value of potentials at 40% 
of the ST segment between the J-point and the peak of the T-wave (ST40%) provided the 
metric for local ischemia.
To minimize the effects of signal noise, an average of 10 potential values around the 
ST40% was taken. In addition, to minimize beat to beat fluctuations, the average of 
ST40% of five consecutive beats was computed. A key step in the signal processing was 
determining the regions of the heart that showed electrical indications of ischemia. For 
this, we computed potential differences between ST segment potentials (ST40%) recording 
during each ischemic episode relative to immediately preischemia controls. We defined a 
threshold for ischemic ST segment elevations in the resulting difference maps as two standard 
deviations from control values.
5.3.4 Statistical A nalysis
Ischemic regions during an episode were characterized by local ST40% potentials ex­
ceeding the threshold value. The shape, size, and volume of these ischemic regions were 
tracked through the duration of the episode. Computing the singular value decomposition 
(SVD) of ischemic regions enabled us to determine the direction of maximal expansion.
Fig. 5.2 shows the SVD approach to the analysis of spatio-temporal progression of 
ischemia. The first column shows a representative heart with an initial ischemic region 
(blue) and the same ischemic region (red) expanded as a result of increased stress. The 
next three columns show the result of SVD on the two regions to identify the directions of 
the variation. The first singular vector correlates with the direction of maximal variation. 
The second and the third singular vectors map to the direction of the second and third 
most variation, respectively. For the sample case, the direction of maximal variation was 
circumferential, followed by longitudinal and then radial.
A chi-square test of goodness-of-fit was performed to determine whether the three 
directions of expansion—circumferential, longitudinal, and radial—were equally preferred. 
Statistical significance was set at alpha <0.05.
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Example of Ischemic First Singular Second Singular Third Singular
Region Expansion Vector Vector Vector
Ischemic Expanded Circumferential Longitudinal Radial
Region Ischemic Region Direction Direction Direction
Fig. 5.2. Singular value decomposition (SVD) of the ischemic region expansion into first, 
second, and third singular vectors.
5.4 Results
For this study, we conducted 19 experiments in which there were 100 episodes of supply
(50) and demand ischemia (50). All animals participated in the study. We show here 
representative data from supply ischemia and also demand ischemia experiments, depicting 
the spatial and temporal evolution of intramural and epicardial ST40% potential changes 
during acute ischemia.
Fig. 5.3 highlights data from one of the canine supply ischemia studies designed to 
induce graded reduction in LAD perfusion at a maintained heart rate of 171 BPM. The first 
row shows the subject-specific heart with location of plunge needle electrodes, the study 
protocol, and a table of the computed volumetric size of the ischemic regions at the specified 
instances (A, B, C, and D) during the ischemic episode. The threshold for epicardial and 
intramural markers was at 3 mV (ST40%), corresponding to two standard deviations from 
control conditions. The second row shows the volumetric (three-dimensional) intramural 
ST40% potential difference map and the plunge needle electrodes at control and at the 
corresponding time points, from which we computed the size of the intramural regions 
exceeding the ischemic threshold. The onset of ischemia when the perfusion was reduced to 
25% (A) was characterized by two distinct regions. With continued stress (B), these regions 
expanded in size in all three directions— circumferentially, radially, and longitudinally. 
Moreover, an additional region appeared. The shapes of the ischemic regions suggested 
faster expansion circumferentially relative to the other two directions. At time point C, the 
regions had not only further expanded but two of them had merged together. With increased 
stress (0% perfusion) at time point D, these regions merged to become one transmural
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Fig. 5.3. Canine supply ischemia: The first row displays the heart location, plunge needle 
locations, study protocol, and a table of computed volumetric size of ischemic regions. The 
second row shows the volumetric intramural ST40% potential difference map. The third 
row displays the surface intramural ST40% potential difference map. The fourth row shows 
the epicardial ST40% potential difference map.
region. The third row displays a sample slice in two dimensions (surface) of the intramural 
ST40% potential difference map corresponding to the described behavior. The fourth row 
shows the equivalent epicardial ST40% potential difference map. The transmural nature of 
ischemic regions is captured on the epicardial surface at time point D.
Fig. 5.4 highlights data from one of the canine demand ischemia studies designed to 
induce graded increased in heart rate at perfusion reduced to no flow. The first row shows 
the subject-specific heart with location of plunge needle electrodes, the study protocol, and a
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Fig. 5.4. Canine demand ischemia: The first row displays the heart location, plunge needle 
locations, study protocol, and a table of computed volumetric size of ischemic regions. The 
second row shows the volumetric intramural ST40% potential difference map. The third 
row displays the surface intramural ST40% potential difference map. The fourth row shows 
the epicardial ST40% potential difference map.
table of the computed volumetric size of the ischemic regions at the specified instances (A, B,
C, and D) during the ischemic episode. The threshold for epicardial and intramural markers 
was at 4 mV (ST40%), corresponding to two standard deviations from control conditions. 
The second row shows the volumetric (three-dimensional) intramural ST40% potential 
difference map and the plunge needle electrodes at control and at the corresponding time 
points. The onset of ischemia when the heart rate was increased to 160 BPM (A) was
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characterized by two distinct regions. With continued stress (B), these regions expanded 
in size in all three directions. With increased heart rate to 184 BPM at time point C and 
D, the regions had expanded and merged together. The third row displays a sample slice 
in two dimensions (surface) of the intramural ST40% potential difference map. The fourth 
row shows the corresponding epicardial ST40% potential difference map.
Fig. 5.5 displays the summary information from the 19 animal experiments. The bar 
graph represents three groups of ischemic regions based on their size (1000, 2000, or 
3000 mm3) and the direction of maximal expansion based on SVD analysis of their shapes. 
The right top panel shows the three directions, and the table below shows the results of 
the chi-square test of goodness-of-fit for each group. During the early stages of ischemia 
characterized by smaller ischemic regions, preference for the three directions was not equally 
distributed, with faster expansion seen circumferentially, X2 (2, N=19) =  8.00, p < 0.05.
5.5 Discussion
The aim of this study was to evaluate whether the spatio-temporal progression of acute 
ischemia was comparable to the transmural wavefront phenomenon seen in myocardial in­
farction. To that end, we conducted a series of acute ischemia in situ experiments on canines 
and characterized the resulting intramural and epicardial potentials. As seen in Fig. 5.3 and 
Fig. 5.4, we demonstrated that acute ischemia is characterized by multiple distinct regions 




Longitudinal Radial Circumferential 
Direction Direction Direction
Chi-square test of goodness-of-fit (DF = 2, N = 19)
2000 5.16 p > 0.05
3000 5.16 p > 0.05
1000 8.00 p < 0.05
1000 2000
Size of the Ischemic Region (mmA3)
★ p < 0.05
3000
Fig. 5.5. Study summary: The bar graph displays the summary results from the study. 
The right top panel shows the three directions of expansion. The table shows the results of 
chi-square test of goodness-of-fit.
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becoming transmural. Moreover, in the early stages, the expansion of ischemic regions is 
faster in the circumferential direction relative to the radial and longitudinal directions. The 
main finding of this study is that spatial and temporal progression of acute ischemia does 
not follow the pattern documented for myocardial infarction.
The findings of this study depend on the assumption that local shifts in extracellular ST 
segment potentials can be detected with sufficient spatial resolution and that they reflect the 
underlying ischemia. The intramural extracellular ST segment potentials have been shown 
to be a sensitive marker for ischemia and correlate well with regional blood flow [150, 147, 
186]. Moreover, with the spatial resolution of our intramural recordings, which was 1.5 mm 
along the axial direction (the recording needle shaft) and approximately 10 mm along the 
longitudinal direction (between adjacent needles), the resulting identification of intramural 
ischemia is precise enough for comparison with nearby epicardial potentials recorded from 
a high-resolution epicardial sock electrode.
To our knowledge, this is the first study to characterize the spatio-temporal progression 
of acute myocardial ischemia. Reimer et al., in their pioneering study on canine models, 
measured regional blood flow using microspheres and showed that irreversible ischemic in­
jury characterized by necrosis progresses as a transmural wavefront from subendocardium to 
epicardium. Other studies have also reported that ischemia is detected in the subendocardial 
zone earlier than on the epicardial surface [152, 187]. It would be reasonable to construe 
that myocardial ischemia would display similar spatio-temporal evolution as myocardial 
infarction, expanding radially from subendocardium towards the epicardium. Our results, 
however, do not support this interpretation as none of the studies have been supported by 
measurements of three-dimensional parameters such as our studies describe.
Our study suggests that spatio-temporal progression of acute ischemia is characterized 
by distinct regions that expand in all directions and with increased stress eventually merge to 
become transmural. Moreover, in the early stages of ischemia development, the expansion 
is more rapid in the circumferential direction. This behavior makes sense, if one takes 
the geometry of the myocytes into consideration. Cardiomyocytes have elongated shapes 
with a shorter width (10-40 microns) than length (50-200 microns) [22]. Thus, for the 
same number of ischemic myocytes stacked radially and circumferentially, the shape of 
the resulting ischemic region would be larger in the circumferential direction. During the 
later stages of development, these merge to become larger regions, and the resulting shapes 
along the longitudinal and circumferential directions suggest a possible correlation with 
the orientation of myocardial fibers. The more rapid expansion of ischemia along the
118
circumferential and longitudinal directions as opposed to radially could also be tied back to 
the anisotropic and syncytial nature of the cardiac tissue. Indeed, studies have shown that 
in both the intracellular space and the interstitial space, conductivity is higher along the 
fiber direction than in the transverse direction [200]. Although ischemia expansion in the 
radial direction has the shortest distance to cover to reach the epicardium, the electrical 
anisotropy of the cardiac tissue, myocardial fiber orientation, and the shape of the individual 
cardiomyocytes all appear to play a role in faster expansion in the other two directions.
Of critical importance is the question of how these results might translate to the body 
surface, where ST segment changes certainly arise during ischemia but have yet to be linked 
precisely to the degree of intramural ischemia, as in this study. The clinical model of myocar­
dial ischemia used for ECG-based diagnosis is tied to the expectation that spatio-temporal 
evolution of myocardial ischemia follows the myocardial infarction progression pattern. 
Our studies indicate that acute ischemia exhibits a more dynamic behavior with multiple 
ischemic regions across the ventricular wall that expand in all directions and eventually 
merge to become transmural. Thus, the current clinical model of ischemia may not be 
completely accurate and could be part of the problem with indeterminate results and false 
negatives routinely observed in the emergency room and during ET. We believe that the 
findings from this study may provide future insights into ways to localize ischemia from 
the cardiac surface and may impact how we interpret potentials measured on the body 
surface. A possible approach we have also begun to evaluate successfully is to identify other 
electrical markers (T-wave, QRS complex, etc.) in combination with the ST segment that 
could improve the ability to detect and localize the extent of myocardial injury [198].
5.6 Conclusion
In summary, our findings show that the spatial and temporal evolution of acute ischemia 
is characterized by multiple distinct regions that expand in all three directions, with max­
imal expansion in the circumferential direction, especially in the early stages of ischemic 
development. Furthermore, with increased stress, these regions continue to expand and 
eventually merge into one another, and in the extreme become transmural. These findings 
also point to the possibility of the combination of microvasculature distribution and cardiac 
fiber orientation affecting the shape, size, and location of the ischemic regions, a topic of 
ongoing research. In conclusion, the spatio-temporal progression of acute ischemia is a 
more complex phenomenon than previously believed and necessitates refining the current 
electrocardiographic model of ischemia.
CHAPTER 6
EPICARDIAL SENSITIVITY TO 
MYOCARDIAL ISCHEMIA
Our goal in this study was to evaluate whether electrical markers other than the ST 
segment changes are visible during acute ischemia and thus could improve diagnosis and 
localization. The following research was published in the Journal of Electrocardiology [198] 
and has been adapted for reprint with their permission.1
6.1 Abstract
We hypothesize that electrocardiographic measurements from the intramyocardial space 
contain more sensitive markers of ischemia than those detectable on the epicardium. The 
goal of this study was to evaluate different electrical markers for their potential to detect 
the earliest phases of acute myocardial ischemia.
We conducted acute ischemia studies in open-chest animals, by creating finely controlled 
demand or supply ischemic episodes and recording intramyocardial and epicardial poten­
tials.
Under the conditions of mild perfusion deficit, acute ischemia induced changes in the 
T-wave that were larger and could be detected earlier on the epicardial surface than ST 
segment changes.
Our findings indicate that in the setting of very acute ischemia, epicardial T-waves have 
higher sensitivity to mild degrees of acute ischemia than epicardial ST segment potentials. 
These results suggest that changes in the T-wave shape may augment shifts in ST segments 
to improve ECG-based localization of ischemia.
1Adapted from Journal of Electrocardiology, vol. 47(6), K. Aras, B. Burton, D. Swenson, and R. MacLeod, 




Despite a century of research and practice, the clinical accuracy of the electrocardiogram 
(ECG) to detect and localize myocardial ischemia remains less than satisfactory [172]. 
Myocardial ischemia occurs when the heart does not receive adequate oxygen-rich blood 
to keep up with its metabolic requirements, and severe ischemia can lead to myocardial 
infarction and life-threatening arrhythmias. Early and accurate detection is an essential 
component of managing this condition. Ischemia is known to be a dynamic condition 
that reflects a changing imbalance between blood supply and metabolic demand so that 
it is natural that examination under physical stress conditions or exercise testing (ET) is 
in widespread clinical use. However, ET is characterized by poor sensitivity (68%) and 
specificity (77%) [1], limiting its diagnostic usefulness.
The most common clinical ECG marker for myocardial ischemia detection is the ST 
segment, that portion of the ECG time signal that lies between the QRS and the T-wave. 
The ST segment represents approximately the period when the ventricles are depolarized, 
i.e., the ventricular action potentials are all in the plateau phase and in a healthy heart have 
approximately the same transmembrane potential. As a result, this phase is approximately 
isoelectric in a normal ECG. Changes in the ST segment arise in response to spatial 
heterogeneity of plateau potential and can occur within 15-30 seconds after the onset of 
ischemia [173], and hence are considered one of the earliest markers of the condition.
The mechanism for the ST segment potential shifting above (ST segment elevation) or 
below (ST segment depression) the baseline during myocardial ischemia is the flow of what 
are known as “injury currents.” These currents are the result of voltage gradients between 
normal and ischemic regions that occur because of reduced amplitude and duration of 
ischemia action potentials. Changes in the action potentials can affect not only the ST 
segments but also the morphology of other electrical features of the ECG including the 
QRS complex [201, 202] and the T-wave [203, 202].
ECG leads that show ST segment elevation are spatially linked to the region of ischemia 
and thus provide a means of localizing transmural ischemia from the body surface. However, 
the ability of ST segment depression to locate ischemia is considered much less specific [179, 
202]. ST segment depression is seen in patients with acute occlusion of the left circumflex 
artery (LCx) in leads V2-V3 and is an effect of ischemia in the free (postero) lateral wall. 
Moreover, patients with demand ischemia during exercise testing (ET) paradoxically show 
maximum ST segment depression in lead V5. Acute ischemia studies with animal models 
have shown that even on the cardiac surface (epicardium), ST segment changes have poor
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sensitivity [150]. Thus, the ST segment, by itself, is not a reliable index of ischemia.
Our goal in this study was to evaluate whether electrical markers other than the ST 
segment changes are visible during acute ischemia and thus could improve diagnosis and 
localization. To this end, we conducted a series of acute ischemia studies on animal models to 
measure epicardial surface and three-dimensional, transmural potential distributions while 
varying both local coronary supply and global metabolic demand.
6.3 Methods
6.3.1 E xperim en ta l P rep aration
The goal of these experiments was to evaluate ischemia-induced changes in epicardial 
electrical markers during the acute phase of short episodes of ischemia created by reduced 
coronary flow or increased heart rate. To this end, we performed experiments on 10 open- 
chest, intact swines using multipolar intramural needle electrodes and epicardial surface 
electrodes, following the approval of the Institutional Animal Care and Use Committee 
at University of Utah and conforming to the Guide for the Care and Use of Laboratory 
Animals (NIH Pub. No 85-23, Revised 1996).
An open-chest preparation following midsternal thorocotomy allowed direct access to 
the heart for recording epicardial and transmural electrical potentials. The animal was 
anesthetized by bolus injection of isofluorane gas (1-3% inhalant to effect), followed by 
maintenance doses administered as needed. After the thorocotomy, the heart was suspended 
in a pericardial cradle. A suitable left anterior descending (LAD) segment was then dissected 
and freed from the underlying tissue. The coronary flow was regulated using a hydraulic 
occluder (Access Technologies Inc) placed around the dissected segment of the left anterior 
descending artery. Calibration of the fluid volume injected enabled us to perform graded, 
reproducible reductions in coronary perfusion. The study protocol was designed to simulate 
two forms of acute ischemia: 1) Demand ischemia, as would arise, for example, during a 
stress test with pacing as a surrogate for exercise, and 2) supply ischemia, through episodes 
of reduced coronary perfusion to simulate spasm or other transient reduction in coronary 
artery flow. To create demand ischemia, we progressively elevated metabolic demand (by 
reducing pacing interval stepwise in 30-50 milliseconds increments) under stable (often 
below normal) perfusion conditions. Supply ischemia was induced by keeping the pacing 
rate constant (but often elevated) and decreasing the perfusion in steps of 25% of normal.
Fig. 6.1 contains a schematic of the animal preparation. The experiment setup including 
the cartoon of the hydraulic occluder, 247-epicardial electrode sock, and 25 plunge needles 
is shown in Panel A of the figure. An example study protocol (supply ischemia) can be seen
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Fig. 6.1. A schematic of the animal preparation. The experiment setup including the 
cartoon of the hydraulic occluder, 247-epicardial electrode sock and 25 plunge needles shown 
in Panel A of the figure. An example study protocol (supply ischemia) can be seen in 
Panel B. Sample epicardial and intramural electrograms recorded during the experiments 
are shown in Panel C. Panel D shows epicardial electrical markers extracted for analysis. 
The threshold for localized ST40% potential elevation is calculated as shown in Panel E.
in Panel B. Sample epicardial and intramural electrograms recorded during the experiments 
are shown in Panel C. Panel D shows epicardial electrical markers extracted for analysis. 
The threshold for localized ST40% potential elevation is calculated as shown in Panel E.
6 .3 .2  E xperim en ta l P ro to co ls  and D ata  A cqu isition
Each resulting ischemic episode was 8-10 minutes in duration depending on the protocol, 
the intrinsic values of the animal, and the maximum heart rates tolerated. Each experiment 
consisted of four to six such episodes and the recovery period (at intrinsic heart rates and 
perfusion) between episodes was approximately 25-30 minutes. Electrical recordings were 
taken for 3 seconds every 15 seconds during the ischemic episode, as well as during the 
recovery period.
Epicardial potentials were recorded from the surfaces of both ventricles using a 247- 
electrode flexible sock array [162]. In addition, 25 flexible fiberglass needles [163], each
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carrying 10 electrodes along its length spaced at approximately 1.5 mm, were inserted into 
the left ventricle (LV) in and around the region presumably perfused by the occluded LAD, 
taking care to avoid injuring the epicardial arteries. The spacing between needles within 
the epicardial region they covered did not exceed 1 cm. Localized ST segment elevations in 
the needle electrograms were considered indications of nearby ischemia and served as the 
gold standard for the presence and location of ischemic regions. The potentials from sock 
and needle electrodes were recorded using a custom acquisition system [164].
At the end of the experiment, the locations of preselected sock electrodes and all the 
plunge needles on the cardiac surface were digitally recorded using a Microscribe three­
dimensional digitizer (Microscribe Inc, Oella, Maryland). Interactive visualization of the 
resulting spatio-temporal maps of cardiac potentials was by means of SCIRun.
6 .3 .3  P ostexp erim en t Im aging and  Signal P rocessin g
Following each experiment, the anatomical MRI scans of the excised heart were seg­
mented to identify the atria and ventricles using the Seg3D [165] program, and the segmen­
tations became the basis of a volumetric tetrahedral mesh created using BioMesh3D [168]. 
The digitized sock and needle electrodes were then registered to this mesh geometry and 
visualized in SCIRun.
The global root mean squared (RMS) signal computed from the electrograms at all the 
sock and needle electrodes were used to identify the J-point and T-peak time instants. The 
value of potentials at 40% of the ST segment between the J-point and the peak of the 
T-wave (ST40%) provided the metric for local ischemia. The peak amplitude of the T-wave 
also served as a T-wave marker. Other markers evaluated in this study included the peak 
to peak amplitude of the QRS complex and the R-wave amplitudes.
A key step in the signal processing was determining the regions of the heart that showed 
electrical indications of ischemia. For this, we computed potential differences between ST 
segment potentials (ST40%) recording during each ischemic episode relative to immediately 
preischemia controls. We defined a threshold for ischemic ST segment elevations in the 
resulting difference maps as two standard deviations from control values.
6.3 .4  Statistical A nalysis
True positive (TP) was defined as the number of sock electrodes that correctly detected 
the underlying intramural ST segment potentials above a threshold. False negative (FN) 
was defined as the number of sock electrodes that identified the underlying intramural ST 
segment potentials above the threshold as normal. True negative (TN) was defined as
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the number of sock electrodes that correctly identified intramural ST segment potentials 
below the threshold. False positive (FP) was defined as the number of sock electrodes 
that identified the underlying intramural ST segment potentials below the threshold as 
ischemic. From these values, we computed sensitivity as (TP/(TP+FN )) and specificity as 
(TN/(TN+FP)) of the epicardial electrical markers.
The receiver operating characteristic (ROC) curves were calculated for the three epicar- 
dial markers: ST40%, T-wave, and R-wave. The area under the curve (AUC) was used as the 
metric for performance comparison. A one-way between subjects ANOVA was conducted 
with post hoc comparisons using the Tukey HSD (Honest Significance Difference) to evaluate 
the performance of ST40%, T-wave, and R-wave markers under demand ischemia, and 
supply ischemia conditions. Statistical significance was set at alpha <0.05.
6.4 Results
For this study, we conducted 10 experiments in which there were 44 episodes of supply
(22) and demand ischemia (22). All animals participated in the study, and we rejected 
data from 12 episodes because of animal preparation degradation during the course of 
the experiment, resulting in ischemia persisting at control conditions. We show here 
representative data from only the supply ischemia experiments, depicting the spatial and 
temporal progression of epicardial ST segment and T-wave changes during acute ischemia.
Fig. 6.2 highlights data from one of the swine ischemia studies designed to induce a 
graded decrease in LAD perfusion at a maintained heart rate of 172 BPM (supply ischemia).
The figure includes electrograms recorded from one plunge needle and the overlying 
epicardial sock electrode with the locations of the plunge needle and the sock electrode 
shown in Panel A. Panel B shows the study protocol, and Panel C shows examples of 
epicardial and intramural electrograms recorded at control and during an acute ischemia 
episode at the designated stages of perfusion deficit. At 75% perfusion (A), changes in 
the intramural electrograms included elevated and upright T-waves and to a smaller extent 
changes in the QRS and ST segment. On the epicardial surface, there were corresponding 
changes only in the T-wave, which became elevated and upright. At 50% reduction (B), 
there were additional, progressive changes in all markers from the intramural electrograms, 
whereas on the epicardial surface, the electrogram displayed only slightly elevated ST 
segments in addition to the progressively elevated T-wave. At 25% perfusion (C), the 
epicardial electrode displayed elevated R-wave, ST segment, and T-wave, matching trans­
mural ischemic conditions represented by the underlying plunge needle electrograms but 
delayed in their time of onset. Thus, the first changes seen anywhere on the epicardium
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Fig. 6.2. Data from one of the swine ischemia studies designed to induced graded decrease 
in LAD perfusion at a maintained heart rate of 172 BPM (supply ischemia). The figure 
includes electrograms recorded from one plunge needle and the overlying epicardial sock 
electrode with locations of the plunge needle and the sock electrode shown in Panel A. 
Panel B shows the study protocol while Panel C shows examples of epicardial and intramural 
electrograms recorded at control and during acute ischemia episode at the designated stages 
of perfusion deficit.
were in the T-waves, subsequently followed, under conditions of increased ischemic load, 
by corresponding ST segment and R-wave changes. This progression in the appearance of 
changes in electrograms was not dependent on time but rather on the extent of ischemia 
induced by progressive reduction in coronary perfusion levels.
Fig. 6.3 highlights data from the same swine study, and includes spatio-temporal pro­
gression for epicardial and intramural electrograms.
The locations of the sock and the plunge needle electrodes, as well as the study protocol 
are seen in Panel A. Panel B highlights the corresponding epicardial ST40% and T-wave 
potential difference maps at control and at different perfusion rates. The thresholds for the 
epicardial markers were 1.5 mV (ST40%) and 3 mV (T-wave), respectively, corresponding to 
two standard deviations from baseline conditions. At 75% perfusion (A), there was diffused 
epicardial ST segment elevation over the anterior apical region, but sharp T-wave elevation 
on the anterior apical and midregions. At 50% perfusion (B), there was a marked increase in 
the size of the elevated T-wave regions on the epicardial surface. Moreover, the ST segment 
potential map displayed the first sharply elevated regions in the mid— and apical region. At
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Fig. 6.3. Data from the same swine study, and spatio-temporal progression for epicardial 
and intramural electrograms. The locations of the sock and the plunge needle electrodes, 
as well as the study protocol are seen in Panel A. Panel B highlights the corresponding 
epicardial ST40% and T-wave potential difference maps at control and at different perfusion 
rates. The thresholds for epicardial markers were 1.5 mV (ST40%) and 3 mV (T-wave), 
respectively, corresponding to two standard deviations (SDs) from baseline conditions.
25% perfusion (C), there was a progressive increase in the elevated T-wave regions and to a 
lesser extent in the ST segment elevated regions on the epicardial surface. Panel C highlights 
the corresponding intramural ST40% and T-wave difference maps within the volume of the 
ventricle at the corresponding time points, from which it was possible to compute the size 
of the intramural regions exceeding the respective thresholds. There is a strong spatial 
correlation seen between the T-wave and ST segment potentials at the intramural level and 
also on the epicardial surface. Panel D displays the receiver operating characteristics (ROC) 
curves for the three most sensitive epicardial markers (ST40%, T-wave, R-wave) at 75% 
and 50% perfusion, relative to intramural ST segment elevations documented in Panel C. 
At 75% perfusion (mild acute ischemia), the epicardial T-wave marker consistently showed 
higher sensitivity at similar values of FPR, when compared to ST40% and R-wave epicardial 
markers. At 50% perfusion (moderate acute ischemia), the predictive value of epicardial 
T-wave and ST40% became comparable. Even so, the epicardial T-wave exhibited slightly 
higher sensitivity compared to ST40% at similar FPR values.
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Fig. 6.4 shows the statistical summary of the epicardial sensitivity of electrical markers 
to acute ischemia detection from the studies on 10 swine animals. To summarize all the 
supply ischemia episodes, under the conditions of mild perfusion deficit (>50% perfusion), 
the area under the ROC curve was 0.83 + /-  0.03 for the T-wave, 0.60 + /-  0.07 for the 
ST40%, and 0.55 + /-  0.01 for the R-wave, respectively. The T-wave performed better than 
both ST40% and R-wave (p < 0.05) under mild perfusion deficit conditions. There was no 
statistical significance in the performance of ST40% and T-wave markers under moderate 
and severe perfusion deficit conditions.
For all the demand ischemia episodes, under the conditions of moderately elevated heart 
rates (172 BPM), the area under the ROC curve was 0.85 + /-  0.02 for the T-wave, 0.56 + /-
0.04 for the ST40%, and 0.33 + /-  0.03 for the R-wave, respectively. The T-wave performed 
better than both ST40% and R-wave (p < 0.05) under both moderate (172 BPM) and high 
heart rate (200 BPM) demand ischemia conditions.
6.5 Discussion
The aim of this study was to evaluate the sensitivity and specificity of epicardial electrical 
markers of acute ischemia relative to markers derived from intramural electrograms. To that 
end, we conducted a series of acute ischemia in situ experiments on swines and profiled the 
resulting intramural and epicardial potentials. As seen in Fig. 6.2, Fig. 6.3, and Fig. 6.4 
we demonstrated that early in the development of acute ischemia, while the intramural 
electrograms were characterized by shortening of QRS potentials and elevation of T-wave 
and ST segment potentials, the corresponding epicardial electrograms showed changes only
ST40% T-wave R-wave ST40% T-wave R-wave
Mild (>50%) Moderate (25-50%) Severe (0%) 
Supply Ischemia
Moderate (172 BPM) High (200 BPM)
Demand Ischemia
Fig. 6.4. Statistical summary of epicardial electrical markers to acute ischemia detection 
from the studies on 10 swine animals.
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in the T-wave morphology. As the severity of acute ischemia increased, the epicardial 
electrograms eventually showed ST segment shifts and changes in the QRS morphology. 
The key finding from this study is that the epicardial T-wave is a more sensitive index of 
acute ischemia than epicardial ST segment changes, especially in the early stages of acute 
ischemia development.
The findings of this study depend on the assumption that local shifts in extracellular ST 
segment potentials can be detected with sufficient spatial resolution and that they reflect 
the underlying ischemia. Intramural extracellular ST segment potentials, an indirect marker 
of what is fundamentally a perfusion deficit, have been shown to be sensitive markers for 
ischemia and correlate well with regional blood flow [150]. Moreover, the spatial resolution 
of our intramural recordings, which was 1.5 mm along the axial direction (the recording 
needle shaft) and approximately 10 mm along the longitudinal direction (between adjacent 
needles), has never been achieved in any previously reported study to our knowledge. The 
resulting identification of intramural ischemia is therefore precise enough for comparison 
with nearby epicardial potentials recorded from a high-resolution epicardial sock electrode.
While our results are suggestive of new metrics for evaluating acute ischemia, they are 
based on epicardial and not body-surface potentials. Poor sensitivity of standard ECG 
stems, at least in part, from the fact that the magnitude of body surface potentials varies 
inversely with the distance between the recording leads and the heart [204]. Thus, the body 
surface electrodes, even those placed over the ischemic zone, would be expected to record 
lower ST segment deviation than cardiac surface electrodes placed near the ischemic area. 
The rational of our approach is that while good performance of an epicardial marker is 
no guarantee of similar results on the body surface, any useful body surface marker must 
perform at least as well on the epicardium. Moreover, an open-chest preparation, com­
bined with intramural measurements, provides unparalleled documentation of the electrical 
consequences of ischemia and thus a robust ground truth for any more remote marker.
Within this framework, our results show that, even on the epicardial surface, the ST 
segment by itself has poor sensitivity during the early development of acute ischemia 
that does not extend to the epicardial wall, i.e., nontransmural acute ischemia. Several 
other groups have described the limited sensitivity of the epicardial ST segment to acute 
ischemia [150, 189]. For example, Smith et al. [189] reported that epicardial ST segment 
elevation implied ischemic injury; however, lack of ST segment elevation did not exclude 
the possibility of ischemia being present. Our results are consistent with these reports 
and suggest that the epicardial ST segment has high specificity but low sensitivity to
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acute ischemia especially under mild perfusion (75%) deficit conditions. These results also 
suggest that performance based on body surface ECGs will likely be even worse under these 
conditions.
Previously described, ischemia-induced changes in the T-wave include the inverted T- 
wave turning shallow, flat, or upright [205]. These changes are attributed to shortening of 
the action potential duration in the ischemic cells, which reverses the direction of normal 
transmural potential gradients between the endocardium and the epicardium. Our results 
showed that the changes in epicardial T-waves were highly sensitive to low levels of acute 
ischemia. Moreover, the epicardial T-wave changes showed strong spatial correlation to 
ischemia-induced changes in the intramural T-wave and ST segment potentials. Miller et 
al. [206] have suggested that during repolarization (T-wave), the energy consuming process 
(N a+/K + -ATPase) required to restore resting potential of the cell is likely to suffer from 
ischemia-induced hypoxia. As a result, this phase of the action potential might be expected 
to be more sensitive than others to the reduction in perfusion and energy substrate supply. 
Our results support these studies.
Of critical importance is the question of how these results might translate to the body 
surface, where ST segment and T-wave changes certainly arise during ischemia but have 
yet to be linked precisely to the degree of intramural ischemia, as in this study. It should 
be noted that our studies were, by design, focused on the early development of ischemia as 
characterized by the degree of perfusion and on measurements performed during this very 
acute phase. This restriction may limit translation to the broad clinical setting, as patients 
with acute supply ischemia are not likely to have their ECG recorded during the first few 
minutes of the ischemic episode. However, during exercise testing or other acute ischemic 
events, e.g., during surgery, our findings are likely to be, once again, relevant.
6.6 Conclusions
In summary, our results show that in the setting of very acute ischemia, epicardial 
T-waves have higher sensitivity to mild degrees of acute ischemia than epicardial ST segment 
potentials. Epicardial QRS potentials show even less sensitivity to mild ischemia than the 
ST segments and thus are likely to have very limited ability to localize the spatial extent or 
degree of myocardial ischemia. These results suggest the possibility of combining epicardial 
ST segment and T-wave markers to provide a more reliable index of acute ischemia than 
either in isolation, a topic of ongoing research.
CHAPTER 7
CONCLUSIONS AND FUTURE WORK
The research goal of this project on bioelectric source characterization of acute my­
ocardial ischemia was to seek a better understanding of the electrical sources of ischemia. 
Motivation for this approach is the persistent lack of accuracy of current ECG based methods 
for ischemia evaluation. Rather than performing research on improved signal analysis or 
image reconstruction approaches our central goal was to capture with high spatial and 
temporal resolution the structure, location, organization and dynamic development of acute 
ischemia. Specifically, we asked three questions. First, where are these ischemic sources 
located? Second, how do they evolve? Third, how does the electrical data we collect relate 
to this ischemic sources? In this chapter, we summarize key findings and outline research 
ideas that could drive future research in this area.
7.1 Conclusions
Despite a century of research and practice, the clinical accuracy of the electrocardiogram 
(ECG) to detect and localize myocardial ischemia remains less than satisfactory [172]. 
Myocardial ischemia occurs when the heart does not receive adequate oxygen-rich blood 
to keep up with its metabolic requirements, and severe ischemia can lead to myocardial 
infarction and life-threatening arrhythmias. Early and accurate detection is an essential 
component of managing this condition.
The most common clinical ECG marker for myocardial ischemia detection is the ST 
segment, that portion of the ECG time signal that lies between the QRS complex and the 
T-wave. Changes in the ST segment can occur within 15-30 seconds after the onset of 
ischemia [173] and hence represent one of the earliest markers of the condition. The ST 
segment connects the QRS complex (ventricular depolarization) and the T-wave (ventricular 
repolarization) and represents the period when the ventricles are depolarized, i.e., the 
ventricular action potentials are all in the plateau phase and thus in a healthy heart have 
approximately the same transmembrane potential. As a result of the spatially homogeneous
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transmembrane potentials, this phase of the normal ECG is isoelectric. However, the ST 
segment potential can shift above (ST segment elevation) or below (ST segment depression) 
the baseline during myocardial ischemia depending on the flow of what are known as 
“injury currents.” These currents are the result of voltage gradients between normal 
and ischemic regions, gradients that arise because of changes that occur in the action 
potentials of ischemic cells: localized shortening, diminishing amplitude, and a decrease 
(more positive value) in resting membrane potential. The resulting injury currents can 
produce an ST segment elevation in an extracellular or body-surface electrode if they are 
directed toward the recording electrode or ST segment depression if they are directed away 
from the electrode.
Ischemia is known to be a dynamic condition that reflects a changing imbalance between 
blood supply and metabolic demand so that it is natural that examination under physical 
stress conditions or exercise testing (ET) is in widespread clinical use. However, ET is 
characterized by poor sensitivity (68%) and specificity (77%) [1], limiting its diagnostic 
usefulness and providing the motivation to address some gaps in our understanding of 
myocardial ischemia and its ECG signature. The goal of this research was to characterize the 
bioelectric sources of acute myocardial ischemia through a series of acute ischemia studies 
using high-resolution mapping of cardiac potentials on both canine and swine models.
The current literature suggests that myocardial ischemia originates from the subendo­
cardium. However, studies done in the past have relied on measurements primarily on the 
epicardial and endocardial surfaces. Moreover, intramural measurements have been limited 
by sparse spatial resolution. Despite widespread use, the link, especially quantitatively, 
between the direction and extent of ST segment shifts and the putative ischemia is equivocal 
and thus the cause of persistent clinical error.
The aim of the first study was to evaluate the conventionally held mechanisms for 
nontransmural ischemia using intramural electrodes to measure three-dimensional potential 
distributions in the ventricles of animals exposed to acute ischemia. To that end, we 
conducted a series of demand and supply ischemia in situ experiments on canine and swine 
models and profiled the resulting intramural and epicardial potentials.
We benefited from the most detailed and comprehensive electrical measurements re­
ported to date: a 247-electrode sock array to record epicardial potentials and up to 260 
needle electrodes to measure intramural potentials, thus providing a high degree of three­
dimensional spatial resolution. Additionally, the plunge needle electrodes were finer than 
previously available, creating less tissue injury and therefore more sensitive measurements
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compared to previous studies.
We demonstrated that the electrocardiographic response of acute myocardial ischemia 
originated throughout the ventricular wall, i.e., in the subendocardium, midmyocardium, or 
the subepicardium under various conditions. The most important finding from this study 
is that the electrical response of the heart to acute ischemic stress is not localized in the 
subendocardium. Nor is there a clear link between the type of ischemic insult and the 
location of electrocardiographic response.
Understanding the spatial and temporal nature of these underlying bioelectric sources 
may provide future insights into ways to localize ischemia from the cardiac surface and may 
impact how we interpret potentials measured on the body surface. At a minimum, the 
spatial heterogeneity of the ischemic response that we have documented suggests the need 
to refine the current electrocardiographic model of ischemia.
The results from the first study provided the motivation for the second study, which 
was to profile the spatio-temporal evolution of acute myocardial ischemia. The literature 
suggests that cell death (necrosis) during a myocardial infarction progresses transmurally 
as a wavefront from the inner (endocardium) surface and toward the outer (epicardium) 
surface [9].
Our goal in the second study was to evaluate whether acute myocardial ischemia follows 
a pattern of spatial and temporal evolution similar to that seen in myocardial infarction. 
To that end, we conducted a series of acute ischemia in situ experiments on canines and 
characterized the resulting intramural and epicardial potentials. Our findings show that the 
spatial and temporal evolution of acute ischemia is characterized by multiple distinct regions 
that expand in all three directions, with maximal expansion in the circumferential direction, 
especially in the early stages of ischemic development. Furthermore, with increased stress, 
these regions continue to expand and eventually merge into one another, and in the extreme 
become transmural. These findings also point to the possibility of the combination of 
microvasculature distribution and cardiac fiber orientation affecting the shape, size, and 
location of the ischemic regions.
The implication of our findings is that the clinical model of ischemia used for ECG-based 
diagnosis may not be completely accurate and could be part of the problem, resulting in 
indeterminate results and false negatives routinely observed in the emergency room and 
during ET. The data generated in this study strongly suggest that the spatio-temporal 
progression of acute myocardial ischemia is a complex phenomenon. Based on these findings, 
we suggest an alternative model of spatio-temporal evolution of acute myocardial ischemia,
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as shown in Fig. 7.1. We suggest that ischemia is not localized in the endocardium. 
Moreover, it is characterized by multiple regions distributed across the ventricular wall. 
These regions expand in all directions with increased stress. Moreover, they often merge 
together and in the extreme become transmural.
ECG leads that show ST segment elevation are spatially linked to the region of ischemia 
and thus provide a means of localizing transmural ischemia from the body surface. However, 
the ability of ST segment depression to locate ischemia is considered much less specific [203, 
206]. ST segment depression is seen in patients with acute occlusion of the left circumflex 
artery (LCx) in leads V2-V3 and is an effect of ischemia in the free (postero) lateral wall. 
Moreover, patients with demand ischemia during exercise testing (ET) paradoxically show 
maximum ST segment depression in lead V5. Acute ischemia studies with animal models 
have shown that even on the cardiac surface (epicardium), ST segment changes have poor 
sensitivity [179]. Thus, the ST segment, by itself, is not a reliable index of ischemia.
The aim of the third study was to evaluate the sensitivity and specificity of epicardial 
electrical markers of acute ischemia relative to markers derived from intramural electro­
grams. To that end, we conducted a series of acute ischemia in situ experiments on swines 
and profiled the resulting intramural and epicardial potentials. We demonstrated that early 
in the development of acute ischemia, while the intramural electrograms was characterized 
by shortening of QRS potentials and elevation of T-wave and ST segment potentials, the 
corresponding epicardial electrograms showed changes only in the T-wave morphology. As 
the severity of acute ischemia increased, the epicardial electrograms eventually showed ST 
segment shifts and changes in the QRS morphology. The key finding from this study is 
that the epicardial T-wave is a more sensitive index of acute ischemia than epicardial ST 
segment changes, especially in the early stages of acute ischemia development. Epicardial 
QRS potentials show even less sensitivity to mild ischemia than the ST segments and thus 
are likely to have a very limited ability to localize the spatial extent or degree of myocardial 
ischemia. These results suggest the possibility of combining epicardial ST segment and 
T-wave markers to provide a more reliable index of acute ischemia than either in isolation.
7.2 Future Work
This dissertation sought to understand the bioelectric sources of acute myocardial is­
chemia relative to how they arise, evolve, and manifest on the epicardial surface. The results 
from the three studies have provided new information that contributes to our knowledge 
of acute myocardial ischemia and its ECG signature. Even so, there is much we do not
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Fig. 7.1. Current and proposed model of acute myocardial ischemia. The proposed model 
suggests multiple ischemic regions distributed across the ventricular wall that expand in 
all three directions with increased stress. Moreover, they often merge together and in the 
extreme become transmural.
yet understand. In addition, the results from our studies have provoked new questions 
that merit further investigation. The following sections identify some of these questions 
and suggest potential studies that could help answer them. To achieve symmetry, we have 
organized the future work into three categories mapping to the three studies from the 
dissertation.
7.2.1 Spatial O rgan ization  o f  Ischem ia
The aim of the first study was to evaluate the conventionally held mechanisms for 
nontransmural ischemia originating in the subendocardial region. The most important 
finding from this study was that the electrical response of the heart to acute ischemic 
stress results in distributed ischemia arising throughout the myocardial wall. However, the 
biophysical basis for distributed ischemia remains a matter of speculation. In addition, 
ancillary research questions that merit further exploration are briefly described below.
7.2.1.1 D em and  Ischem ia V ersus S upply  Ischem ia
We conducted ischemia studies to simulate two forms of acute ischemia: a stress test 
with pacing as a surrogate for exercise, also called demand ischemia, and episodes of reduced 
coronary perfusion to simulate coronary artery disease, also called supply ischemia. Our 
research focused on understanding where the acute sources of ischemia arise when induced 
by demand or supply ischemia. An extension of this study would be to investigate if
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demand and supply ischemia interventions conducted on the same animal would produce 
acute ischemia in similar locations.
7 .2 .1 .2  Ischem ic P recon d ition in g
Myocardial preconditioning refers to the phenomenon where brief episodes of ischemia 
produce a cardioprotective response during a subsequent longer episode of ischemia [95]. 
Our studies were designed to repeat the study protocol multiple times (four to six episodes 
per animal). The upshot of this approach was the likely preconditioning effect on the heart 
from the first episode affecting subsequent episodes. Thus, an extension of this study would 
be to compare the size, shape, and location of ischemic regions produced during the first 
episode with subsequent episodes.
7.2 .1 .3  S tu dy P ro to c o l
Kroll et al. [145], using canine studies, demonstrated that ATP levels were better 
maintained during demand ischemia, when compared to supply ischemia and attributed 
the results to protective effect of adenosine and adrenergic stimulation. This suggests that 
the pathway taken to reach a specific level of stress, whether demand or supply ischemia, 
could affect the onset of acute ischemia. An extension to our study would be to induce a 
given level of stress (e.g., elevated heart rate and reduced perfusion) using supply or demand 
ischemia study protocols on the same animal to determine if the pathway to stress affects 
the shape, size, and locations of acute myocardial ischemia.
7.2 .1 .4  A b sen ce  o f  S T  Segm ent D epression  
on  the E picard iu m
A key finding from our study was the lack of epicardial ST segment depression to 
detect and localize nontransmural ischemia and suggests a complex and dynamic behavior 
of nontransmural bioelectric sources of ischemia. We used plunge needles to generate 
three-dimensional intramural surface maps. Moreover, since each plunge needle has 10 
electrodes along its length, we can reconstruct up 11 (including the epicardium) cardiac 
potential distribution surface maps. An extension of this study could include a stepwise 
forward problem simulation from intramural needle surface 1 to intramural needle surface
2 and so on until we reach the epicardium. This approach would in theory provide a more 
systematic method to simulating epicardial potentials from intramural ischemic sources.
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7.2.1 .5  P rim ary  S T  Segm ent D epression  
on  the E picard iu m
Kligfield [207] suggested that metabolic severity of acute myocardial ischemia may be the 
primary factor driving exercise-induced ST segment depression. Based on our studies, we 
were able to produce primary ST segment depression (ST segment depression not adjacent 
to ST segment elevation) on the epicardial surface only in cases of demand ischemia at 
rapid heart rates. This result suggests that ST segment depression during demand ischemia 
is driven largely by increasing voltage gradients across the ischemic boundary. Thus, an 
extension of this study would be to conduct a forward problem simulation that evaluates 
a range of voltage gradients across the ischemic boundary and the effect on the epicardial 
potential distribution.
7 .2 .1 .6  M ask ing E ffect o f  D istribu ted  
M yoca rd ia l Ischem ia
This research has focused on experimental evaluation of myocardial ischemia and its 
bioelectric sources. Based on our findings, we have suggested a refined source model of 
ischemia relative to its spatial organization and spatio-temporal evolution. In the future, 
this study could be augmented through computational modeling and simulation of ischemia 
using the proposed model. Specifically, an extension of this study could entail a forward 
problem simulation that compares a subendocardial ischemia source model to a distributed 
ischemia source model and determines whether the latter produces a masking effect on the 
resulting epicardial potential distribution.
7.2.2 S p atio -T em p ora l E volu tion  o f  Ischem ia
The goal in the second study was to evaluate whether acute myocardial ischemia fol­
lows a similar pattern of spatial and temporal evolution as seen in myocardial infarction. 
The results from this study demonstrated that the spatio-temporal progression of acute 
myocardial ischemia is a more complex phenomenon characterized by multiple distinct 
regions that expand in all three directions and eventually merge together and become 
transmural. However, the relationship between the shape, size, location, and expansion 
pattern of these ischemic regions and their correlation with the myocardial fiber orientation 
and microvasculature has not yet been explored and could be an interesting future research 
topic. We briefly describe the correlation studies.
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7.2.2.1 C orre la tion  S tu dy W ith  M yoca rd ia l F iber 
O rien tation  and M icrovascu la tu re
Based on our findings, we have suggested the possibility that the combination of mi­
crovasculature and the organization of cardiac fibers may also contribute to the more rapid 
expansion of ischemia along the circumferential and longitudinal directions as opposed to 
radially. Given that we can extract high-resolution, CT-based microvasculature images 
and DT-MRI-based organization of cardiac fibers, this idea could be further explored by 
doing a subject-specific qualitative and quantitative correlation study of cardiac fibers and 
microvasculature to the shape, size, location, and expansion of ischemic regions.
7.2.3 Sensitiv ity  o f  E lectrica l M arkers to  Ischem ia
The aim of the third study was to evaluate the sensitivity and specificity of epicardial 
electrical markers of acute myocardial ischemia. The key finding from this study was that 
the epicardial T-wave is a more sensitive index of acute ischemia than epicardial ST segment 
changes, especially in the early stages of acute ischemia development. Alternately, the ST 
segment remains a more specific marker to acute ischemia. These complementary strengths 
of the two markers suggest that a combination marker could potentially be a more reliable 
marker. In addition, there could be other temporal, integral, and potential difference 
markers that have not been evaluated and could be an interesting future research question. 
We describe a possible multivariate analysis approach to help answer these questions.
7.2.3.1 M ultivariate  A nalysis o f  S T  Segm ent and 
T -W a v e  M arkers
An extension of the study would be conduct a multivariate analysis of different electrical 
markers (e.g., ST segment, T-wave, R-wave, S-wave, QRS complex, QT interval, QRS 
duration, STT interval, QRS integral, STT integral, and QRST integral) using statistical 
tools such as linear discriminant analysis, stepwise linear regression, etc., to identify markers 
sensitive or specific to acute ischemia. A further exploration of this idea could include 
creating a weighted scorecard of these markers, with the weights assigned based on the 
respective sensitivity and specificity scores.
7.2.4 D esign  o f  E xperim ents
We have been able to conduct robust studies based on the technology available to 
us. Specifically, the use of plunge needles enabled us to produce high-resolution three­
dimensional intramural cardiac potential maps. In addition, with access to software tools 
from the SCI Institute, we were able to produce subject-specific spatial and functional
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cardiac surface and volume potential maps. Even so, there are ways we can augment our 
experimental designs to improve our understanding of the bioelectric sources of ischemia. 
We describe some of these suggested improvements below.
7.2.4.1 M icrosp h eres
The findings of this research depend on the assumption that local shifts in extracellular 
ST segment potentials can be detected with sufficient spatial resolution and that they reflect 
the underlying ischemia. Intramural extracellular ST segment potentials, an indirect marker 
of what is fundamentally a perfusion deficit, have been shown to be a sensitive marker for 
ischemia [129, 150] and correlate well with regional blood flow [147] and local gas tension 
measurements [186]. One way to augment this study would be to use fluorescent labeled 
microspheres, injected into coronary arteries to track regional blood flow deficits. This 
approach would complement our localized ST segment marker for ischemia. Microspheres 
traditionally have low spatial resolution (in the order of centimeters) but remain a trusted 
means of measuring perfusion.
7 .2 .4 .2  G eom etry  P rocessin g
The spatial resolution of our intramural recordings was 1.5 mm along the axial direction 
and 10 mm along the longitudinal direction, thus enabling a precise enough identification 
of intramural ischemia. The use of a three-dimensional Microscribe digitizer to digitally 
record the locations of preselected sock electrodes and plunge needles and subsequent 
registration to subject-specific mesh geometry has been basic to creating high-resolution 
three-dimensional and four-dimensional cardiac potential maps. The accuracy of the reg­
istration process was further improved by tracking the location of plunge needles from the 
anatomical MRI scans of the excised hearts and using it to register the digitally recorded 
electrode locations. Currently, there is variability from experiment to experiment, and it 
is possible to further improve the registration process and achieve higher precision and 
consistency across experiments. One possible approach to explore could be using depth 
cameras (e.g., Microsoft Kinect) that capture visual images (e.g., heart with sock and 
needle electrodes) along with per-pixel depth information and generate three-dimensional 
maps of the heart and electrode locations.
7 .2 .4 .3  E xperim en ta l Setup
The experimental preparations we have employed to study ischemia include use of a 
cannula or the hydraulic occluder. The cannulation technique allows for controlled perfusion
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of the heart by adjusting the rate of blood perfusate. However, the preparation can be tricky 
and can cause inadvertent tissue injury to the heart during the procedure. The use of a 
hydraulic occluder is a more convenient, less intensive, and relative injury-free procedure to 
achieve controlled perfusion. Although we have employed both techniques in the past, we 
migrated to using the hydraulic occluder for the majority of our experimental preparations. 
The calibration of fluid volume injected into the occluder allows for graded reductions in 
coronary perfusion. However, the regulation of perfusion using the occluder is less precise 
than using the cannulation technique as calibration of the fluid invariably includes air in the 
occluder that can never be completed removed. Thus, there are opportunities to improve 
upon the hydraulic occluder preparation. One likely approach is to employ a hydraulic 
pressure gauge to track cuff pressure and thus allow for occlusion at a definite cuff pressure 
in lieu of measuring the volume of the fluid injected into the occluder.
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